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Abstract 
 
In this thesis the synthesis of new mixed bidentate phosphine ligands and their 
application in selected enantioselective transformations is presented.  
Based on a phosphine-phosphoramidite lead structure, a modular synthetic pathway 
was used to synthesise different types of mixed bidentate phosphine ligands. 
Variation of the organic moiety at the amine or at the diol building block afforded 
three novel phosphine-phosphoramidites, while replacement of the diol by an 
aminoalcohol gave four different phosphine-phosphorodiamidites. Phosphine-
phosphorodiamidites are not known in literature so far and this is the first study on 
their synthesis, purification, stability and application in asymmetric catalysis. 
The application of these new structures as ligands in selected enantioselective 
transformations enabled a systematic study of the influence of variations in the lead 
structure on the behaviour in catalytic reactions. The novel phosphine-
phosphoramidites and -phosphorodiamidites were applied in different asymmetric 
hydrogenation reactions (C=C, C=N, C=O) using different active metal centres (Rh, Ir 
and Ru, respectively). In addition, the phosphine-phosphorodiamidites were applied 
in Rh-catalysed asymmetric hydroformylation and Pd-catalysed 
hydrophosphorylation.  
The results of the catalytic reactions prove a high versatility of the new structures and 
include one of the highest enantioselectivities for the hydrogenation of 2-substituted 
quinolines (using phosphine-phosphoramidites). Replacement of the diol bulding 
block in the phosphine-phosphoramidite lead structure by a diamine afforded the first 
phosphine-phosphortriamide ligand, whose application in enantioselective 
transformations needs to be explored in future research. 
 
 
 
 
 
 
 
  
 
 
 
 
Kurzbeschreibung 
 
 
Die vorliegende Doktorarbeit befasst sich mit der Synthese von gemischten 
bidentaten Phosphinliganden und deren Anwendung in ausgewählten 
asymmetrischen Transformationen.  
Ausgehend von einer bekannten Phosphin-Phosphoramiditstruktur wurde deren 
modularer Syntheseweg zur Herstellung unterschiedlicher Typen von gemischten 
bidentaten Phosphinliganden verwendet. Variation des Substituenten am Amin-, bzw. 
am Diol-Baustein lieferte drei neue Phosphin-Phosphoramiditliganden, während ein 
Austausch des Diols durch einen Aminoalkohol die Synthese vier verschiedener 
Phosphin-Phosphordiamidite ermöglichte. Da Phosphin-Phosphordiamidite in der 
Literatur bisher unbekannt sind, ist dieser Teil der Arbeit die erste Studie zu deren 
Synthese, Aufreinigung, Stabilität und Verwendung in der asymmetrischen Katalyse.  
Die Verwendung der neuen Strukturen als Liganden in ausgewählten 
enantioselektiven Reaktionen ermöglicht ausserdem eine systematische Studie des 
Einflusses von Strukturvariationen auf das Verhalten in katalytischen Reaktionen. 
Hierfür wurden die neu synthetisierten Phosphin-Phosphoramidite und –
phosphordiamidite unter Verwendung unterschiedlicher Übergangsmetalle (Rh, Ir, 
Ru) als Liganden in unterschiedlichen asymmetrischen Hydrierungen (C=C, C=N, 
C=O) getestet. Zusätzlich wurden die Phosphine-Phosphordiamidite in der 
asymmetrischen Rh-katalysierten Hydroformylierung und Pd- katalysierten 
Hydrophosphorylierung verwendet.  
Die Ergebnisse der Katalysen belegen eine hohe Vielseitigkeit der neuen 
Ligandstrukturen und beinhalten einen der höchsten Enantiomerenüberschüsse für 
die Hydrierung von 2-substituierten Chinolinen (unter Verwendung von Phosphin-
Phosphordiamiditen). Ein Austausch des Diolbausteins in der Phosphin-
Phosphoramiditleitstruktur gegen ein Diamin lieferte ausserdem den ersten bisher 
bekannten Phosphin-Phosphortriamidliganden, dessen Einsatz in der 
enantioselektiven Katalyse  noch für zukünftige Forschungsprojekte aussteht.  
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1 Introduction 1 
1  Introduction 
 
1.1  Chirality and asymmetric synthesis 
 
A chiral (optically active) molecule lacks an internal plane of symmetry and has a 
non-superimposable mirror image (Figure 1.1.1). These stereoisomers are called 
enantiomers and can differ in their biological activity.  
 
 
 
Figure 1.1.1: Central Chirality 
 
For instance, R-adrenaline is more active affecting bodily functions than S-
adrenaline.[1] In the case of carvone (2), the enantiomers have a completely diverse 
smell. S-carvone smells of caraway while R-carvone smells of spearmint.[2] Both 
enantiomers are used in food and flavour industry and therefore it is necessary to 
have them enantiomerically pure. Many pharmaceutical compounds are optically 
active molecules where one enantiomer provides the desired medical effect 
(eutomer) while the other one is not active or even very toxic (distomer).  
 
 
 
Figure 1.1.2: Adrenaline (1), carvone (2), thalidomide (3) 
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A well-known example is thalidomide (3), which was sold in racemic form as a 
drug against morning sickness during pregnancy by the German company 
Grünenthal (trade names: Contergan, Softenon). Indeed thalidomide had a sedative 
effect but unfortunately it also turned out to be highly teratogenic causing numerous 
birth defects (deformities). Further investigations showed that S-thalidomide was 
claimed to be responsible for the unwanted adverse reactions, but since the 
enantiomers of thalidomide quickly interconvert in vivo, this assumption is not 
completely proven.[3] Nevertheless, this incident forced the pharmaceutical industry to 
put more effort in exploring the diversity of enantiomers. Many countries prescribe 
that both enantiomers are to be tested separately to identify their (side-)effects. In 
general, there are three possible approaches to produce non-racemic molecules:[4,5] 
1. Racemic synthesis is followed by resolution-wise crystallisation, 
chromatography or chemical kinetics 
2. The desired product is obtained as a derivative of a readily available chiral 
substance from the natural “chiral pool” 
3. A prochiral molecule is converted selectively via a stereocontrolled (catalytic) 
transformation (asymmetric synthesis)[6] 
 
The first route is generally not very resource efficient since the unwanted 
enantiomer is 50% by-product at the beginning and the mixture always needs further 
purification. For some separations a costly chiral auxiliary[7,8] is needed in 
stoichiometric amounts. But for several components, a racemisation of the unwanted 
enantiomer or dynamic kinetic resolution methods can push the theoretical yield up to 
100 % making the process more atom-economical. Route 2 is limited to the naturally 
available chiral molecules as building blocks. That is why a lot of research in 
academia focusses on the development and improvement of asymmetric synthetic 
pathways. For an efficient asymmetric transformation a highly enantioselective chiral 
source is needed in catalytic amounts. This chiral source can be an organic molecule 
(organocatalysis[9]), a transition metal complex where chiral ligands are attached to 
the catalytically active metal atom,[10,11,12] an enzyme (biocatalysis[13,14,15]) or a chiral 
medium.[16,17,18,19]  
Particularly transition metal catalysts promote a large variety of asymmetric 
transformations like C-C bond forming reactions, hydrogenation of unsaturated bonds 
or oxidation reactions with high activity and enantioselectivity.[12] Despite numerous 
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efforts in academical research, the number of industrial applications remains 
limited,[20,21,22] since a lot of requirements need to be fulfilled. A “perfect” system is 
not only highly selective but also highly productive, stable, cost-efficient, easily 
available and environmentally-friendly. Nevertheless, there is a continuous growth in 
single-enantiomer drug sales[1] signifying a growing interest in developing pathways 
to enantiomerically pure compounds. Most of the asymmetric homogeneous 
processes in industry are hydrogenation reactions. 
 
 
1.2  Development of asymmetric homogeneous hydrogenation 
 
Asymmetric hydrogenation is one of the most important enantioselective 
processes used in industry.[21] It is a synthetic pathway to many enantiomerically pure 
compounds for pharmaceuticals, fragrance compounds or plant protection 
chemicals.[23] The first publication of a homogeneous (not yet asymmetic) 
hydrogenation was presented by Calvin in 1938 using copper acetate in a solution of 
quinoline.[24] Only one year later rhodium was introduced as an active metal for 
homogeneous hydrogenation by Iguchi.[25] A lot of systems nowadays consist of a 
transition metal atom coordinated by taylor-made ligands for specific reactions. 
Within the constantly rising number of ligands, phosphorus ligands took over a 
significant role in the development of asymmetric hydrogenation reactions right from 
the beginning.[26]  
One of the most distinguished studies on the mechanism of homogeneous 
hydrogenation of alkenes was done during the 1960s by the groups of Halpern and 
Wilkinson on the Rh/PPh3 catalytic system.[27] According to these studies, a 
hydrogenation catalysed by “Wilkinson’s catalyst” follows a cycle (Scheme 1.2.1) 
starting with the dissociation of a phosphine ligand (A). The formed 14-electron 
species consecutively undergoes an oxidative addition with H2 (B) and an attachment 
of the alkene (C). The rate determining step is the insertion of the alkene into the 
metal-H bond (D). After a trans  cis rearrangement (E), a reductive elimination (F) 
generates the desired product regenerating the active catalytic species. 
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Scheme 1.2.1: Mechanism by Wilkinson & Halpern[27] 
 
The “Wilkinson catalyst” was the basis for the idea of using chiral phosphine 
ligands to induce enantioselectivity. During the late 1960s, Mislow,[28] Knowles[29] and 
Horner[30] did pioneering research on monodentate tertiary phosphines featuring 
chirality directly at the phosphorus, but mainly achieved low enantioselectivities. In 
1971, an important break-through was made by Kagan and Dang with the 
development of the tartaric acid-derived bidentate ligand DIOP (1).[31,32] 
 
 
 
Figure.: 1.2.1: Bidentate phosphine ligand DIOP (4) 
 
In this bisphosphine the chiral information is no longer located at the phosphorus 
atom itself but at carbon atoms in the backbone structure. This leads to significantly 
more variable structures. In the hydrogenation of acetamidocynnamic and 
phenylacetamidoacrylic acid enantioselectivities up to 68% were induced by 4. Due 
to these results it was believed that a rigid bidentate ligand structure is necessary to 
induce high ees. Therefore, most research was focused on the development of 
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bidentate phosphine ligands during the following years.[26] Very important was the 
establishment of an industrial process for the production of L-DOPA (7, anti 
Parkinson’s desease) by Knowles et al.[33] 
 
 
 
 
Scheme 1.2.2: Synthesis of L-DOPA (7) 
 
The key step in this process is the enantioselective hydrogenation of a prochiral 
dehydroaminoacid 5 (Scheme 1.2.2). Using a [Rh(COD)(DIPAMP)]BF4 complex 
enantioselectivities up to 95% were achieved. Another milestone in the development 
of chiral phosphorus-based ligands for asymmetric transformations was reported in 
1980 by Noyori and Takaya: BINAP[34] (9, Figure 1.2.2). This ligand was applied in a 
lot of different catalytic reactions inducing high enantioselectivities and is therefore 
known to be a “priviledged ligand”.[35] Since then, many ligands have been reported 
that feature an axially chiral backbone moiety.[36,37,38,39] Also successfully used for a 
broad variety of substrates are DuPHOS (10) and BPE (11) by Burk et al. (Figure 
1.2.2).[40,41] 
 
 
 
 
Figure 1.2.2: Bisphosphine ligands BINAP (9), DuPHOS (10) and BPE (11) 
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Another industrial application of great importance is the production of the 
herbicide (S)-metholachlor (14) developed by the company Novartis in 1999 (Scheme 
1.3).[42] Xyliphos is used as a ligand for the asymmetric key step – an iridium 
catalysed enantioselective hydrogenation of an enamide (12). 
 
 
 
Scheme 1.2.3: Synthesis of S-metolachlor (14) 
 
A relatively low enantiomeric excess of ca 80% is achieved but due to an extremely 
high  TOF and TON this is still acceptable for this type of application. 
Since 1999 monodentate phosphorous ligands have come back into the focus of 
research. In hydrogenation studies of α-dehydroaminoacid esters, 
enantioselectivities of more than 92% could be induced by phophoramidites,[43] 
phosphites[44] or phosphonites[45] (Figure 1.2.3). The use of two equivalents of the 
monodentate species was even more effective than one equivalent of the 
corresponding bridged ligand. These results clearly show that a rigid bidentate 
chelating structure is not mandatory to achieve high enantiomeric excesses.  
 
 
 
Figure 1.2.3: Monodentate phosphorus ligands 
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Apart from simple phosphorous ligands, countless investigations in mixed ligands 
containing additional N- or O-donor atoms have been reported. For example, P,N 
ligands[46] are a very important type of structures for asymmetric hydrogenation 
reactions. A well-known and successfully applied system is the combination of iridium 
and phosphino oxazolines by Pfaltz et al.[47] Complex 19 was used for a broad pool of 
substrates inducing high enantioselectivities >99%. 
 
N
O
(R2)2P
R1
Ir
19
 
 
Figure 1.2.4: Phosphino oxazoline system (Ir) 
 
A combinatorial approach of de Vries et al. applied successful monodentate chiral 
phosphine ligands (like phosphoramidites) together with simple phosphines (like 
PPh3) in one catalytic reaction.[48] This approach enables the induction of electronic 
asymmetry via two different phosphorus donor atoms while using monodentate 
ligands. This combination of a phosphine group with a heteroatom-substituted 
phosphorous moiety is well established in bidentate ligands. Over the last three 
decades, a lot of different mixed bidentate phosphine ligands have been reported. 
 
 
1.3  Mixed bidentate phosphine ligands[36] 
 
Although a lot of chiral ligands prepared for asymmetric catalysis are C2-
symmetrical diphosphines, mixed bidentate phosphine ligands – where a phosphine 
group is combined with a heteroatom-substituted phosphorous moiety – are the 
ligands of choice for an increasing number of applications. In many cases they are 
easier to prepare than bisphosphines and are available via highly modular synthetic 
pathways, that also opens the possibility to produce ligand libraries. Bearing two 
different phosphorus donor atoms, they are able to generate electronic asymmetry on 
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the catalytically active metal atom and often induce high enantioselectivities. A 
selection of the most common mixed bidentate phosphine ligands described in 
literature will be presented in the following part of this chapter. A structural  overview 
is shown in figure 1.3.1. 
 
 
 
 
Figure 1.3.1: General structures for typical mixed bidentate phosphorus ligands 
 
 
Phosphine-aminophosphines, which have one nitrogen and two carbon 
substituents at the heterophosphorous moiety, are rather underrepresented in use for 
asymmetric catalysis.  
 
 
 
 
Figure 1.3.2: Selected phosphine-aminophosphines 
 
Fe PPh2
N
R
PAr2
20 21
N
Ph2P
Ph2P
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The first phosphine-aminophosphine ligand (20) reported in literature is a proline-
derived species complexed with palladium that was not explored in catalysis. In 2002, 
Boaz and co-workers presented ligands (example: 21) containing planar and central 
chirality that were synthesised from enantiomerically pure N,N-1-
dimethylaminoethyl(2diphenylphosphino)ferrocene in a two-step synthesis that is 
shown in scheme 1.3.1. They were successfully used in the Rh-catalysed asymmetric 
hydrogenation of C=C bonds.[49,50]  
 
 
 
 
Scheme 1.3.1: Synthesis of phosphine-aminophosphine 21 
 
This system was remarkably air-stable but has a narrow substrate scope. Due to 
its air-stability Barnard et al. developed an immobilised version anchored on carbon 
in 2005.[51] Attached to ruthenium, the same type of ligands was applied in the 
asymmetric hydrogenation of ß-keto esters achieving ees up to 94%.[52] With the 
introduction of a fluorinated moiety in this structure, Chan et al. created an effective 
and water/air stable system for the asymmetric hydrogenation of enamides and 
dehydro-aminoacids.[53] 
Phosphine-phosphinites have a heterophosphorous moiety with one P-O and two 
P-C bonds. Typically, they are synthesised by the coupling of a hydroxy-phosphine 
intermediate with a chlorodiarylphosphine in the presence of a base as shown in 
scheme 1.3.2. 
  
 
Scheme 1.3.2: Synthesis of a phosphine-phosphinite 
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Since several molecules from the chiral pool have hydroxy groups, they are often 
used as readily accessible building blocks for this type of synthesis. The first 
phosphine-phosphinite containing a bicyclic moiety was published by Brunner et al. in 
1980 (22).[54] More recently structures based on binaphthyl (23)l[55] or ferrocenyl 
(24)[56] backbones have been published.  
 
 
Figure 1.3.3: Phosphine-phosphinites - structure and examples 
 
There are much less successful applications of phosphine-phosphinites in 
catalysis compared to applications of the corresponding phosphite species that are 
synthesised in an analogous way. Apart from classical hydrogenation and 
hydroformylation reactions of selected substrates, where the best results were 
obtained by the binaphthyl- and ferrocene-based phosphine-phosphinites, only tests 
in allylic substitution reactions with low enantioselectivities were reported.  
Phosphine-phosphonite ligands contain a heterophosphorous moiety with one P-
C and two P-O bond. Apart from some publications on their synthesis there is only 
one paper that also involves their use in asymmetric catalysis. Reetz and Gosberg 
produced a set of structures within a three-step synthesis from o-dibenzyl bromide 
(Scheme 1.3.3).  
 
 
Scheme 1.3.3: Synthesis of phosphine-phosphonites by Reetz and Gosberg 
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These ligands showed moderate enantiomeric excesses up to 88 % (induced by 25) 
in the Rh-catalysed hydrogenation of dimethyl itaconate.[57] 
 
 
Figure 1.3.4: Example for a phosphine-phosphonite 
 
Phosphine-Phosphites possess a heterophosphine moiety that contains three P-O 
bonds. Since Takaya[58] and Pringle[59] simultaneously reported the first examples of 
enantiopure phosphine-phosphites, a lot of different structures have been published 
in literature. Most of them follow the same synthetic route coupling a  phosphine that 
includes a hydroxy-function with a chlorophosphite. Scheme 1.3.4 exemplarily shows 
the synthesis of Takaya’s (R,S)-BINAPHOS (26).[58] 
 
 
 
 
Scheme 1.3.4: Synthesis of (R,S)-BINAPHOS (26) 
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BINAPHOS is one of the most extensively studied ligands in enantioselective 
catalysis. The ligand was successfully applied in various asymmetric transformations 
(especially in hydroformylation)[60] and is therefore a “privileged chiral ligand”.[35] 
Surprisingly, its high efficiency in asymmetric hydrogenation was revealed ony fairly 
recently. 
 
O
Ph2P
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O
O
O
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O
26
Fe PPh2
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P
O
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27
 
Figure 1.3.5: Selected phosphine-phosphites 
 
An alternative synthetic pathway to new phosphine-phosphites, reported mainly 
by van Leeuwen,[61] Vidal-Ferran[62] and Bakos,[63] combines enantiomerically pure 
epoxides and nucleophilic phosphorus-containing reagents. Chan and Yeung 
introduced phosphine-phosphites containing a ferrocene moiety (27). Although this 
type of bidentate mixed phosphine ligands was successfully applied for many 
different asymmetric transformations (conjugate addition, allylic substitution, etc.), 
most publications still report results in hydrogenation or hydroformylation.  
Because of it’s outstanding catalytic properties, a lot of published structures in this 
field are related to (R,S)-BINAPHOS.[64] Most common variations include substitution 
or partial hydrogenation of one or both of the binaphthyl moieties or replacement of 
the linker between the phosphorus units by a similar skeleton. More recently, new 
phosphine-phosphites have also been synthesised in a multi-step reaction using 
building blocks from the chiral pool (example: 28).[65] 
Phosphine-phosphoramidites have two P-O and one P-N bond and are 
electronically similar to the corresponding phosphites. However, they differ a lot in 
their steric demand because the nitrogen atom is trisubstituted. Since the first 
phosphine-phosphoramidite (29, QUINAPHOS[66]) was reported in 2000 by Franciò, 
Leitner and Faraone, a lot of different structures have been published.  
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Figure 1.3.6: Selected phosphine-phosphoramidites 
 
In Crévisi’s review[67] they are divided into four classes based on their amine 
moiety: Cyclic amines, ferrocene-amine, benzyl/aryl-amines and chiral-pool 
diphenylphosphino-amines. Reek’s classification[68] is based on the linker unit 
between phosphine and phosphoramidite: a rigid cyclic amine (class 1), rigid 
(bi)cyclic moiety (class 2) or a flexible chain containing at least one non-cyclic sp3-
hybridised carbon atom (class 3). In general there are two classical ways to 
synthesise a phosphine-phosphoramidite: The reaction of a prepared phosphine-
amine with A) a chlorophosphite or B) with phosphorus trichloride followed by a 
reaction with a diol. Most phosphine-phosphoramidites are available via pathways 
that only differ from these common routes in small details. For example, in the 
synthesis of Quinaphos (29) the lithium organyl is not only used as a base but also as 
a building-block providing a substituent to the structure (Scheme 2.1.2).[66] 
 
 
Scheme 1.3.5: Synthesis of Quinaphos 
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A structure that is synthesised in a different sequence is a bisphosphine-
phosphoramidite (34) published by Zhang and coworkers in 2006 (Scheme 
2.1.3).[69,70] To create this bisphosphine-phosphoramidite structure, a readily 
prepared bisphosphine-diol (35) is treated with HMPT or HETP, respectively.  
 
 
 
 
Scheme 1.3.6: Synthesis of 34 
 
Most phosphine-phosphoramidites are used for asymmetric hydrogenation of 
C=C bonds and show good to excellent results for various substrates.[71] For 
example, Me-Anilaphos (33) by Börner et al. is able to induce up to 98 % ee in the 
hydrogenation of acetamidocinnamate.[72] Some of the ligands were also successfully 
applied in the hydrogenation of C=N or C=O bonds, or hydroformylation reactions. So 
far, 30 is known as the best ligand for the hydroformylation of styrene, being even 
superior to (R,S)–BINAPHOS.[73] One phosphine-phosphoramidite was tested in a 
Cu-catalysed conjugated addition of diethylzinc to enones, but gave just moderate 
enantiomeric excess.[74] Recently, Eggenstein presented a phosphine-
phosphoramidite structure in his PhD thesis that is based on Me-Anilaphos bearing 
an additional stereocentre at the amine moiety and applied it successfully in various 
asymmetric hydrogenations.[75] The synthetic route of this ligand is very modular and 
therefore bears a high potential for structural variations. 
Other mixed bidentate phosphorus ligand structures that logically follow along the 
line of heteroatom substitution are for example phosphine-phosphorodiamidites or 
phosphine-phosphortriamides (Figure 1.3.7).  
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Figure 1.3.7:  Possible types of mixed bidentate phosphorus ligands 
 
Syntheses or applications of these ligand structures have not been reported in 
literature yet, so that the potential of these ligand-classes in catalytic reactions is 
completely unexplored. 
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1.4  Research objective 
 
Aim of this thesis is the synthesis of new mixed bidentate phosphine ligands and 
their application in asymmetric catalysis. Because of its modular synthetic pathway 
and good results in asymmetric hydrogenation phosphine-phosphoramidite 36[75] is 
used as the lead structure. Modifications of this structure will be investigated to 
explore the variability of the established synthetic pathway and the influence on 
applications in catalytic reactions.  
 
 
 
Figure 1.4.1: Possible variations of 36 leading to new phosphine-phosphoramidites 
 
Figure 1.4.1 shows aspired variations of 36 that lead to new phosphine-
phosphoramidites wich will be the first main topic of this thesis. To vary the 
phosphine-amine moiety, new phosphine-amines have to be prepared as building-
blocks that can be tested in the synthetic route of 36. Another interesting modification 
of the general structure that leads to a new phophine-phosphoramidite is the 
utilisation of other diols.  
An exchange of the diol moiety at the phosphoramidite leads to different types of 
mixed bidentate phosphine ligands (Figure 1.4.2). Since phosphine-
phosphorodiamidite and -phosphortriamide structures are unknown in literature the 
synthesis of those types will be the second key issue of this thesis. Therefore, the 
diol will be replaced by an aminoalcohol or a diamine following the same general 
synthetic pathway. 
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Figure 1.4.2: Variations of 36 leading to new types of mixed bidentate phosphine ligands 
 
The performance of all new ligands in asymmetric homogeneous catalyses needs 
to be tested and compared. They will be benchmarked in hydrogenations of C=C, 
C=N, or C=O bonds, since 36 was successfully used for these types of 
transformations. The newly synthesised phosphine-phosphorodiamidites will also be 
tested in other asymmetric transformations like hydrophosphorylation or 
hydroformylation. 
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2  Results & Discussion 
 
2.1  General routes for the synthesis of phosphine-phosphoramidites 
 
The synthesis of phosphine-phosphoramidites usually consists of consecutive 
reactions that combine different building blocks in a modular way.[36] As already 
mentioned in the introduction, the last step in such a synthetic route usually is the 
reaction of a readily prepared phosphine-amine with A) a chlorophosphite or B) with 
phosphorus trichloride followed by a reaction with a diol. These possible synthetic 
pathways are shown in scheme 2.2.1 exemplified by routes to 36. 
 
 
 
Scheme 2.1.1: General synthetic pathways to 36 
 
 
The synthesis of 36 has been demonstrated to be possible via route A.[75] Thus, a 
solution of phosphine-amine 37 is treated with n-butyllithium in the presence of 
TMEDA at -78˚C and a solution of chlorophosphite 38 is consecutively added to the 
mixture. To vary the substituent at the amine moiety, the first aim of the thesis will be 
the synthesis of alternative phosphine-amines. 
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2.2 Synthesis of phosphine-amines 
 
The synthesis of new phosphine-amines was carried out according to the 
procedure used for the preparation of phosphine-amine 37.[76,77] A chiral primary 
amine was coupled via a palladium-catalysed Buchwald-Hartwig amination with 1-
bromo-2-fluorobenzene (Scheme 2.2.1).  
 
 
 
Scheme 2.2.1: General synthetic route of phosphine-amines  
 
This coupling reaction is selective towards the bromo substituent, so that the 
obtained product is a fluorinated secondary amine. After extraction with DCM the 
product was purified via column chromatography.  
 
 
 
Figure 2.2.1: Synthesised secondary amines 
 
 
To produce a small library of building blocks six chiral amines were converted into 
fluorinated secondary amines (Figure 2.2.1). The yields of the purified product vary 
from 37-93 % depending on the amine. 
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These secondary amines are all air-stable solids or liquids. Under inert 
atmosphere they could be converted into the corresponding air-sensitive phosphine-
amines (Scheme 2.2.1, B) by stirring under reflux with potassium diphenylphosphite 
in 1,4-dioxane. The product was extracted with DCM and purified via filtration over 
basic alumina and precipitation. The products (Figure 2.2.2) were obtained as solids 
or highly viscous oils in reasonable yields (32-77%). 
 
 
 
Figure 2.2.2: Synthesised phosphine-amines 
 
 
The phosphine-amines are all water-stable but air-sensitive. Neither compounds 48-
52 nor their corresponding fluorinated amines 42-46 have been reported in literature 
prior to this work (Scifinder, February 2011).  
 
2.3 Synthesis of new phosphine-phosphoramidites 
 
The first coupling experiments to obtain new phosphine-phosphoramidites were 
performed under the same conditions as for the synthesis of 36 (Scheme 2.3.1).[75] 
Under argon the phosphine-amine was stirred with n-butyl lithium and TMEDA in THF 
for 2 h at –87 °C to form the lithium amide. TMEDA was added for the disaggregation 
of n-butyl lithium to induce higher conversions. Consecutively, a THF solution of the 
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PCl-species 38[71] was added to obtain the desired phosphine-phosphoramidite and 
LiCl as a byproduct.  
H
N
PPh2
R*
TMEDA, n-BuLi
THF/toluene
O
O
P N
R*
Ph2P
O
O
PCl
O
O
PCl
O
O
PCl = O
O
PCl
;
S-38 R-38
 
 
Scheme 2.3.1: Synthesis of phosphine-phosphoramidites 
 
 
After 16 h of stirring at room temperature the conversion was monitored via 31P-
NMR analysis. Every newly synthesised phosphine-amine was tested in the coupling 
with S-38 and R-38 in THF and additionally in toluene. The results are shown in table 
2.3.1. Equivalent experiments using NEt3 as a base instead of n-butyllithium/TMEDA 
at 0°C showed no conversion to phosphine-phosphoramidites for all phosphine-
amines.  
 
Table 2.3.1: Results of coupling experimentsa) 
entry phosphine-amine 
coupling (THF) 
R/S 
coupling (toluene) 
R/S 
purification 
1 48 -/- -/- n.d. 
2 49 -/+ +/+ +/+ 
3 50 -/- -/- n.d. 
4 51 +/+ +/+ -/- 
5 52 -/- -/- n.d. 
a) 0.5 mmol phosphine-amine, 1.2 eq TMEDA, 1 eq n-BuLi, 1.1 eq enantiomerically 
                   pure 4-chlorodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine, 10 mL + 5mL solvent, -78 °C 
               + = successful  - = not successful 
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The coupling experiments of phosphine-amines 48, 50 and 52 with both PCl-
species showed no traces of phosphine-phosphoramidite. For 49, the reaction with S-
38 was successful in toluene and THF while the reaction with R-38 only proceeded in 
toluene. The coupling of 51 with R-38 and S-38 was successful in both solvents. The 
chemical shifts of the obtained phosphine-phosphoramidites were detected between 
-15 and -18 ppm for Pphosphine and 135 - 140 ppm for NPO2P . The synthesis was 
repeated several times and usually high conversions (80-95%) were obtained. 
However, 31P-NMR analysis always showed a signal of unconverted phosphine-
amine around -18 to -20 ppm and small signals around 40 ppm due to oxidised 
species, such as oxidised starting material. Possible causes for impurities and 
differences in  conversion, that can be excluded are the water content of the 
components (checked by Karl-Fischer titration) and a variation of the concentration of 
n-butyl lithium stock solution (checked by titration with 2,2-diphenylacetic acid).  
Since the desired phosphine-phosphoramidites are sensitive towards air and 
moisture, purification must also be performed under inert conditions. First, the crude 
product was dissolved in toluene to remove LiCl (unsoluble in toluene) via filtration. 
The filtration was done over a small patch of degassed and dried basic alumina to 
remove oxidised materials at the same time. Even though oxidised materials and LiCl 
were successfully removed, it turned out to be important to use a small amount of 
basic alumina (column: Ø~ 3cm, h~3-4cm), because the P-N bond of the 
phosphoramidite unit in 49 and 51 tends to cleavage being flushed over this material. 
This decomposition was observed by 31P-NMR analysis before and after filtration. 
Therefore the resonances’ integrations of the phosphine-amine (substrate) and the 
phosphine-phosphoramidite (product) were compared. This decomposition excludes 
column chromatography where larger amounts of alumina would have been 
necessary. The phosphoramidite unit of 49 and 51 was even more sensitive towards 
silica, so that the usage of that must be excluded as well. To completely avoid 
cleavage of the P-N bond, LiCl can also be removed via filtration through a PTFE 
membrane. A disadvantage of this method is that other impurities like oxidised 
materials or rests of unconverted phosphine-amine are not removed at the same 
time. 
For separation of the phosphine-phosphoramidite from remaining impurities 
(mainly phosphine-amine) different recrystallisation or precipitation methods with 
different solvent combinations were tested. The phosphine-phosphoramidites based 
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on phosphine-amine 51 could not be purified by any of the tested methods. Both 
phosphine-phosphoramidites based on phosphine-amine 49 could be purified via 
precipitation from toluene with ethanol and were obtained in analytically pure form.  
 
 
 
 
Figure 2.3.1: Analytically pure phosphine-phosphoramidites  
 
 
After one precipitation L1 and L2 were obtained with a purity of 86 % (L1, yield: 66 
%) and 94 % (L2, yield: 44 %). Purer material was obtained via a second 
precipitation at the expense of the isolated yield (L1: 5 %; L2: 7 %).  
 
 
 
 
                     
31P-NMR of L1           31P-NMR of L2 
 
Figure 2.3.2:  31P-NMR spectra of L1 and L2 
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Another desired variation of 36 is a phosphine-phosphoramidite with an 
alternative diol building-block. Particularly interesting is the usage of a partially 
hydrogenated BINOL (53) species instead of the normal BINOL (54) since this 
exchange is known to give higher enantiomeric excesses in many cases.[78] 
Therefore, commercially available S-BINOL was hydrogenated at 100 °C and 80-90 
bar of hydrogen using palladium on charcoal as catalyst (Scheme 2.3.2).[79]  
 
 
 
 
 
Scheme 2.3.2: Synthesis of H8-BINOL-PCl compound (55) 
 
 
PCl-compound 55 could be obtained by refluxing 53 with PCl3 in toluene. After 
removing the excess of PCl3 under reduced pressure, 55 was obtained as a white-
yellowish powder that could be used directly in the next step. In a coupling 
experiment under the same conditions that were used to synthesise L1 and L2, PCl-
compound 55 reacted with the lithiated phosphine-amine 47 (Scheme 2.3.3). 31P-
NMR analysis showed high conversion to the desired phosphine-phosphoramidite 
L3, which could be purified via filtration and precipitation from toluene with ethanol. In 
contrast to the compounds with non-hydrogenated BINOL backbones, L3 is also 
soluble in n-pentane.  
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Scheme 2.3.3: Synthesis of L3 and 31P-NMR analysis 
 
 
31P-NMR data of L1-L3 showed that the resonances for Pphosphine and NPO2P  were 
observed at chemical shifts that are typical for phosphine-phosphoramidites (Table 
2.3.2). The 31P-NMR spectrum of phosphine-phosphoramidite L1 shows two broad 
singlets, which were also observed in the the spectrum of 36. This line broadening 
may be due to hindered rotation within the molecule. Molecules L2 and L3 already 
show two different rotamers (listed as major and minor) at room temperature. The 
rotamers of L2 show a ratio of 1.3:1 and give broad doublet for both Pphosphine and 
NPO2P . The coupling constant *JPP of the major rotamer is ca. twice as high as the one 
for the minor rotamer. L3 shows a broad singlet for Pphosphine and two sharp 
overlaping singlets for NPO2P . The partially hydrogenated backbone of L3 results in a 
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slight upfield shift (~136 ppm) for the NPO2P  compared to the aromatic BINOL 
backbone (~140 ppm). The ratio of rotameric isomers for L3 and L2  are very similar 
(1.26:1 vs. 1.3:1).  
 
 
Table 2.3.2: 31P-{1H}-NMR-shifts and coupling constants of synthesised 
 phosphine-phosphoramiditesa) 
entry compound ppm/Pphosphineδ  mult. ppm/P NPO2δ  mult. Hz/J PP−  
1b 36 -17.1 b 140.1 b - 
2 L1 - 17.2 b 138.4 b - 
3 L2 
maj: - 19.4 d 140.3 d 32.1 
min: - 17.1 d 141.8 d 16.4 
4 L3 -17.1 b 
maj: 136.2 s - 
min: 135.9 s - 
           a) measurements at room temperature in CD2Cl2  
 b) data of M.Eggenstein 
 
 
2.4 Rh-complexes of phosphine-phosphoramidites 
 
The synthesis of transition metal complexes can be used to support the 
assumption that different rotamers of one molecule are the cause for line broadening 
in NMR analysis. The coordination to a transition metal should “freeze” the rotation 
and sharp signals should be observed. Rhodium is the transition metal of choice for 
complexation of ligand L1-L3, since its rhodium complex can be used as a readily 
preformed species for catalytic reactions. Former results showed that the preformed 
metal complex of 36 induced slightly higher enantiomeric excesses in the asymmetric 
hydrogenation of C=C bonds than a complex produced in situ.[75]  
A convenient synthesis for rhodium complexes of bidentate phosphorus ligands 
starts from [Rh(acac)(COD)] (Scheme 2.4.1). The rhodium precursor is stirred with 
HNTf2 in ethanol to protonate the acetyl acetonato ligand in order to get two free 
coordination sites. The obtained complex is stabilised by coordinating solvent 
molecules. In contrast to [Rh(acac)(COD)], the [Rh(EtOH)2(COD)] species is soluble 
in ethanol and the formation of a clear yellow solution indicates that the reaction is 
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complete. Adding the phosphine-phosphoramidite the solution turns from yellow to 
orange while the desired complex is formed.  
 
 
 
 
Scheme 2.4.1: Synthesis of Rh-phosphine-phosphoramidite-complexes 
 
 
Upon removal of the solvent, the desired complex was obtained as an orange solid 
that was purified via precipitation from THF/Et2O or DCM/pentane. Rhodium 
complexes with a NTf2- counter ion of all newly synthesised phosphine-
phosphoramidites and 36 were prepared (Figure 2.4.1). 
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Figure 2.4.1: Structure of Rh-complexes 56-59 
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Ligand chelation to the transition metal is confirmed by a huge shift of both 
phosphorus signals in NMR analysis (Table 2.4.1). For the obtained rhodium 
complexes, the resonances for Pphosphine and NPO2P  were observed between 13-22 
ppm and 135-150 ppm, respectively. While a free ligand molecule can assume 
different conformations, coordination to a metal atom blocks this interconversion even 
at room temperature. Due to the more fixed structure, sharp signals in NMR analysis 
should be obtained. For 56-59, both phosphorus signals are indeed sharp doublets of 
doublets. The P-P coupling constants of the complexes (JPP ≈ 60 Hz) are twice 
compared to the free ligands.  
 
Table 2.4.1: 31P-{1H}-NMR shifts of [Rh(COD)(PP*)][NTf2] complexesa) 
entry compound 
ppm/Pphosphineδ
( Hz/J RhP− ) 
mult. 
ppm/P NPO2δ
( Hz/J RhP− ) 
mult. Hz/J PP−  
1 56 21.5 (136.4) dd 136.4 (249.3) dd 61.2 
2 57 13.4 (135.1) dd 149.6 (237.7) dd 67.5 
3 58 14.3 (141.1) dd 141.1 (242.9) dd 58.7 
4 59 15.0 (142.0) dd 135.4 (236.6) dd 61.1 
a) measurements at room temperature in CD2Cl2,  
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2.5 Phosphine-phosphoramidites in asymmetric hydrogenation reactions 
 
Apart from applications in hydroformylation reactions[80] and few applications in 
conjugate additions on enones[81] and Pd-catalysed allylic alkylations[82], phosphine-
phosphoramidite ligands were still most often very successfully applied in asymmetric 
hydrogenations.[83,84]  
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Figure 2.5.1: Selected phosphine-phosphoramidites used for hydrogenation 
 
 
Common benchmark substrates such as dimethyl itaconate (dmi) and methyl-2-
acetamidoacrylate (maa) can be hydrogenated by phosphine-phosphoramidites with 
ees up to 96-99% (Figure and table 2.5.1).[85] 
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Table 2.5.1: dmi hydrogenation results of phosphine-phosphoramiditesa 
entry ligand (config. binol) pH2 (bar) ee (%) 
1 Quinaphos (R) 30 99 R 
2 IndolPhos (S) 10 98 S 
3b 39 (R) 1 99 R 
4 THNAPhos (R) 10 99 R 
5 Me-AnilaPhos (R) 1 96 R 
6 36 (S) 10 99 S 
7 31 (S) 10 99 S 
8 PEAPhos (S) 10 99 nd 
                            a)Rh/L ≤ 1:1.1, Rh/substrate ≤ 1:100, 25 °C, DCM, ≤ 24h  
                            using [Rh(nbd)2]BF4 or [Rh(COD)2]BF4; b) solvent:trifluoroethanol 
 
The first phosphine-phosphoramidite, Quinaphos, was also tested in the Ru-
catalysed hydrogenation of ketones inducing ees up to 94%.[66,86] IndolPhos has 
been tested in the hydrogenation of dmi, maa, α-dehydroamino acid esters, β-
dehydroamino acid esters, 2-hydroxymethylacrylates, arylenamines, α-enamido and 
α-enol phosphonates and cinnamic acid derivatives also inducing  high enantiomeric 
excesses.[87,88] Ligand 39 developed by Zhang gave ees up to 99% in the 
hydrogenation of arylenamides, dehydroamino acid esters and itaconic acid 
derivatives.[69,70] TNHAPhos by the group of Zheng is also very successful in the Rh-
catalysed hydrogenation of various prochiral olefins including α-enol phosphonates, 
dehydroamino acids, arylenamides, hydroxymethylacrylates and α-dehydroamino 
acid esters.[89,90] Ees up to 99.9% were obtained for a broad range of stubstrates 
including β-dehydroamino acid esters using ligand 31 developed by  the groups of 
Chang and Zheng.[91] Also developed by Zheng, PEAPhos was evaluated in the 
hydrogenation of α-dehydroamino acid esters, arylenamides and dmi.[92]  
Since 36 has successfully been applied in the asymmetric hydrogenation of 
olefins, β-ketoesters and quinolines,[75] the synthesised ligands L1-L3 were also 
tested in these types of reaction (see chapters 2.5.1-3). A comparison of the results 
between 36 and L1-L3 can show the influence of different structural characteristics 
on activity and enantioselectivity of the catalyst.  
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2.5.1 Rh-catalysed hydrogenation of C=C bonds 
 
As a first benchmark reaction the new phosphine-phosphoramidites L1-L3 were 
used in the asymmetric homogeneous hydrogenation of dimethyl itaconate (Scheme 
2.5.1.1). For this reaction, preformed Rh-complexes 57-59 were applied in a 
substrate/catalyst ratio of 1000:1 in a stainless steel autoclave with glass inlet at 
room temperature in DCM with 10 bar of hydrogen.  
 
 
 
 
Scheme 2.5.1.1: Asymmetric hydrogenation of dmi 
 
After a reaction time of 1 h the conversion and enantiomeric excess were determined 
(Table 2.5.1.1). All three newly synthesised ligands showed full conversion and 
therefore turn over frequencies are estimated to exceed on ≥ 1000 h-1. 
 
Table 2.5.1.1: Hydrogenation of dmi - resultsa) 
entry ligand ee (%) TOF (h-1) 
1b) 36 >99 S ≥1000 
2 L1 >99 S ≥1000 
3 L2 94 R ≥1000 
4 L3 >99 S ≥1000 
                            a) 1 mmol S, S/Rh = 1000:1, 2 mL DCM, 1h, pH2 = 10 bar, RT, conversion >99% 
                            b) data: [75]; BF4--counter anion 
 
Phosphine-phosphoramidite L1 – where the phenyl substituent is replaced by a 
naphthyl rest compared to 36 – induced the same high enantioselectivity as 36 
(>99% S). Hydrogenation using L2 (the diastereomer of L1) shows that the axial 
configuration of the BINOL backbone is mainly responsible for the configuration of 
the product. Changing from an Sa- to an Ra-configurated BINOL moiety, the 
configuration of the produced dimethyl-2-methylsuccinate also changes from S to R 
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with a slightly lower enantiomeric excess of 94 % R. Thus, the two distinct chiral 
elements of the structure (axial chirality at the BINOL backbone and chirality at the 
amine moiety) result in a matched or in a miss-matched fashion and the combination 
of Sa,Sc leads to higher enantioselectivities than the combination of Ra,Sc. Changing 
the BINOL-backbone into a partially hydrogenated H8-BINOL-moiety does not show a 
significant effect. By achieving full conversion and >99% ee for the S-configurated 
product, the application of ligand L3 is as successful as 36 and L1. 
To broaden the substrate scope, ligands L1-L3 were applied in the hydrogenation 
of methyl 2-acetamidoacrylate (maa) and (E)-methyl 2-acetamido-3-phenylacrylate 
(mapa) (Scheme 2.5.1.2). 
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Scheme 2.5.1.2: Asymmetric hydrogenation of maa and mapa 
 
 
Hydrogenation of α-dehydroamino acid esters maa and mapa was performed 
using the preformed Rh-complexes under the same conditions as the hydrogenation 
of dmi. Within one hour, full conversion (TOF≥1000 h-1) and high enantioselectivities 
were achived in all cases (Table 2.5.1.2).  
  
Table 2.5.1.2: Hydrogenation of maa and mapa - resultsa) 
entry ligand substrate ee (%) TOF (h-1) 
1b) 36 maa 99 R ≥1000 
2 L1 maa 98 R ≥1000 
3 L2 maa 96 S ≥1000 
4 L3 maa 98 R ≥1000 
5b) 36 mapa 99 R ≥1000 
6 L1 mapa 97 R ≥1000 
7 L2 mapa 97 S ≥1000 
8 L3 mapa 99 R ≥1000 
                            a) 1 mmol S, S/Rh = 1000:1, 2 mL DCM, 1h, pH2 = 10 bar, RT, conversion: >99% 
                            b) Data: [75]; BF4--counter anion 
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Again a chiral switch of the product’s conformation depending on the conformation of 
the BINOL backbone and a minor match/miss-match effect of the ligand’s chiral 
elements were observed. 
Another interesting substrate for asymmetric hydrogenation is 3,3,3-trifluoroprop-
1-en-2-yl acetate (fpa) (Scheme 2.5.1.3). A derivative of the hydrogenated chiral form 
of fpa is known to be an important building block for an active pharmaceutical drug 
used for the treatment of neurological and neuropsychiatric disorders.[93]  
 
 
 
 
Scheme 2.5.1.3: Asymmetric hydrogenation of fpa 
 
 
Since the product is very volatile, dichloromethane can not be used as a solvent 
because it would interfere with the standard work-up procedure and GC analysis that 
has been used for dmi, maa and mapa. Therefore, these catalytic reactions with fpa 
were performed without any solvent, dissolving the preformed Rh-complex in neat 
substrate. For 0.5 mL of substrate a hydrogen pressure of 15 bar was used at room 
temperature for 1 h. 1H-NMR spectra, taken directly from the reaction mixture 
showed full conversion for every tested catalyst. 
 
Table 2.5.1.3: Hydrogenation of fpa - resultsa) 
entry ligand ee (%) TOF (h-1) 
1 L1 98 R ≥1000 
2 L2 95 S ≥1000 
3 L3 >99 R ≥1000 
                            a) 3.9 mmol S, S/Rh = 1000:1, 1h, pH2 = 15 bar, RT, conversion >99% 
 
Enantiomeric excess was measured by GC analysis directly from the gas phase 
above the mixture without any work-up. For the hydrogenation of fpa excellent 
enantioselectivities were achieved (Table 2.5.1.3). The dependence of the chiral 
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outcome of the reaction on the BINOL backbone conformation was also observed in 
this case. The highest enantiomeric excess (>99% R) was achieved with ligand L3.  
In summary, all new phosphine-phosphoramidites gave full conversion after 1 h and 
induced high enantiomeric excess for every tested substrate showing excellent 
potential for asymmetric C=C hydrogenation reactions. The diastereomers L1 and L2 
show that the conformation of the BINOL backbone has the strongest influence on 
the chiral outcome of the reaction. 
To gain more precise information of the initial catalyst activity, further experiments 
were carried out at higher substrate to catalyst ratio by monitoring the hydrogen 
consumption. A substrate to catalyst ratio of 5000:1 and a slightly increased 
hydrogen starting pressure (15 bar at t0) were used at a constant temperature of 20 
°C. The hydrogen pressure over time was monitored and plotted using labview 
software. Figures 2.5.1.1-3 show the obtained pressure curves for the reactions with 
complexes 57 (L1), 58 (L2) and 59 (L3), respectively.  
The characteristics of the three curves are very similar and are typical for a 
homogeneous hydrogenation with a prelocated equilibrium (Bodenstein kinetics).[94] 
At the beginning of the reaction the hydrogen pressure decreases in a linear fashion 
and reaction order seems to be pseudo n = 1. The concentration of the active 
species can be considered as quasi-stationary since the concentration of the 
substrate is very high.  
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Figure 2.5.1.1 Hydrogen consumption, hydrogenation of dmi using 57 
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Figure 2.5.1.2 Hydrogen consumption, hydrogenation of dmi using 58 
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Figure 2.5.1.3 Hydrogen consumption, hydrogenation of dmi using 59 
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Figure 2.5.1.4 Hydrogen consumption, hydrogenation of dmi using 56 
 
At higher conversion (lower substrate concentration), the hydrogen pressure 
decreases exponentially. The point in time where hydrogen pressure becomes stable 
is defined as 100% conversion (verified via GC analysis). The observation, that 
achieved stable hydrogen pressures vary from two to five bar should be taken into 
account for the estimation of accuracy of this method. Therefore, a qualitative 
comparison of the results can be made but further investigation is necessary to 
achieve quantitatively reliable results.  
 
Table 2.5.1.4: TOF-,  TOFinit ., T50 and T100 of kinetic experiments 1-4a) 
entry complex TOF /h-1 
TOFinit. /h-1 calculated at 
                   (min) 
T50 
(h) 
T100 
(h) 
1 57 1250 3333 18.00 0.83 4.00 
2 58 1250 2789 17.75 0.98 4.00 
3 59 972 2673 19.08 0.70 5.14 
4 56 1859 1946 18.50 1.08 2.69 
a) TOF = n(substrate)/{n(catalyst)*h} at 100 % conversion 
         TOFinit. = n(substrate)/{n(catalyst)*h} at a particular time within linear part of graph 
     T50: Time at 50 % conversion; T100: Time at 100% conversion 
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For the [Rh(PP)(COD)]BF4 complex of 36 conversion was complete after 32 min 
(TOF: 9600 h-1 , TOFinit.: 14100 h-1). The curves for the complexes of the new 
phosphine-phosphoramidites show that they are less active in the hydrogenation of 
dmi. Table 2.5.1.4 presents all data calculated from the graphs. 
For the [Rh(PP)(COD)]NTf2 complexes of the naphthyl-substituted phosphine-
phosphoramidites 57 and 58, an average turnover frequency of 1250 h-1 was 
obtained. This is about seven times less active than the complex of 36 possessing a 
phenyl moiety. The relative configuration of the BINOL backbone does not seem to 
have an influence on activity, since the TOFs of 57 and 58 are the same. Also the 
initial TOFs calculated from the first linear part of the curves are in the same range. 
The productivity of the complex of the phosphine-phosphoramidite with the partially 
hydrogenated backbone L3 is almost ten times lower than for the Rh-complex of 36 
even if the initial TOF is in the same range as for complexes 57 and 58.  
Beside the ligand, a difference between the newly synthesised complexes and the 
Rh-complex of 36 is that they have an NTf2- counterion instead of BF4-. To investigate 
whether the counterion has an influence on the activity, [Rh(36)(COD)]NTf2 (56) was 
synthesised for comparison and tested in catalysis. A turnover frequency of 1859 h-1 
was obtained for 56, which is higher than that of the complexes of L1-L3, but still 
considerably lower than for [Rh(36)(COD)]BF4-. These data support the notion that 
the anion has an influence on the activity of the catalyst, which is contradictory to the 
assumption of Heller et al. Studying [Rh(BINAP)(diolefin)]anion compexes with 
different anions in the hydrogenation of dimethyl itaconate, they came to the 
conclusion that different anions have no effect on activity or enantioselectivity.[95]  
A brief qualitative look at the curves comparing TOFinit., T50 and T100 shows that 
a catalytic system, which was most active in the beginning, was not necessarily the 
fastest in achieving 100 % conversion. The catalytic system with complex 65 for 
example showed the lowest TOFinit. and the highest T50, but was the fastest to reach 
100 % conversion (lowest T100). 
 
 
 
Scheme 2.5.1.4: Equations for hydrogenation with prelocated eqilibrium 
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Looking at the equations for a hydrogenation with prelocated equilibrium (Scheme 
2.5.1.4), one can roughly estimate that the TOFinit. represents the reactivity of the 
catalyst-substrate complex (k2), while differences in T50 and expecially in T100 
express differences in the equilibrium constant K, which consist of association 
constant k1 and dissociation constant k-1 ( stength of substrate-catalyst 
interaction).[96] 
 
2.5.2 Ir-catalysed hydrogenation 2-substituted quinolines 
 
In contrast to the asymmetric hydrogenation of prochiral olefins, ketones or 
imines, the asymmetric hydrogenation of heteroaromatic compounds is much less 
explored.[97] A very interesting field is the enantioselective hydrogenation of  
substituted quinolines, since 1,2,3,4-tetrahydroquinolines are constituents of natural 
alkaloids and therefore important for the synthesis of many pharmaceutical and 
agrochemical agents.[98] Often the extraction of single pure alkaloids from natural 
sources is not very successful, so that the development of efficient synthetic 
pathways is very beneficial. 
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Figure 2.5.2.1: Examples of biologically active quinoline alkaloids 
 
 
The first successful example for the asymmetric hydrogenation of 2-substituted 
quinolines was reported in 2003 by the group of Zhou (Scheme 2.5.2.1).[99] They 
used the bisphosphine (R)-MeO-Biphep (62) in combination with [Ir(COD)Cl]2 as 
metal precursor and iodine as an additive to obtain full conversion and 
enantioselectivities up to 96%. Without iodine as an additive activities and 
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enantioselectivities are much lower. More recently, this system has been used by 
Zhou et al. as a key step in the total synthesis of the alkaloid (-)-galipeine.[100]  
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Scheme 2.5.2.1: Hydrogenation of quinolines with MeOBiphep (62) 
 
Apart from MeOBiphep, other ligands have been successfully applied for the Ir-
catalysed asymmetric hydrogenation of quinolines. In many cases, bisphosphines 
that induce good enantioselectivities are structural variations of MeOBiphep (for 
example: P-Phos (65),[101,102] tunable bisphosphines[103,104]) or BINAP (for example: 
(S)-SegPhos 63,[105] (S)-SynPhos,[106] (S)-GenDenBINAP,[107] H8-BINAPO[108]).  
 
 
Figure 2.5.2.2: Examples of ligands used for hydrogenation of quinolines 
 
Besides bisphosphines, Zhou and coworkers have also investigated P,N-ligands, 
such as ferrocenyloxazolines (67, up to 95 % ee).[109] A chiral phosphine-sulfoximine 
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(66, P,N) was successfully used for the Ir-catalysed hydrogenation of 2-
methylquinoline by the group of Bolm (up to 92 % ee).[110] In 2010 Zhou et al. used 
water/silane as a hydrogen source in the hydrogenation of quinolines via an Ir-(S)-
Segphos (63) system at room temperature and normal pressure obtaining 
enantioselectivities up to 93 %.[111] An extremely active and enantioselective 
phosphine-free Cp*-Ir-system was presented by the group of Xu.[112] The only 
successful system using another active transition metal was published by the group 
of Chan. They achieved some excellent enantioselectivities up to 99 % with a 
diamine ligand coordinated to ruthenium using an ionic liquid as a solvent.[113]  
Feringa combined a monodentate chiral phosphoramidite in a 1:1 ratio with an 
achiral phosphine and obtained enantioselectivities up to 89 %.[114] Because of the 
similar mixed donor system phosphine-phosphoramidite 36 was applied in the 
hydrogenation of 2-substituted quinolines and induced enantiomeric excesses up to 
96 %.[75] Therefore, ligands L1-3 were also tested in the hydrogenation of the 
common benchmark substrate 2-methylquinoline (2mq, scheme 2.5.2.2).  
 
 
 
Scheme 2.5.2.2: Asymmetric hydrogenation of 2mq 
 
The conditions optimised by the group of Zhou[99] and also by Eggenstein[75] were 
adapted to test the ligands, so [Ir(COD)Cl]2 was used as metal precursor and iodine 
as an additive. The reaction was performed in toluene at 40 bar of hydrogen and 
room temperature (Table 2.5.2.1).  
 
Table 2.5.2.1: Asymmetric hydrogenation of 2mq - resultsa) 
entry ligand time (h) conversion (%) ee (%) 
1b 36 16 >99 96 R 
2 L1 48 >99 97 R 
3 L2 48 >99 81 S 
4 L3 16 96 96 R 
                            a) 1 mmol S, S/Ir/Lig/I2 = 100:1:1.1:5, 2 mL toluene, pH2 = 40 bar, RT 
                            b) Data: [75] 
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Ligand L1, where the phenyl moiety at the amine part is changed into a naphthyl 
moiety, showed full conversion after an increased reaction time of 48 h but also gave 
a slightly increased enantiomeric excess of 97 % R. The corresponding diastereomer 
L2 induced 81 % enantioselectivity for S. Again a strong dependence of the 
stereochemical outcome on the configuration of the BINOL moiety and a match-
mismatch effect of the two stereochemical elements was observed. Ligand L3 with 
the partially hydrogenated backbone gave almost full conversion in 16 h and the 
same enantioselectivity as 36.  
 
 
 
 
Scheme 2.5.2.3: Asymmetric hydrogenation of 2bq and 2pq 
 
The reaction scope was briefly evaluated using 2-nbutyl- (2bq) and 2-
phenylquinoline (2pq) as substrates (Scheme 2.5.2.3). These derivatives have a 
higher sterical demand than 2-methylquinoline and their asymmetric hydrogenation is 
known to be more challenging. Diastereomers L1 and L2 induce slightly lower 
enantioselectivities than 36 for both substrates (Table 2.5.2.2).  
 
Table 2.5.2.2: Asymmetric hydrogenation of 2bq and 2pq - resultsa) 
entry ligand substrate time (h) conversion (%) ee (%) 
1b 36 2bq 16 >99 94 R 
2 L1 2bq 48 >99 92 R 
3 L2 2bq 48 >99 81 S 
4 L3 2bq 16 84 97 R 
5b 36 2pq 16 >99 90 S 
6 L1 2pq 48 >99 89 S 
7 L2 2pq 48 92 65 R 
8 L3 2pq 16 78 95 S 
                            a) 1 mmol S, S/Ir/Lig/I2 = 100:1:1.1:5, 2 mL toluene, pH2 = 40 bar, RT 
                            b) Data: [75] 
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Again a switch in the stereochemical outcome of the reaction and a match-mismatch 
effect between stereochemical elements of the ligand can be observed. Replacement 
of the BINOL backbone with the partially hydrogenated analogue (L3) results in 
increased enantiomeric excesses at good conversions for both substrates. An 
enantiomeric excess of 95 % is the highest selectivity for the hydrogenation of 2-
phenylquinoline known in literature to date (SciFinder, Feb 2011).  
 
Table 2.5.2.4: Asymmetric hydrogenation of 2mq, 2bq and 2pq using KI - resultsa) 
entry ligand substrate conversion (%) ee (%) 
1b 36 2mq 90 97 R 
2b 36 2bq 95 95 R 
3b,c 36 2pq 59 92 S 
4 L1 2mq 24 89 R 
5 L1 2bq 58 93 R 
6 L1 2pq 33 87 S 
7 L2 2mq 30 74 S 
8 L2 2bq 39 81 S 
9 L2 2pq 10 79 R 
                            a) 1 mmol S, S/Ir/Lig/KI = 100:1:1.1:100, 2 mL toluene, 48 h, pH2 = 40 bar, RT 
                            b) Data: [75] 
                            c) 72 h 
 
Since the additive has a big influence on conversion and selectivity, potassium 
iodide was tested as an alternative additive. For ligand 36, lower activity but slightly 
higher enantioselectivities were observed using KI instead of iodine. In contrast, L1, 
L2 and L3 induced lower enantioselectivities using KI, except for ligand L2 in the 
hydrogenation of 2pq (Table 2.5.2.4). The decrease in conversion is also much 
higher than for ligand 36. In general, the new phosphine-phosphoramidites are 
excellent ligands for the Ir-catalysed hydrogenation of 2-substituted quinolines, 
showing high conversions and among the highest enantioselectivities for these 
substrates. 
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2.5.3 Ru-catalysed hydrogenation of β-keto esters 
 
Chiral β-hydroxy esters are important structural building blocks in a number of 
pharmaceuticals (for example atorvastatin, a drug to lower cholesterol level; trade 
names: Sortis®, Lipitor®) and the asymmetric hydrogenation of β-keto esters is a 
valuable method for their synthesis.[115,116] Although nickel[117] and rhodium[118,119] 
have been reported as an active centre, most successful catalytic systems are based 
on ruthenium[120,121] and for long time the ligands of choice for this transformation 
were C2-symmetric bisphosphines.  
A milestone was the introduction of BINAP for this transformation by Noyori et 
al.[122,123] BINAP-Ru(II) catalysts were able to hydrogenate several different β-keto 
esters with full conversion and high enantioselectivities. Recently, several bidentate 
C1-symmetrical phosphines, phosphinites or chiral amine and imine ligands have 
been developed.[116] Even monodentate phosphine ligands have been used with 
success.[124,125] Another concept is the combination of a chiral amine or imine ligand 
with a chiral or achiral diphosphine ligand to induce high enantioselectivities in the 
hydrogenation of simple ketones.[115]  
 
 
 
 
Scheme 2.5.3.1: Asymmetric hydrogenation of mop 
 
 
Ligand 36 was able to induce 96% enantiomeric excess in the hydrogenation of 
benchmark substrate methyl 3-oxopentanoate (mop), so L1-3 were also tested for 
this reaction (Scheme 2.5.3.1). The catalyst was preformed by stirring the ligand with 
[RuCl2(p-cymene)]2 for 1 h in toluene at 80 °C. Toluene was removed and methanol 
and substrate were added to the solid catalyst. The hydrogenation was performed at 
60 °C and 60 bar of hydrogen pressure (Table 2.5.3.1). 
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Table 2.5.3.1: Asymmetric hydrogenation of mop – resultsa) 
entry ligand conversion (%) ee (%) 
1b 36 >99 96 R 
2 L1 >99 94 R 
3 L2 >99 81 S 
4 L3 >99 86 R 
                              a) 1 mmol S, S/Ru/L = 100:1:1, 16 h, 60°C, pH2=60bar, 2mL MeOH;  
                                  (Preform: 1 h, 80°C, 1 mL toluene) 
                              b) Data: [75] 
 
All three ligands led to full conversion after 16 h. Ligand L1 (where the phenyl 
moiety at the nitrogen is replaced by a naphthyl substituent) induced nearly the same 
high enantiomeric excess as 36. The ligand with the partially hydrogenated backbone 
L3 resulted in a lower enantioselectivity of 86%. The lowest selectivity was obtained 
with ligand L2, which again afforded the opposite enantiomer. Even if the obtained 
enantioselectivities for this reaction are slightly below the benchmark of 99 % ee, the 
good results attest the versatility of the synthesised phosphine-phosphoramidites. 
These new ligands are able to induce high enantioselectivities in three completely 
different types of hydrogenation reactions using rhodium, iridium or ruthenium as an 
active metal centre.  
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2.6 Phosphine-phosphorodiamidites 
 
In the literature many different mixed phosphine ligands – where a phosphine 
group is combined with a heteroatom-substituted phosphorous moiety – have been 
reported. Common combinations like phosphine-phosphites or phosphine–
phosphoramidites have already been described in the introduction (Chapter 1.3). To 
develop a new class of ligands, one can attempt to combine a different heteroatom-
substituted moiety with a phosphine group. For the phosphine-phosphoramidites L1-
3 a diol unit is always used to create the phosphoramidite part. Replacing the diol 
with an aminoalcohol, the phosphoramidite unit would turn into a phosphorodiamidite 
moiety (Figure 2.6.1). This combination would be very interesting to synthesise since 
phosphine-phosphorodiamidites are not known in literature so far.  
 
 
 
 
 
Scheme 2.6.1: Creating a phospine-phosphorodiamidite 
 
 
In contrast to phosphoramidites, phosphorodiamidites are in general rather rare in 
literature.[126] In 1974, a phosphorodiamidite structure derived from ephedrine 68 was 
reported by the group of Burgada but they did not use it as a ligand in asymmetric 
catalysis.[127] Arzoumanian et al. synthesised a phosphorodiamidite based on (S)-
prolinol 69 in 1988 and used it for the Pd-catalysed carbonylation of α-methylbenzyl 
bromide achieving moderate enantioselectivities.[128] More recently, these structures 
were used by the group of Alexakis for the asymmetric conjugate addition of 
organocopper reagents to enones, giving moderate to high enantioselectivities.[129,130] 
In 1995, Bentrude reported on the conformational equilibria of a phosphorodiamidite 
structure 70.[131]  
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Figure 2.6.1: Examples of phosphorodiamidites 
 
 
Bondarev and coworkers used an (S)-α,α-diphenylprolinol derived 
phosphorodiamidite 71 in the Rh-catalysed asymmetric hydrogenation of C=C bonds.  
The hydrogenation of methyl α-acetamidoacrylate gave enantioselectivities up to 
91%.[132] Besides ligands where an aminoalcohol is combined with an amine there 
are also a few examples of ligands where a diamine moiety is combined with a diol to 
get an OPN,N type structure.[133,134] These structures are different because they can 
be C2-symmetric whereas structures derived from an aminoalcohol and an amine can 
not. 
Comparison of a phosphorodiamidite moiety with a phosphoramidite structure 
shows some distinctive differences. Changing one of the oxygen atoms to a nitrogen 
atom not only affects the electronical properties of the phosphorus donor atom but 
also changes the possible sterical properties of the molecule since nitrogen is 
trivalent. Another difference is that the phosphorus atom becomes a chiral centre with 
three different substituents and a free electron pair. This can have an influence on 
the outcome of asymmetric catalytic reactions.  
 
2.7 Synthesis of new phosphine-phosphorodiamidites 
 
To study the change in behaviour in catalytic reactions going from a 
phosphoramidite moiety to a phosphorodiamidite, the rest of the ligand structure 
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should remain unmodified. The easiest phosphine-phosphorodiamidite most closely 
related to 36 will be based on enantiomerically pure 2'-amino-1,1'-binaphthyl-2-ol 
(NOBIN) instead of BINOL. Since enantiomerically pure NOBIN is expensive, it was 
synthesised via a route published by Brückner in 2009 (Scheme 2.7.1).[135]  
 
 
 
 
Scheme 2.7.1: Synthesis of (S)-NOBIN 
 
The synthesis starts with the monotriflation of enantiomerically pure (S)-BINOL 
followed by protection of the unreacted alcohol moiety via a MOM ether. To avoid the 
use of the carcinogenic chloromethyl methyl ether, phosphorus pentoxide and 
dimethoxymethane were used instead. Subsequently, a Buchwald-Hartwig amination 
at the triflate moiety introduces a benzyl amine group, which can be debenzylated 
with hydrogen. Methanolysis of the MOM group afforded the desired product with an 
overall yield of 28 % (Lit.: 67 %).  
 
 
 
Scheme 2.7.2: Synthesis of (S)-2'-(phenylamino)-1,1'-binaphthyl-2-ol 
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To introduce a substituent at the nitrogen atom, a part of the produced NOBIN 
was reacted in a Buchwald-Hartwig amination with phenyl bromide to obtain the 
phenyl-substituted (S)-2'-(phenylamino)-1,1'-binaphthyl-2-ol 72 (Scheme 2.7.2).[136] 
Both aminoalcohols have to be tranformed into a PCl-species that can be coupled 
with the readily prepared phosphine-amine 47 analogous to the phosphorochloridites 
of (R)- and (S)-BINOL. This reaction was attempted by refluxing the aminoalcohol 
(NOBIN or 72) with PCl3 in toluene adding a drop of N-methyl-2-pyrrolidone (NMP) 
(Scheme 2.7.3). Theoretically, two different stereoisomers of 73 can be produced by 
this reaction. 
 
 
 
Scheme 2.7.3: Synthesis of phosphorochloridites using aminoalcohols 
 
While 72 was converted selectivly into one enantiomer of the corresponding 
chlorophosphorodiamidite (31P-NMR: δ = 176.16 ppm), 31P-NMR analysis showed 
that the reaction of unsubstituted (S)-NOBIN with PCl3 delivered various products.  
 
 
 
Scheme 2.7.4: General synthetic pathways for phosphine-phosphorodiamidites 
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Without a pure PCl-compound in hand, the synthetic pathway A (Scheme 2.7.4) is 
no opportunity. Another possibility is the generation of a PCl2-compound of the 
phosphine-amine to obtain the desired ligand via synthetic pathway B. To be able to 
produce different diastereomers without repeating the five-step synthesis of NOBIN, 
the corresponding enantiomer of the phosphine-amine (S)-47 has been synthesised 
((R)-47) via the two-step synthesis described in chapter 2.2. 
 
 
 
 
Figure 2.7.1: Pair of enantiomers of phosphine-amines used for ligand synthesis 
 
The desired PCl2-species 74 were obtained by stirring the phosphine-amines S-47 
and R-47 with an excess of PCl3 in the presence of NEt3 in dichloromethane 
(Scheme 2.7.5). The toluene-insoluble ammonium chloride by-product could be 
removed from the reaction mixture via filtration through a PTFE membrane.  
 
 
 
Scheme 2.7.5: Synthesis of phosphine-amine PCl2-compounds 74 
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The first coupling experiment towards a phosphine-phosporodiamidite followed 
synthetic pathway A via lithiation of phosphine-amine 47 with n-buthyllithium in the 
presence of TMEDA in THF (Scheme 2.7.6). 
.  
 
 
Scheme 2.7.6: Coupling experiment pathway A 
 
To this mixture (11bS)-4-chloro-5-phenyl-4,5-dihydrodinaphtho[2,1-d:1',2'-f][1,3,2] 
oxazaphosphepine (S-73) in THF was added dropwise and the reaction mixture was 
stirred for 16 h. Since 31P-NMR analysis showed a very low conversion of 5 % to a 
possible phosphine-phosphorodiamidite, the experiment was repeated with a 
reaction time of 48 h. Another experiment was performed in toluene instead of THF. 
However, both longer reaction time and a different solvent did not improve the 
conversion. Therefore, the coupling of the ligand fragments was attempted via 
pathway B.  
In the first coupling experiment following route B, the phenyl-substituted S-NOBIN 
was stirred with an excess of NEt3 in DCM and one equivalent of the PCl2-compound 
(S)-73 in DCM was added dropwise (Pathway B-1, scheme 2.7.7). 31P-NMR analysis 
showed one broad singlet in the phosphine region and two broad singlets at 128.8  
ppm and 135.9 ppm, respectively  (Figure 2.7.2, p.52, red spectrum).  
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Scheme 2.7.7: Coupling experiments pathway B-1 
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The signal in the phosphine region and the latter match with the obtained 
chemical shifts for the coupling experiment via pathway A (Scheme 2.7.6). To find a 
way to purify and identify the products, TLC on alumina and silica plates were 
perfomed. A mixture of THF and pentane (1:4) on a silica TLC plate showed the best 
separation results after removing residual NEt3 via filtration over a small amount of 
silica. Filtration over a bigger amount of silica was done to test the stability of the 
products during a column chromatography. Finally, the two different products could 
be separated by column chromatography over silica using dried THF and pentane 
(1:4)  under inert gas conditions. One of the products could be identified by NMR and 
mass spectroscopy as the desired phosphine-phosphorodiamidite L4. The other 
product could be either the corresponding diastereomer or another coupling product 
consisting of three building blocks (for example: 2x PCl2-compound + aminoalcohol 
or 2x amioalcohol + PCl2-compound) but this could not be veryfied via NMR or mass 
spectroscopy. To optimise the selectivity of the reaction towards the desired product, 
the reaction pathway was slightly changed. 
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Scheme 2.7.8: Coupling experiments pathway B-2 
 
 
In a second coupling experiment the aminoalcohol was stirred with an excess of 
NEt3 in dichloromethane and that solution was added dropwise to one equivalent of 
1,1-dichloro-N-(2-(diphenylphosphino)phenyl)-N-(1-phenylethyl)phosphinamine (72) 
dissolved in DCM (Pathway B-2, Scheme 2.7.8). NMR analytics showed that this 
sequence of addition preferentially gave the desired species (Figure 2.7.2, p. 52, blue 
spectrum). 
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Figure 2.7.2: 31P{1H}-NMR spectra (crude mixture) reaction pathway B-1 and B-2 
 
L5 was obtained by the same reaction pathway using (R)-74 instead of (S)-74. Via 
column chromatography the new phosphine-phosphorodiamidites L4 and L5 could 
be isolated in 31% and  25 % yield, respectively (Figure 2.7.3).  
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Figure 2.7.3: New phosphine-phosphorodiamidites L4 and L5 
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To obtain phosphine-phosphorodiamidites based on unsubstituted NOBIN 
coupling experiments were performed with (S)-NOBIN and (S)-74 as well as (R)-74 
(Scheme 2.7.9). (S)-NOBIN was stirred with an excess of NEt3 in DCM and was 
added dropwise to one equivalent of the PCl2-compound 74 dissolved in DCM.  
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Scheme 2.7.9: Coupling experiments pathway B-2, unsubstituted NOBIN 
 
For both combinations, the 31P-NMR spectra indicated high conversion to a single 
phosphine-phosphorodiamidite species L6 / L7 showing one broad singlet for a 
phosphorodiamidite and a sharp doublet signal for a phosphine (Figure 2.7.4).  
 
 
Figure 2.7.4: 31P{1H}-NMR spectrum of crude reaction mixture containing L6  
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Figure 2.7.5: New phosphine-phosphorodiamidites L6 and L7 
 
The purification method that was developed for the phenyl-substituted phosphine-
phosphorodiamidite could not be adapted since L6+7 are not stable enough. 
Flushing a solution of crude product in toluene or THF over a pad of silica or alumina 
gave cleavage of the P-N bond, as indicated by an increased phosphine signal of 47. 
Stability tests in which the silica or alumina patch were pretreated with NEt3 or where 
NEt3 was added to the eluent were successful in the case of alumina.  
Finally, both synthesised phosphine-phosphorodiamidite species (L6 and L7) 
could be isolated via column chromatography under argon using alumina and an 
eluent of THF:pentane:NEt3 (Figure 2.7.5). An overview of the 31P-NMR data of all 
new phosphine-phosphorodiamidites is given in Table 2.7.1. 
 
 
Table 2.7.1: 31P{1H}-NMR-shifts and coupling constants of synthesised 
 phosphine-phosphorodiamiditesa) 
entry compound ppm/Pphosphineδ  mult. ppmPPON /2δ  mult. Hz/J PP−  
1 L4 -21.1 b 135.9 b - 
2 L5 -22.0 b 132.2 b - 
3 L6 -17.8 d 142.2 b 42.4 
4 L7 -19.4 b 138.3 b - 
           a) measurements at room temperature in CD2Cl2  
 
 
The chemical shifts for the phosphine and the phosphorodiamidite resonances are 
in the same range as those observed for the phoshine-phosphoramidites. The 
chemical shifts phosphinePδ  are at around -20 ppm while 2PONPδ  are between 132 and 
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142 ppm. All observed signals are broad, with the exception of the phosphine signal 
of ligand L6, which is a sharp doublet with a coupling constant of 42.4 Hz.  
The observation of several broad signals in the 31P- and 1H-NMR spectra 
suggests the existence of different rotational isomers. This can be proven by 
additional measurements at lower temperatures to freeze out the rotation. Ligands L4 
and L6 were dissolved in CD2Cl2 and at first 1H- and 31P-NMR spectra were recorded 
at room temperature (blue, figure 2.7.6). The second set of spectra was recorded at 
283 K (red), then the temperature was lowered in steps of 10 K to record a 1H- and a 
31P-spectrum at each temperature. For ligand L4, variable temperature 
measurements down to 243 K were recorded. In the 31P-NMR spectra series (left in 
figure), a simultaneous split of the phosphine and the phosphorodiamidite signal can 
be observed. At a temperature of 243 K (orange) two sharp signals instead of one 
broad singlet can be identified for each phosphorus atom, respectively. Therefore, 
the existence of two different rotamers can be presumed.  
To identify the part in the molecule where this rotation takes place a look into the 
set of 1H-NMR spectra is necessary. The right spectra set of figure 2.6.1.6 shows the 
broad singlet for the CH3-group of the ligand, which also splits up into two signals at 
lower temperature. Hence, the identified rotation can be located along the N-C bond 
at the phenyl-ethyl rest of the amine moiety. A ratio of 17:83 between the two 
rotamers can be determined from 31P-as well as from 1H-NMR measurement.  
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Figure 2.7.6: Low temperature NMR measurement L4: left = 31P{1H}; right = 1H spectra 
 
 
In the 31P-NMR spectrum of ligand L6 at room temperature the signal of the 
phosphine group is already a sharp doublet. The set of low temperature 31P-NMR 
spectra in the figure 2.7.7 (left) only shows the varying signal for the 
phosphorodiamidite. For this ligand the measurements are carried out down to 223 K 
(pink). At this temperature the former broad singlet is split 50:50 into two signals. The 
set of 1H-NMR spectra (Figure 2.7.7, right) also shows a 50:50 split of the (at room 
temperature very broad) NH-signal and an initiating split of the CH-signal. Therefore, 
rotation of the same moiety as for ligand L4 along the C-N bond in the molecule can 
be presumed.  
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Figure 2.7.7: Low temperature NMR measurement of L6: left = 31P{1H}; right = 1H spectra 
 
 
Another theoretically possible configurational change in the molecule that can be 
responsible for signal splitting in low-temperature NMR-measurements is a change in 
chirality at the phosphorus of the phosphorodiamidite moiety (See scheme 2.7.10). 
To exclude that possibility, the energies for this transition have been calculated by 
DFT simulations for ligands L4 and L6. Activation energies (∆Grel) of 67.9 Kcal/mol 
for ligand L4 and 73.4 Kcal/mol for ligand L6 were obtained, which exclude a change 
of the chiral configuration at room temperature. Thus, the signal splitting observed at 
lower temperatures while obtaining broad signals at room temperature can definitely 
be attributed to the existence of rotational conformers. 
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Scheme 2.7.10: Transition of the phosphorodiamidite conformation 
  
 
To identify the absolute configuration at the phosphorus of the 
phosphorodiamidite moiety, crystallisation from different solvents or solvent 
combinations was attempted to obtain single crystals for X-ray analysis. For ligand 
L6, single crystals could be obtained by slow evaporation of a concentrated solution 
in acetonitrile. X-ray diffraction measurements indicate an absolute configuration of S 
at the phosphorodiamidite moiety. The obtained structure and selected data is shown 
in figure 2.7.8. 
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Bond distance (Å) 
P1-O1 1.6573(15) 
P1-N1 1.6890(17) 
P1-N2 1.7142(19) 
 
 
Angle (˚) 
O1-P1-N1   92.95(8) 
N1-P1-N2 110.18(9) 
N2-P1-O1   97.27(8) 
 
 
Angle sum (˚) 
N1 359.36 
N2 351.43 
  
 
 
 
Figure 2.7.8: Crystal structure of ligand L6 
 
 
Taking the free electron pairs into account both phosphorus-containing moieties 
have a tetrahedral structure. The free electron pairs face each other so that a 
chelating coordination to a metal atom is easily possible. This can also result in a 
through space coupling of the phosphorus atoms in the free ligand, which was 
actually observed for L6 in the 31P{1H}-NMR (p.54, table 2.7.1; JP-P = 42.4 Hz). The 
distance between P1 and P2 of 3.599 Å is larger than the distance between the two 
phosphorus donors in Quinaphos (29, 3.140 Å). That would lead to a larger bond 
angle of P1-M-P2 in a metal complex, and can have an influence on catalysis. The 
seven-membered OPN-containing heterocycle is asymmetric and distorted with a 
bond length of 1.6573(15) Å for P1-O1 and 1.7142(19) Å for P1-N2. The phenyl-ethyl 
amine substituent and the PPh2-moiety are twisted relative to the binaphthyl 
backbone. P2 is closer to O1 than to N2 of the binaphthyl moiety. A comparison of 
the sum of angles at N1 and N2 suggests that N2 is significantly less planar than N1. 
It must be taken into account however, that the position of the proton at N2 is 
determined by calculation rather than full refinement by X-ray crystallography. The 
torsion angle of the NOBIN moiety is 61.61˚. 
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2.8 Rh-complexes of phosphine-phosphorodiamidites 
 
To be able to get results that can be compared to the application of phosphine-
phosphoramidites in asymmetric C-C double bond hydrogenation, rhodium 
complexes of the new phosphine-phosphorodiamidites have been synthesised 
(Scheme 2.8.1).  
 
 
 
 
 
Scheme 2.8.1: Synthesis of Rh-phosphine-phosphorodiamidite-complexes 
 
Unfortunately, the synthetic method that was developed for Rh-phosphine-
phosphoramidite complexes could not be adapted one to one, because phosphine-
phosphorodiamidites were found to decompose in ethanol. Instead, the procedure 
was performed in dichloromethane, stirring [Rh(acac)(COD)] and HNTf2 for 30 min 
before adding the ligand to the mixture. Although DCM is not a coordinating solvent 
that could form an intermediate [Rh(solvent)2(COD)]NTf2 species like ethanol, 31P-
NMR analysis showed full conversion to the desired products. A rhodium complex of 
every new phosphine-phosphorodiamidite could be isolated (Figure 2.8.1) 
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Figure 2.8.1: Synthesised Rh-complexes 75-78 
 
 
The chemical shifts of the doublets of doublets (Table 2.8.1) were in the same 
region as for the corresponding complexes containing phosphine-phosphoramidites. 
One can see a coupling of the two different phosphorus atoms wich differs depended 
on the N-substituent. For complexes 77 and 78 the coupling constant is around 65 
Hz while for complexes 75 and 76  at around 40 Hz. The phosphorus-rhodium 
coupling constants are also dependend on the N-substituents. For complexes 77 and 
78 it is around 140 Hz (phosphine) and 200 Hz (phosphorodiamidite) while for 
complexes 75 and 76  at around 150 Hz and 220 Hz. 
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Table 2.8.1: 31P{1H}-NMR shifts of [Rh(COD)(PP*)][NTf2] complexesa) 
entry compound ppm/Pphosphineδ  mult. ppmPPON /2δ  mult. Hz/J PP−  Hz/J RhP−  
1 77 13.18 dd 138.58 dd 68.5 141.3/199.3 
2 78 12.98 dd 138.71 dd 66.4 140.6/202.3 
3 75 13.78 dd 138.71 dd 40.0 151.1/219.2 
4 76 12.75 dd 140.40 dd 36.2 152.2/221.4 
a) measurements at room temperature in CD2Cl2  
 
 
2.9 Ir-complexes of phosphine-phosphorodiamidites 
 
The phosphine-phosphorodiamidites were also applied in the synthesis of iridium 
complexes. The same method as for the rhodium complexes was used (Scheme 
2.9.1). Ir(acac)(COD) was stirred with an equivalent of HNTf2 in DCM for 30 min and 
the ligand was added dissolved in DCM. 31P-NMR spectroscopy showed that the 
reaction of the NPh-substituted ligands L4 and L5 gave a mixture of several different 
species that could not be separated. Only for the NH-substituted ligands L6 and L7 
well-defined species could be isolated (Figure 2.9.1). 
 
 
 
 
 
 
Scheme 2.9.1: Synthesis of Ir-phosphine-phosphorodiamidite-complexes 
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Figure 2.9.1: Synthesised Ir-complexes 79 and 80 
 
The data from the 31P-NMR spectra of complexes 79 and 80 are collected in table 
2.8.1. Chemical shifts for the iridium complexes are very different from those 
obtained for the rhodium-complexes. The phosphine resonance appears at <10 ppm, 
which is significantly higher while the phosphorodiamidite signal comes at ~115 ppm, 
which is significantly lower. The phosphorus-phosphorus coupling constants amount 
~44 Hz, which is comparable to the *JPP-values for the Rh-complexes of the phenyl-
substituted ligands L4 and L5. 
 
 
Table 2.9.1: 31P-{1H}-NMR shifts of [Ir(COD)(PP*)][NTf2] complexesa) 
entry compound ppm/Pphosphineδ  mult. ppmPPON /2δ  mult. Hz/J PP−  
1 79 8.92 d 115.87 d 43.8 
2 80 6.42 d 113.87 d 43.5 
a) measurements at room temperature in CD2Cl2 
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2.10 Application of phosphine-phosphorodiamidites in asymmetric catalyses   
 
2.10.1 Rh-catalysed hydrogenation of C=C double bonds 
 
First of all, the  rhodium-complexes of the phosphine-phosphorodiamidites were 
tested for the hydrogenation of asymmetric hydrogenation of prochiral olefins. The 
first benchmark substrate that was used is dimethyl itaconate (dmi, figure 2.10.11). 
Under the same reaction conditions as used for the phosphine-phosphoramidites, 
phosphine-phosphorodiamidites L4-7 showed different trends in conversion and 
enantioselectivity (Table 2.10.1.1). The ligands with Sa,Sc-configuration induced 
conversions of more than 99 % in contrast to the ligands with Ra,Sc-configuration 
(max: 47 %).  
 
Table 2.10.1.1: Hydrogenation of dmi - resultsa) 
entry ligand conversion (%) ee (%) 
1 L6 >99 79.0 S 
2 L4 >99 14.4 R 
3 L7 47.1 97.9 S 
4 L5 7.7 41.3 R 
                            a) 1 mmol S, S/Rh = 1000:1, 2 mL DCM, 1h, pH2 = 10 bar, RT 
 
 
Furthermore, a switch in the stereochemical outcome of the reaction depending 
on the substituent at the diamidite nitrogen atom was observed. The hydrogen-
substituted ligands led preferentially to the S-enantiomer, while the phenyl-
substituted ligands favoured the R-enantiomer. Since the absolute configuration of 
the phosphorodiamidite moiety in the phenyl substituted ligands could not be 
identified yet, it is not clear if the conformational switch in catalysis only depends on 
the different substituent or on a possible difference in configuraton. Generally, the 
achieved enantioselectivities are lower than the ees induced by the phosphine-
phosphoramidites. Ligand L7 showed the highest enantioselectivity of the tested 
phosphine-phosphorodiamidites (98% S) and was therefore the only phosphine-
phosphorodiamidite that gave ees in the same range as the phosphine-
phosphoramidites.  
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Figure 2.10.1.1: Substrates for C=C hydrogenations 
 
To broaden the substrate scope other benchmark compounds (Figure 2.10.1.1) 
were also tested under the same conditions. The results are again very different from 
the hydrogenation results using phosphine-phosphoramidites (Table 2.10.1.1).  The 
switch of the product configuration that depends on the substituent at the diamidite 
nitrogen atom of the ligand can be observed more or less distinctive for all 
substrates. On average, ligand L7 induced the highest enantiomeric excesses for the 
hydrogenation of maa, mapa and fpa, but the observed selectivities for these 
substrates were lower than those induced by phosphine-phosphoramidites L1-3. For 
the hydrogenation of methyl amidoacrylate (maa) all phosphine-phosphorodiamidites 
show conversions below 56 %, respectively.  
 
Table 2.10.1.1: Hydrogenation of maa, mapa and fpa - resultsa) 
entry ligand substrate conversion (%) ee (%) 
1 L6 maa 32 48 R 
2 L4 maa 1 10 S 
3 L7 maa 56 75 R 
4 L5 maa 2 2 R 
5 L6 mapa > 99 83 R 
6 L4 mapa 14 68 S 
7 L7 mapa > 99 89 R 
8 L5 mapa 2 n.d. 
9 L6 fpa 3 30 R 
10 L4 fpa 1 52 S 
11 L7 fpa 5 82 R 
12 L5 fpa 6 67 S 
a) 1 mmol S, S/Rh = 1000:1, 2 mL DCM, 1h, pH2 = 10 bar, RT 
 
 
Enantioselectivities between 2% and 75% have been observed. (E)-methyl 2-
acetamido-3-phenylacrylate (mapa) can be hydrogenated with enantioselectivities up 
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to 89%. Here the difference in conversion between the results for hydrogen- and 
phenyl-substituted ligands is even more distinctive. The hydrogen-substituted 
phosphine-phosphorodiamidites give full conversion, while the highest conversion 
observed for the phenyl-substituted phosphine-phosphorodiamidites is 14%. The 
hydrogenation of the fluorinated substrate fpa showed moderate to good 
enantioselectivities up to 82%, but low conversions < 6%.  
Although the new phosphine-phosphorodiamidites L4-7 seem to be less effective 
and selective for this type of reaction and substrate scope as the corresponding 
phosphine-phosphoramidites, they definetly show a general potential. Structural 
optimisations that lead to different phosphine-phosphorodiamidites and their 
application can be promising for future research. 
 
 
2.10.2 Ir-catalysed hydrogenation of C=N double bonds 
 
A) 2-methyl quinoline 
 
The first model substrate for testing L4-7 in iridium-catalysed asymmetric 
hydrogenation was 2-methylquinoline (2mq), which has also been used before in 
combination with the phosphine-phosphoramidites (Scheme 2.5.2.2). All reactions 
were run at room temperature for 16 h and at a hydrogen pressure of 40 bar (Table 
2.10.2.1).  
 
Table 2.10.2.1: Hydrogenation  of  (2mq) 
entry ligand conversion (%) ee (%) 
1 L6 >99 78 R 
2 L4 >99 84 R 
3 L7 >99 77 R 
4 L5 94 78 R 
a) 1 mmol 2mq, 2mq/Ir/Lig/I2 = 100:1:1.1:5, 2 mL toluene, 16 h, pH2 = 40 bar, RT 
 
 
Ligands L4-7 were found to be very active for the hydrogenation of 2-
methylquinoline. Ligand L5 showed a conversion of 94 %; all other ligands gave full 
conversion. The obtained enantioselectivities were all in the range between 78% and 
84%, which is lower than the enantioselectivities induced by the phosphine-
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phosphoramidites (up to 97 %). Interestingly, a different substituent at the nitrogen 
atom of the phosphorodiamidite moiety or a difference in configuration at the amine 
part appears to have no influence on the configuration of the product in this reaction 
system. All phosphine-phosphorodiamidites used for the hydrogenation of 2-
methylquinoline induced an R-configurated product. For the phosphine-
phosphoramidites, the dependence of the chiral outcome of the reaction on a 
structural feature of the ligand (axial chiality of the binaphthyl moiety) could be 
observed in the rhodium-catalysed hydrogenation of olefines as well as in the iridium-
catalysed hydrogenation of 2-substituted quinolines. Since the enantioselectivities 
were lower than for the tested phosphine-phosphoramidites, no other more 
demanding 2-substituted quinolines were tested in combination with phosphine-
phosphorodiamidites. 
 
B) (E)-N-(1-phenylethylidene)aniline 
 
Another class of imines that has been subjected to intense investigations in 
literature is acyclic N-arylimines. Different transition metals such as rhodium, 
ruthenium and iridium have been used in combination with a variety of ligands to 
obtain chiral arylamines via enantioselective hydrogenation of their corresponding 
prochiral imines.[137] This is particularly interesting since chiral arylamines are very 
often biologically active compounds or building blocks for biologically active agents. A 
notable example is the industrially applied synthesis of S-metholachlor that is used as 
a herbicide.[42] The key step in the synthesis is the iridium-catalysed enantioselective 
hydrogenation of an N-aryl ketimine using a bisphosphine ligand, which was alredy 
presented in the introduction (Scheme 1.2.3).  
Most of the systems leading to high enantioselectivities are a combination of 
iridium as the active metal and a bidentate ligand such as a bisphosphine or various 
P/N-ligands.[137] A typical benchmark substrate for the evaluation of a catalytic 
system in this type of reactions is (E)-N-(1-phenylethylidene)aniline (pea). One of the 
earliest systems that gave high enantioselectivities (up to 98%) for this substrate was 
published in 2001 by Zhang and co-workers using an Ir-f-binaphane catalyst (81).[138]  
In 2005, Bolm and coworkers hydrogenated a family of ten different aryl methyl N-
p-MeO-phenylimines via an Ir-diphenylphosphanylsulfoximine catalyst (82) with 
enantioselectivities up to 98%.[139] A bisphosphine-containing system of Imamoto 
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(83), published in 2006, even achieved 99% enantioselectivity in the hydrogenation 
of (E)-N-(1-phenylethylidene)aniline.[140] High selectivities for the hydrogenation of 
pea and a set of derivatives were also achieved by Ir-SIPHOX systems reported by 
Zhou (84),[141] by iridium-based ligands in combination with BINOL-based phosphoric 
acid counter ions (85)[142] and by  the ferrocenyl P,N ligands of Knochel (86).[143]  
 
 
 
Figure 2.10.2.1: Selected ligands for hydrogenation of acyclic N-arylimine 
 
 
Mixed bidentate phosphine ligands (phosphine-phosphites) have been used by 
Pizzano in 2005 (87) achieving good enantioselectivities up to 84% in the 
hydrogenation of pea.[144] Encouraged by these results, phosphine-
phosphorodiamidites L4-7 and their iridium-complexes 79 and 80 were applied in the 
hydrogenation of (E)-N-(1-phenylethylidene)aniline (pea, scheme 2.10.2.1). 
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Scheme 2.10.2.1: Hydrogenation of (E)-N-(1-phenylethylidene)aniline (pea) 
 
 
The iridium-complexes derived from the NH-substituted ligands were used in 
catalysis in a substrate to catalyst ratio of 1000:1. Full conversion was achieved by 
stirring the mixture in DCM at 40°C at a hydrogen pressure of 30 bar for 20 h (Table 
2.10.2.2). Addition of iodine as an additive was found to lead to higher 
enantioselectivities. 
 
Table 2.10.2.2: Hydrogenation of (E)-N-(1-phenylethylidene)aniline (pea) – complexesa) 
entry complex I2 ee (%) 
1 79 (L6) - 12 R 
2 79 (L6) 0.01mmol 70 R 
3 80 (L7) - rac 
4 80 (L7) 0.01mmol 78 R 
a) S:1mmol, S/Cat./I2 = 1000/1/10, 40°C, 20h, 2mL DCM, 
                                       pH2 = 30bar, C: [Ir(cod)L]NTf2, cv: > 99% 
 
The highest ee of 78% was induced by a combination of 80 with iodine as an 
additive. To also be able to compare the catalytic results of the NPh-substituted 
ligands, an in situ method was developed. To optimise the conditions and to check 
the comparability to the method that was used before, the new procedure was 
evaluated with NH-substituted ligand L6 first (Table 2.10.2.3).  
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Table 2.10.2.3: Hydrogenation  of (E)-N-(1-phenylethylidene)aniline – in situa) 
entry ligand iodine (mmol) AgNTf2 (mmol) conversion (%) ee (%) 
1 L6 - - 0 nd 
2 L6 0.01 - >99 65 R 
3 L6 - 0.001 32 38 R 
4 L6 0.01 0.001 >99 68 R 
5 L4 0.01 0.001 >99 24 S 
6 L5 0.01 0.001 >99 21 S 
a) S:1mmol, S/Cat./I2 = 1000/1/10, 40°C, 20h, 2mL DCM, 
                                       pH2 = 30bar, Cat.:[Ir(COD)Cl]2 + 2eq L + 1eq AgNTf2 
 
In a first experiment, two equivalents of ligand L6 were stirred with [Ir(cod)Cl]2 and 
this mixture was used as a catalyst under the same conditions as for the reactions in 
table 2.10.2.2. In a second experiment, AgNTf2 was added; the third one was treated 
with iodine and the fourth one contained AgNTf2 and iodine. The fourth experiment 
gave the best results - with iodine the conversion is much higher than without and the 
presence of AgNTf2 increases enantiomeric excess up to 68% R. This result is 
comparable to the enantiomeric excess of 70% R that was achieved via the 
preformed iridium-complex of the same ligand. The NPh-substituted ligands L4-5 
have been tested with AgNTf2 and iodine as well. Enantiomeric excesses up to 24% 
for the S-enantiomer and the same N-substitutent-dependent switch in configuration 
of the product were observed.  
In general, the obtained results with ees up to 78% are lower than the actual 
benchmark for this substrate, but comparable to the results obtained with Pizzano’s 
phosphine-phosphites. 
 
2.10.3 Asymmetric hydrophosphorylation  
 
Organophosphonate compounds such as arylalkylphosphonic esters are 
particularly interesting because of their biological activity.[145] There are several 
possibilities to synthesise structures of this type, for example the classic Arbuzov 
reaction of P(OR)3 with R’X.[146] A very elegant method is the direct addition of a 
hydrogenphosphonate to an olefin.[146] The first example of a so-called 
hydrophosphorylation was published in 2000 by the group of Tanaka.[147] They 
showed that palladium as active metal centre could induce selectivity towards the 
branched product in the hydrophosphorylation of various unfunctionalised olefines. In 
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2005, Franciò, Leitner and Beletskaya published a screening of different ligands to 
find suitable systems for the hydrophosphorylation of vinylarenes that favour the 
Markovnikov product (regioselectivity) and induce significant levels of enantiomeric 
excess.[148]  
The most successful ligand reported was phosphine-phosphite (R,S)-BINAPHOS, 
which gave a linear:branched ratio of 7:93 and an enantiomeric excess of 56%. More 
recently, an improvement in enantioselectivity to 74% using a new derivative of 
BINAPHOS was reported.[149] The group of Han achieved enantioselectivities up to 
88.5% in the hydrophosphorylation of norbonenes using JosiPhos-type ligands with 
NEt3 as an additive.[150] A system that showed excellent cis:trans ratios in the 
hydrophosphorylation of cyclopropenes was published by Rubin and coworkers.[151]  
Since mixed bidentate phosphine ligands appear to give good results for this type 
of reaction, 36 and L4-7 were tested in the hydrophosphorylation of styrene (Scheme 
2.10.3.1). The first reaction was performed under conditions that were established by 
Shulyupin.[148] A pinacol-derived phosphonate[152], [Pd(Cp)(allyl)][153], and 1.1 
equivalents of 36 were stirred at 100 °C for 45 min in 1,4-dioxane. After addition of 
styrene, the mixture was stirred at 100 °C. After a reaction time of 35 h however, no 
conversion was observed. 
 
 
 
 
Scheme 2.10.3.1: Hydrophosphorylation of styrene 
 
Much better results were obtained with an alternative method, in which all 
components were stirred in a one-pot reaction for 8 h at 100 °C in the microwave 
(Table 2.10.3.1). A conversion of 64%, a linear:branched ratio of 11:89, and a 
moderate enantiomeric excess of 23% were observed for 36.  
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Table 2.10.3.1: Hydrophosphorylation of styrene – resultsa) 
entry ligand conversion (%) linear:branched ee (%) 
1 36 64 11 : 89 23 
2 L6 19 9 : 91 8 
3 L4 2 n.d. - 
4 L7 2 n.d. - 
5 L5 13 23 : 77 9 
a) 0.7 mmol S (styrene), S/C/L/phosponate = 40:1:1.1:20, 1 mL 1,4-dioxane, 
                         microwave: 8 h, 100°C 
 
To test the potential of the phosphine-phosphorodiamidites, they were also 
applied in the hydrophosphorylation of styrene under the one-pot conditions via 
microwave. Conversions were found to be too low to detect regio- and 
enantioselectivities for the reactions with ligands L4 and L7. The best result was 
observed for ligand L6, which gave a good linear to branched ratio of 9:91, but also 
gave a poor enantioselectivity of 8%. From these results it can be concluded that this 
type of ligand is unsuitable for enantioselective hydrophosphorylation. 
 
2.9.4 Asymmetric hydroformylation 
 
Hydroformylation reactions are one of the most important industrial applications of 
homogeneous catalysis. This type of reaction was discovered by Roelen in 1938, 
describing the reaction of an olefin with syngas (CO/H2) to an aldehyde.[154,155] 
Aldehydes can be reacted to alcohols or carbonic acids which are used as softeners 
in plastics or as detergents. In industry, hydroformylation reactions are generally 
catalysed by cobalt or rhodium combined with phosphine ligands.  
The hydroformylation of asymmetric olefins leads to a mixture of linear and  
branched products. When the substituents at the double bond of the olefin are 
different, the branched product is chiral. To control regio- and stereoselectivity in 
asymmetric hydroformylation, a combination of rhodium and bidentate chiral 
phosphites or chiral ligands with mixed donors is applied in most cases.[156,157] This 
method can be used for the enantioselective synthesis of biologically active 
compounds, such as ibubrofen or naproxen (Scheme 2.10.4.1).  
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Scheme 2.10.4.1: Hydroformylation as possible synthetic strategy for ibuprofen and naproxen 
  
Ibuprofen and naproxen can be synthesised via the asymmetric hydroformylation of 
vinyl aromates, followed by an oxidation reaction to obtain the free arylpropionic 
acids. Due to its availability, styrene is often used as a benchmark substrate for the 
evaluation of new catalytic systems in this type of reactions. A well established ligand 
for the hydroformylation of styrene is Takaya’s BINAPHOS (26), which  induces a 
linear to branched ratio of 12:88 and 94% enantioselectivity.[60]  
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Figure 2.10.4.1: Selected ligands for asymmetric hydroformylation of styrene 
 
 
These results are only topped by an analogous phosphine-phosphoramidite (30) 
published in 2006 by Zhang.[73] With 30, a linear to branched ratio of 11:89 and an 
enantioselectivity of 98% have been achieved in the hydroformylation of styrene.  
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Phosphine-phosphorodiamidites L4-7 were also tested in the rhodium catalysed 
hydroformylation of styrene (Scheme 2.10.4.2).  
 
 
 
 
 
Scheme 2.10.4.2: Hydroformylation of styrene 
 
Precursor Rh(acac)(CO)2 was stirred with four equivalents of the ligand for 30 min, 
after which the substrate was added and the mixture was stirred for 16 h at 60 °C at 
a syngas pressure of 40 bar. Except for the run with ligand L6 all reactions achieved 
full conversion (Table 2.10.4.1).  
 
Table 2.10.4.1: Hydroformylation of styrene - results 
entry ligand conversion (%) linear:branched ee (%) 
1 L6  56 8 : 92 8 
2 L4 > 99 16 : 84 17 
3 L7 > 99 7 : 93 2 
4 L5  > 99 3 : 97  57 
a) 2 mmol S, S/Rh/L = 1000:1:4, 2 mL toluene, 16 h, 60°C, pCO/H2 = 40bar 
 
All ligands induced good to excellent selectivities towards the branched product of 
up to 97%. The NPh-substituted ligands showed higher enantioselectivities than the 
NH-substituted ligands. The best results for this set of ligands was provided by ligand 
L5, giving a linear to branched ratio of 3:97 and an enantioselectivity of 57%. 
Compared to benchmark ligand 30, the selectivity towards the branched aldehyde 
are higher but the enantioselectivities are much lower. 
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2.11 Phosphine-phosphortriamides 
 
A phosphortriamide is a diaza-analogue of a phosphoramidite and therefore also 
a possible building block for a mixed bidentate phosphine ligand. There are 
phosphortriamide structures in the literature that have been used as monodentate 
ligands in asymmetric catalysis, but the amount of structures and applications is 
significantly lower compared to phosphoramidites. A first example of an application of 
phosphortriamides in enantioselective catalysis was given by Reetz in 2003 using 88 
in the hydroformylation of styrene and in the hydrogenation of dimethyl itaconate.[158]  
 
 
 
 
Figure 2.11.1: Selected phosphortriamides for enantioselective catalysis 
 
 
In the hydroformylation of styrene, this ligand showed good activity but low 
enantioselectivity; in rhodium-catalysed hydrogenation no conversion was observed. 
One year later, Gennari and coworkers established a pool of 23 phosphortriamides 
combining amines with different sulfonylic groups.[159] Out of that pool only ligand 89 
gave moderate enantiomeric excess of 75% in the copper-catalysed Michael addition 
of diethyl zinc to cyclohexane. All other ligands induced enantioselectivities below 
20%. 
Phosphortriamides based on (S)-phenyl-pyrollidin-2-yl-methylamine (90) have 
been synthesised by Tsarev et al. and were used in the allylic substitution 1,3-
diphenylallyl acetate and gave enantioselectivities up to 62%.[160] In the doctoral 
studies of Barta[161] and Eggenstein[75] a set of phosphortriamides was synthesised 
and tested in the copper-catalysed Michael-addition of diethyl zinc to cyclohexenone 
(ees up to 60%), the nickel-catalysed hydrovinylation of styrene (ees up to 63%), the 
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rhodium-catalysed hydroformylation of styrene (up to 28% ee), and the rhodium-
catalysed hydrogenation of dimethyl itaconate (no conversion). 
While the number of published phosphortriamides applied in asymmetric catalysis 
is rather limited, phosphine-phosphortriamides are completely unknown in literature. 
Therefore, a simple building block known for the synthesis of a monodentate 
phosphortriamide should be tested in the synthetic pathway for mixed bidentate 
phosphine ligands applied for L1-7. A diamine that is easy to synthesise and has 
already been used by Barta for the synthesis of a phosphortriamide is (S)-N-
(pyrrolidin-2-ylmethyl)aniline. It is obtained from L-glutamic acid and aniline via a two-
step synthesis (Scheme 2.11.1).[162]  
 
 
 
Scheme 2.11.1: Synthesis of (S)-N-(pyrrolidin-2-ylmethyl)aniline 
 
(S)-N-(pyrrolidin-2-ylmethyl)aniline was purified and degassed via distillation under 
reduced pressure and was applied in a coupling reaction with compound (S)-74 in 
DCM using NEt3 as a base (Scheme 2.11.2).  
 
 
 
Scheme 2.11.2: Synthesis of phosphine-phosphortriamide L8 
 
2 Results & Discussion 77 
31P-NMR spectroscopy showed two doublets with a coupling constant of 52.8 Hz, 
indicating complete conversion to a single phosphine-phosphortriamide species L8 
(Figure 2.11.2). The chemical shift of -20.55 ppm for the phosphine signal is 
comparable to the phosphine resonances of the phosphine-phosphoramidites and  
-phosphorodiamidites. The signal of the phosphorus atom of the phosphortriamide 
moiety was observed at 107.7 ppm and therefore lies in the same region as the 
signals of the (SP)-cofigurated monodentate phosphortriamides obtained from the 
same diamine by Barta.[161]  
 
 
 
 
Figure 2.11.2: 31P-NMR of phosphine-phosphortriamide L8 
 
The compound could be purified by dissolving it in toluene and removing salts via 
filtration over a PTFE-membrane. A filtration over alumina or silica gave cleavage of 
the newly created P-N bond. Phosphine-phosphortriamide L8 was found to be highly 
sensitive. A 31P-NMR spectrum recorded after three weeks of storage in the glovebox 
just showed the signal of phosphine-amine 47. The application of L8 and related 
structures in asymmetric catalysis still needs to be evaluated in future work, but the 
presented results already prove the accessibility of a new class of ligands. 
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3  Summary & Outlook 
 
Within this thesis eight new mixed bidentate phosphine ligands have been 
developed, taking 36 as a lead structure. Initially, new phosphine-phosphoramidites 
were synthesized by variation of the amine moiety of 36. Instead of a phenyl-
substituted phosphine-amine, a naphthyl-substituted equivalent was combined with 
an S-configurated (L1) and an R-configurated binol backbone (L2). L1 and L2 were 
synthesised via the same pathway as 36, where a readily prepared phosphine-amine 
is coupled with a chlorophosphite. By the same route, an additional variation (L3) has 
been synthesised by replacement of the simple binol moiety with the partially 
hydrogenated tetrahydrobinol. NMR investigations showed the existence of different 
rotamers for L1-3. 
 
 
 
Figure 3.1: Phosphine-phosphoramidites 36 and L1-3 
 
In the asymmetric hydrogenation of C=C-, C=N- and C=O-bonds, L1-3 showed 
high activity and enantioselectivity. Readily prepared Rh-complexes of these ligands 
induced up to >99 % enantiomeric excess at full conversion in the hydrogenation of 
unsaturated acid esters such as dimethyl itaconate with turnover frequencies of up to 
1250 h-1. A catalytic system of L1-3, an iridium salt and iodine as an additive 
achieved one of the highest enantiomeric excesses for the hydrogenation of 2-
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substituted quinolines with up to >99 %. In combination with a ruthenium salt, L1-3 
gave high activity and acceptable enantioselectivities in the hydrogenation of a β-keto 
ester such as methyl 3-oxopentanoate. Interestingly, the stereochemical outcome of 
all hydrogenations performed with L1-3 was mainly influenced by the configuration of 
the diol moiety. These results substantiate the high potential and versatility of ligands 
L1-3, so that an interesting topic for further investigations could be the application in 
other types of asymmetric catalysis.  
The second main type of new mixed bidentate phosphine ligands presented in this 
thesis are phosphine-phosphorodiamidites. These ligands could not be synthesised 
by the same route employed before, but were prepared by the combination of S-
NOBIN or phenyl-substituted S-NOBIN with a dichlorophosphite derivative of S- and 
R-phosphine-amine 47. This synthetic pathway led to four different phosphine-
phosphorodiamidites (L4-7) which have an additional chiral centre located at the 
phosphorus. For L6, the absolute configuration (Sc) at the phosphorus could be 
determined by single crystal X-ray analysis.  
 
 
 
Figure 3.2: Phosphine-Phosphorodiamidites L4-7 
 
While monodentate phosphorodiamidites are rare, bidentate phosphine-
phosphorodiamidites have not been reported in literature before. The similarity of 
chemical shifts in 31P-NMR studies indicates that their electronic properties are 
comparable to the phosphine-phosphoramidites L1-3. Furthermore, variable-
temperature NMR experiments also showed the existence of different rotamers that 
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are responsible for the existence of broad signals in proton as well as in phosphorus 
NMR spectra at room temperature.  
Because of these similarities to L1-3, these ligands were also tested in 
asymmetric hydrogenation reactions. Readily prepared rhodium complexes of L4-7 
were applied in the hydrogenation of different unsaturated acid esters such as 
dimethyl itaconate. Conversion and enantioselectivities were significantly lower (up to 
89 %) for these systems compared to L1-3. A switch of the product configuration that 
depends on the substituent (H- or Ph-) at the diamidite nitrogen atom of the ligand 
could be observed for all substrates. The iridium-catalysed hydrogenation of 2-
methylquinoline resulted in high activities and moderate but notably constant 
enantioselectivities of ca. 80 % R. L4-7 were also tested in the iridium-catalysed 
hydrogenation of acyclic imines such as (E)-N-(1-phenylethylidene)aniline. These 
ligands turned out to be very active for this type of reaction and here too, a switch of 
the product configuration that depends on the substituent (H- or Ph-) at the diamidite 
nitrogen atom of the ligand could be observed here. The enantiomeric excess also 
depends on the use of iodine as an additive.  
Since L4-7 showed very different behaviour in hydrogenation reactions compared 
to L1-3 they were also tested in other asymmetric reactions such as 
hydrophosphorylation and hydroformylation of styrene. Hydrophosphorylation 
reactions catalysed by a Pd salt and L4-7 showed good selectivities towards the 
branched product, but gave low conversion and enantioselectivities. The rhodium-
catalysed hydroformylation of styrene led to high conversions, high selectivities to the 
branched product, but low enantioselectivities compared to established benchmark 
ligands.  
Following the concept of heteroatom substitution to generate new mixed bidentate 
phosphine ligands the last approach of the present thesis was the synthesis of a 
phosphine-phosphortriamide. Bidentate phosphine-phosphortriamides are not known 
in literature yet, while the application of monodentate phosphortriamides has been 
studied for several asymmetric reactions. Within the present thesis a readily available 
diamine (see scheme 2.10.2) was successfully combined with the dichlorophosphite-
derivative of (S)-phosphine-amine 47. 31P-NMR investigations showed that the 
obtained structure L8 is much less stable than L1-7.  
3 Summary & Outlook 81 
 
Figure 3.3: Phosphine-Phosphortriamide L8 
 
Due to its high sensitivity, L8 has not been tested yet in catalytic reactions. 
Further investigations could also be the synthesis of a phosphine-phosphortriamide 
based on a diamine with a binaphthyl backbone analogous to BINOL and an 
application of the resulting phosphine-phosphortriamides in asymmetric catalysis. 
In general, mixed bidentate ligands are very interesting due to their wide variety of 
structual modifications as well as their potential for applications in different 
asymmetric transformations. Out of the ligands tested within this work, phosphine-
phosphoramidites show the most promising results. Nevertheless, a large variety of 
chiral amino alcohols still opens an attractive field exploring various phosphine-
phosphorodiamidite structures. 
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4 Experimental 
 
4.1 General methods, solvents and reagents 
 
4.1.1  Inert gas conditions 
 
Reactions involving substances that are sensitive towards air or moisture were 
performed using standard Schlenk techniques or a glove box. Argon 4.6 (Supplier: 
Westfalen) was dried and purified via a special set-up by MBraun (MB 100HP) and 
used as inert gas. 
 
4.1.2  Autoclave techniques 
 
For all reactions under high pressure stainless steel autoclaves made by the 
institute’s work shop were used. They consist of a cylinder closed by a conic screw 
coupled with a digital or analogue pressure gauge. All catalytic hydrogenation 
reactions were performed in autoclaves that have a total volume of 10 mL using a 
glass inlet and a magnetic stirrer. The synthesis of (S)-4a,5,5',6,6',7,7',8,8a,8'-
decahydro-1,1'-binaphthyl-2,2'-diol (literature procedure) was performed in an 
autoclave of 165 mL total volume. 
 
4.1.3  Solvents 
 
Toluene, dichloromethane and pentane were pre-distilled, then dried and degased in 
a set-up of IT Innovative Technology via two stainless steal columns under inert gas 
atmosphere packed with alumina.  
 
Chloroform-d1  dried over molecular sieve (4 Ǻ), degassed under reduced 
pressure at 40 K, stored under argon 
Dichlormethane-d2  dried over molecular sieve (4 Ǻ), degassed under reduced 
pressure at 40 K, stored under argon  
Acetone-d6 dried over molecular sieve (4 Ǻ), degassed under reduced 
pressure at 40 K, stored under argon  
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1,4-dioxane Aldrich 99.8%, water content < 50 ppm, dried over 
molecular sieve (4 Ǻ), degassed with argon (2h)  
Ethanol pre-dried over KOH, evaporated under reduced pressure, 
dried over molecular sieve (3 Ǻ), degassed with argon (2h)  
Methanol pre-dried over KOH, evaporated under reduced pressure, 
dried over molecular sieve (3 Ǻ), degassed with argon (2h)  
THF  pre-dried over CaCl2, evaporated under reduced pressure, 
dried over molecular sieve (4 Ǻ), degassed with argon (2h) 
 
4.1.4  Commercially available reagents 
 
(±)-BINAP      ABCR        98% 
R-(+)-1,1’-Bi-2-naphtol    RCA    >99.0% 
S-(+)-1,1’-Bi-2-naphtol    RCA    >99.0% 
1-Brom-2-fluorbenzene    Alfa Aesar     99.0% 
n-Buthyllithium (1.6M in hexane)   Alfa Aesar 
Dimethylitaconate     ABCR        99% 
KPPh2 (0.5M in THF)    Aldrich 
Methyl-2-acetamidoacrylate   ABCR        99% 
2-Methylquinoline     Alfa Aesar       97% 
Methyl-3-oxo-pentanoate    Acros      >99% 
Sodium-tert-Butanolate    Aldrich       97% 
N-Methyl-Pyrrolidone    Aldrich    99.5% 
Palladium-(II)-acetate    Aldrich       98% 
Pd/C (10% wt, dry)     Aldrich 
(S)-1-Phenylethylamine    ABCR      >99% 
 
Samples of following substances were kindly provided by BASF: 
 
(S)-1-(naphthalene-2-yl)ethylamine      >99% 
(S)-1-(naphthalene-1-yl)ethylamine        98% 
(S)-1-phenylpropane-1-amine       >99% 
(S)-1,2,3,4-tetrahydronaphthalene-1-amine     >99% 
(S)-2,3-dihydro-1H-indene-1-amine      >99% 
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All other chemicals were present in the laboratory or synthesised via known 
literature procedures. 
 
 
4.1.5 Reagents synthesised via literature procedures 
 
 
Substance Reference 
(11bS)-4-chlorodinaphtho[2,1-d:1',2'-
f][1,3,2]dioxaphosphepine 
T. Pullmann, PhD thesis, RWTH Aachen 
University, 2008. 
(11bR)-4-chlorodinaphtho[2,1-d:1',2'-
f][1,3,2]dioxaphosphepine 
T. Pullmann, PhD thesis, RWTH Aachen 
University, 2008. 
(S)-4a,5,5',6,6',7,7',8,8a,8'-decahydro-
1,1'-binaphthyl-2,2'-diol 
A. Korostylev, V.I. Tararov, C. Fischer, 
A. Monsees, A. Börner J. Org. Chem. 
2004, 69, 3220. 
(S)-2-fluoro-N-(1-phenylethyl)aniline 
M. Eggenstein, A. Thomas, J. 
Theuerkauf, G. Franciò, W. Leitner et al. 
Adv. Synth. Catal. 2009,351, 725. 
(S)-2-(diphenylphosphino)-N-(1-
phenylethyl)aniline 
M. Eggenstein, A. Thomas, J. 
Theuerkauf, G. Franciò, W. Leitner et al. 
Adv. Synth. Catal. 2009,351, 725. 
(11bS)-N-(2-(diphenylphosphino)phenyl) 
-N-((S)-1-phenylethyl)dinaphtho[2,1-
d:1',2'f][1,3,2]dioxaphosphepine-4-
amine 
M. Eggenstein, A. Thomas, J. 
Theuerkauf, G. Franciò, W. Leitner et al. 
Adv. Synth. Catal. 2009,351, 725. 
(S)-2'-hydroxy-1,1'-binaphthyl-2-yl 
trifluoromethanesulfonate 
T. Ooi, K. Ohmatsu, K. Maruoka J. Am. 
Chem. Soc. 2007, 129, 2410. 
(S)-2'-(methoxymethoxy)-1,1'-
binaphthyl-2-yl 
trifluoromethanesulfonate 
D. Sälinger, R. Brückner Synlett 2009, 
1, 109. 
(S)-N-benzyl-2'-(methoxymethoxy)-1,1'-
binaphthyl-2-amine 
T. Ooi, K. Ohmatsu, K. Maruoka J. Am. 
Chem. Soc. 2007, 129, 2410. 
(S)-2'-(methoxymethoxy)-1,1'-
binaphthyl-2-amine 
D. Sälinger, R. Brückner Synlett 2009, 
1, 109. 
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Substance Reference 
(S)-2'-amino-1,1'-binaphthyl-2-ol D. Sälinger, R. Brückner Synlett 2009, 
1, 109. 
(S)-2'-(phenylamino)-1,1'-binaphthyl-2-ol 
Š. Vyskočil, S. Jaracz, M. Smrčina, M. 
Štícha, V. Hanuš, M. Polášek, P. 
Kočovský J. Org. Chem. 1998, 63, 
7727. 
[RuCl2(p-cymene)]2 
G.T. Giuffredi, S. Purser, M. Sawicki, 
A.L. Thompson, V. Gouverneur 
Tetrahedron:Asymmetry 2009, 20, 910. 
[CpPd(allyl)] T. Yoshida, S. Otsuka Inorg. Synth. 
1985, 28, 113. 
pinacol H-phosphonate 
A. Zwierzak Can. J. Chem. 1967, 45, 
2501. 
(S)-5-oxopyrrolidine 2-carboxanilide K. Barta, PhD thesis, RWTH Aachen 
University, 2008. 
(S)-2-anilinomethyl-pyrrolidine J.M. Brunel, T. Constantieux, G. Buono 
J. Org. Chem. 1999, 64, 8940. 
 
 
4.1.6 DFT calculations 
 
The DFT calculations* were carried out by using the Gaussian 09 program {1}. 
Truhlar's M06-L functional {2} was employed together with Ahlrich's triple zeta 
valence basis set with polarization function termed def2-TZVP {3}. Additionally the 
automatic density fitting option implemented in Gaussian 09 was applied {4}. The 
nature of stationary points located was verified by frequency calculations proving the 
presence of local minima (i=0) or transition states (i=1). Gibbs free energies ∆G were 
calculated for standard conditions.  
{1}  Gaussian 09, Revision A.02, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. 
Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. 
Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, 
G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. 
Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. 
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Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. 
Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. 
C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. 
Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, 
O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. 
Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. 
Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, and D. 
J. Fox, Gaussian, Inc., Wallingford CT, 2009. 
{2} Zhao, Yan; Truhlar, Donald G. Journal of Chemical 
Physics (2006), 125(19), 194101/1-194101/18 
{3} Weigend, F.; Ahlrichs, R. Phys. Chem. Chem. Phys. 2005, 7, 3297. 
{4} a) Dunlap, B. I. J. Chem. Phys. 1983, 78, 3140-3142. b) Dunlap, B. J. Mol. Struct. 
THEOCHEM 2000, 529, 37.  
* performed by A. Uhe 
   
4.1.7 Analytics 
 
Nuclear magnetic resonance (NMR) 
 
NMR spectra were recorded at room temperature (unless indicated otherwise) on 
DPX-300, AV-400 and AV-600 spectrometer by Bruker. Operating frequencies:  
DPX-300: 1H: 300 MHz, 31P: 121.5 MHz, 13C: 75.5 MHz, 19F: 282 MHz 
AV-400: 1H: 400 MHz, 31P: 162 MHz, 13C: 100.6 MHz, 19F: 376 MHz 
AV-600: 1H: 600 MHz, 31P: 243 MHz, 13C: 151 MHz 
The substance was dissolved in a deuterated solvent and the chemical shifts δ for 1H 
and 13C spectra are given in ppm using the residual solvent signals as internal 
standard. For 31P spectra 85% phosphoric acid, for 19F spectra a borotrifluoride-
diethylether-complex were used as external standard. Coupling constants are given 
in Hertz. Multiplicity of the signals was assigned assuming spectra of first order and 
described by following abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, 
quint. = quintet, m = multiplet and b = broad. For ligand characterisation several other 
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one dimensional (13C-APT, dept45) and two dimensional NMR techniques (1H-1H 
COSY, HMBC, HSQC) were used. 
  
Thin layer chromatography (TLC) 
 
For thin layer chromatography POLYGRAM SIL G/UV254 plates with a silica layer of 
0.2 mm and POLYGRAM ALOX G/UV254 with alumina layer of 0.2 mm from 
Macherey-Nagel were used. Visualisation was done by UV light. 
  
Column Chromatography and filtration 
 
For the purification via flash column chromatograpy basic alumina (pH >9) from Fluka 
or silica (KIESELGEL 60) by Merck with a particle size distribution of 0.040 – 0.063 
mm was used. For filtration celite from Aldrich, filtration paper from Macherey-Nagel 
(under argon in combination with PTFE tubing) or PTFE syringe filter pads (0.45 µm) 
from Roth were used. 
 
Gas chromatography (GC) 
 
For identification of enantiomeric excess (or conversion) of asymmetric catalyses a 
SiChromat 1-4 or a SiChromat 2-8 by Siemens was used for gas chromatography 
under listed conditions. Integration of the observed signals was done by a HP 5890 
integrator. 
 
A) dimethyl 2-methylsuccinate 
    Ivadex 1, 25m, 80°C, isothermal, detector temperature 250°C (FID), 0.8 bar H2, 
    retention times tr: (R) 15.2 min, (S) 15.5 min. 
 
B) methyl 2-acetamidopropanoate 
Ivadex 7, 25m, 10 min 90°C isothermal – 5°/min to 160°C – 10 min 160°C 
isothermal, detector temperature: 250°C (FID), 0.8 bar H2,  
retention times tr: (S) 10.0 min, (R) 12.2 min. 
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C) methyl 2-acetamido-3-phenylpropanoate 
Lipodex E, 25m, 100-180 °C 2°/min – 10 min 180° C isothermal, detector 
temperature: 250°C (FID), 0.57 bar H2, retention times tr:  (S) 34.7 min, (R) 35.2 
min. 
 
D) 2-methyl-1,2,3,4-tetrahydroquinoline 
    Chirasil-Dex-CB, 25m, 80-120°C, 2°C/min, detector temperature: 250°C (FID),  
    1.0 bar H2, retention times tr: (S) 15.3 min, (R) 16.6 min. 
 
E) methyl 3-hydroxypentanoate 
    Lipodex E, 25 m, 10 min 80°C isothermal – 10°/min to 150°C – 15 min 150° C 
    isothermal, detector temperature: 250°C (FID), 0.8 bar H2, retention times tr:  
    (S) 12.2 min, (R) 12.5 min. 
 
F) 1,1,1-trifluoropropan-2-yl acetate 
    Chirasil-Dex-CB, 5 min 50°C isothermal - 25°C/min to 160 °C, detector  
    temperature: 250°C (FID), 1 bar N2, retention times tr: (S) 3.04 min, (R) 3.45 min. 
 
G) 3-phenylpropanal (linear) / 2-phenylpropanal (branched) 
     Ivadex, 25 m, 2 min 70°C isothermal – 2°C/min to 120°C – 15°C/min to 180°C,   
     detector temperature: 250°C (FID), 1 bar H2, retention times tr: (branched, S)  
     12.44 min, (branched, R) 11.99 min, (linear) 13.97 min. 
 
High performance liquid chromatography (HPLC) 
 
For identification of enantiomeric excess (or conversion) of asymmetric catalyses a 
Jasco HPLC device with a Jasco UV diode array detector was used for HPLC 
measurements under following conditions.  
 
A) 2-butyl-1,2,3,4-tetrahydroquinoline           
    Chiralcel OD-H, heptane/iPrOH 98/2, 0.5 mL/min, 20°C, UV detector 250 nm, 
    retention times tr: (R) 12.3 min, (S) 14.2 min. 
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B) 2-phenyl-1,2,3,4-tetrahydroquinoline 
    Chiralcel OD-H, heptane/iPrOH 90/10, 0.5 mL/min, 20°C, UV detector 250 nm, 
    retention times tr: (S) 19.1 min, (R) 23.9 min. 
 
C) N-(1-phenylethyl)aniline 
     Chiralcel OD-H, heptane/iPrOH 97/3, 0.5 mL/min, 5 °C, UV detector 220 nm,  
     retention times tr: (R) 20.2 min, (S) 24.7 min. 
 
D) 4,4,5,5-Tetramethyl-2-(1-phenylethyl)1,3,2-dioaphospholane 2-oxide 
    Chiralpak AD-H, heptane/ethanol 95/5, 0.5 mL/min, 20 °C, UV detector 209 nm, 
    retention times tr: 29.72 min, 42.63 min.  
 
Mass spectroscopy (MS) 
 
Mass spectra were recorded on a Finnigan MAT 95 (70 eV) at the IAC RWTH 
Aachen. Signals with an intensity >10 and the observed value of the high resolution 
measurement were listed for characterisation. SIMS measurements of ionic 
compounds were performed using an NBS matrix and a Cs+ gun.  
 
X-Ray analysis 
 
For single crystal x-ray diffraction measurements* crystals were mounted on glass 
fibers. Geometry and intensity data were collected with a Bruker SMART D8 
goniometer equipped with an APEX CCD detector and with an Incoatec microsource 
(Mo-Kα radiation, λ = 0.71073 Å, multilayer optics). Temperature was controlled 
using an Oxford Cryostream 700 instrument. Intensities were integrated with SAINT+ 
{1} and corrected for absorption with SADABS {2}. The structure was solved by 
direct methods and refined on F2 with SHELXL-97 {3}. 
 
{1} Bruker AXS, SAINT+, Program for Reduction of Data collected on Bruker CCD  
      Area Detector Diffractometer V. 6.02. Bruker AXS Inc., Madison, Wisconsin,   
      USA,1999. 
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{2} Bruker AXS, SADABS, Program for Empirical Absorption Correction of Area  
      Detector Data V 2004/1, Bruker AXS Inc., Madison, Wisconsin, USA, 2004. 
{3} G. M. Sheldrick Acta Crystallogr., Sect. A 2008, 64, 112–122. 
* performed in the group of Prof. U. Englert, IAC RWTH Aachen 
 
4.2 Syntheses and general procedures 
 
4.2.1  Syntheses 
 
4.2.1.1 (R)-2-fluoro-N-(1-phenylethyl)aniline (41) 
 
 
 
This synthesis was performed under argon. rac-BINAP (280.0 mg, 0.45 mmol) and 
palladium acetate (67.3 mg, 0.30 mmol) were dissolved in toluene (15 mL). 1-Bromo-
2-fluorobenzene (60 mmol, 6.56 mL) and (R)-α-Methyl-benzylamine (60 mmol, 
6.92 mL) were added to the yellow solution. Adding sodium tert-butanolate (70 mmol, 
6.74 g) the solution turned purple. The mixture was refluxed for 48 h and conversion 
was controlled by TLC. After cooling down to room temperature the mixture was 
quenched with destilled water (20 mL) and extracted with dichloromethane 
(3x20 mL). The organic phase was dried over NaSO4 and filtered. The solvent was 
removed under reduced pressure and the oily brownish residue was purified by 
column chromatography (SiO2, pentane:ethylacetate 10:1, Rf = 0.64). The product 
was obtained as a colourless oil that slowly solidified to a waxy solid. 
Yield: 10.7 g, (50 mmol, 83 %). 
1H-NMR (CDCl3, 300 MHz): δ = 1.51 (d, J = 6.6 Hz, 3H, CH3), 4.26 (m, 1H, NH), 6.40 
(m, 1H, CH), 6.52 (m, 1H, Ar), 6.78 (m, 1H, Ar), 6.92 (m, 1H, Ar), 7.20 (m, 1H, Ar), 
7.31 (m, 5H, Ar) ppm. 
13C{1H}-NMR (CDCl3, 75 MHz): δ = 25.1 (CH3), 53.3 (CH), 113.2 (d, J = 3.0 Hz, Ar, 
CH), 114.2 (d, J = 18.8 Hz, Ar, CH), 116.5 (d, J = 7.0 Hz, Ar, CH), 124.4 (d, 
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J = 3.4 Hz, Ar, CH), 125.8 (Ar, CH), 127.0 (Ar, CH), 128.7 (Ar, CH), 135.7 (d, 
J = 11.4 Hz, Ar, Cq), 144.8 (Ar, Cq), 151.4 (d, J = 237.4 Hz, Ar, Cq) ppm. 
19F-NMR (CDCl3, 280 MHz): δ =  -136.5 (s) ppm. 
 
4.2.1.2   (S)-2-fluoro-N-(1-phenylpropyl)aniline (42) 
 
 
 
This synthesis was performed under argon. rac-BINAP (186.7 mg, 0.30 mmol) and 
palladium acetate (44.8 mg, 0.20 mmol) were dissolved in toluene (15 mL). 1-Bromo-
2-fluorobenzene (20 mmol, 2.2 mL) and (S)-1−phenylpropane-1-amine (20 mmol, 
2.54 mL) were added to the yellow solution. Adding sodium tert-butanolate (30 mmol, 
2.883 g) the solution turned purple. The mixture was refluxed for 168 h and 
conversion was controlled by TLC. After cooling down to room temperature the 
reaction was quenched with destilled water (20 mL) and extracted with 
dichloromethane (3x20 mL). The organic phase was dried over NaSO4 and filtered. 
The solvent was removed under reduced pressure and the oily brownish residue was 
purified by column chromatography (SiO2, pentane:ethylacetate 20:1, Rf = 0.54). The 
product was obtained as an orange oil. 
Yield:  3.2577 g (14.2 mmol, 71 %) 
1H-NMR (300 MHz, CDCl3): δ = 0.97 (t, J = 7.1 Hz, 3H, CH3), 1.86 (m, 2H, CH2), 4.23 
(m, 1H, CH), 4.32 (b, 1H, NH), 6.42 (m, 1H, Ar), 6.54 (m, 1H, Ar), 6.80 (m, 1H, Ar), 
6.94 (m, 1H, Ar), 7.31 (m, 5H, Ar) ppm. 
13C{1H}-NMR (75 MHz, CDCl3): δ = 11.0 (CH3), 31.8 (CH2), 59.7 (CH), 113.2 (d, 
J = 3.0 Hz, Ar), 114.2 (Ar), 114.4 (Ar), 116.4 (d, J = 6.7 Hz, Ar), 124.5 (d, J = 3.4 Hz, 
Ar), 126.5 (Ar), 127.1 (Ar), 128.6 (Ar), 136.1 (d, J = 12.8 Hz, Ar), 143.6 (Ar), 150.0 
(Ar) 153.1 (Ar) ppm. 
19F-NMR (280 MHz, CDCl3): δ = -136.43 ppm. 
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[α]D20 =  -19.0 (c = 0.67, DCM) 
MS (EI): m/z (rel. intensity) = 229 (M+, 11 %), 201 (12 %), 200 (100 %), 134 (12 %), 
111 (10 %), 105 (59 %), 91 (18 %), 77 (27 %). 
HR-MS (ESI): C15H16FN (M+)  calculated: 229.126   
      found:  229.126 
 
 
4.2.1.3   (S)-2-fluoro-N-(1-(naphthalene-1-yl)ethyl)aniline (43) 
 
 
This synthesis was performed under argon. rac-BINAP (62.2 mg, 0.10 mmol) and 
palladium acetate (16.8 mg, 0.075 mmol) were dissolved in toluene (15 mL). 1-
Bromo-2-fluorobenzene (30 mmol, 3.3 mL) and (S)-1-(naphthalene-1-yl)ethanamine 
(30 mmol, 5.16 g) were added to the yellow solution. Adding sodium tert-butanolate 
(45.0 mmol, 4.33 g) the solution turned purple. The mixture was refluxed for 96 h and 
conversion was controlled by TLC. After cooling down to room temperature the 
reaction was quenched with destilled water (20 mL) and extracted with 
dichloromethane (3x20 mL). The organic phase was dried over NaSO4 and filtered. 
The solvent was removed under reduced pressure and the oily brownish residue was 
purified by column chromatography (SiO2, pentane:ethylacetate 20:1, Rf = 0.54). The 
product was obtained as a yellow oil that slowly solidified to a waxy solid. 
Yield: 7.46 g (28 mmol, 93 %) 
1H-NMR (CDCl3, 300 MHz): δ = 1.70 (d, J = 6.5 Hz, 3H, CH3), 4.42 (b, 1H, NH), 5.29 
(m, 1H, CH), 6.29 (m, 1H, Ar), 6.54 (m, 1H, Ar), 6.74 (m, 1H, Ar), 6.98 (m, 1H, Ar), 
7.41 (m, 1H, Ar), 7.57 (m, 3H, Ar), 7.76 (m, 1H, Ar), 7.91 (m, 1H, Ar), 8.16 (m, 1H, Ar) 
ppm. 
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13C{1H}-NMR (CDCl3, 75 MHz): δ = 23.8 (CH3), 49.5 (CH), 113.2 (d, J = 3.4 Hz, Ar, 
CH), 114.2 (d, J = 18.9 Hz, Ar, CH), 116.5 (d, J = 6.8 Hz, Ar, CH), 122.5 (d, 
J = 17.5 Hz, Ar, CH), 124.5 (Ar, CH), 124.6 (Ar, CH), 125.6 (Ar, CH), 125.9 (Ar, 
CH),126.2 (Ar, CH), 127.6 (Ar, CH), 129.2 (Ar, CH), 130.7 (Ar, Cq), 134.2 (Ar, Cq), 
135.6 (d, J = 11.5 Hz, Ar, Cq), 139.5 (Ar, Cq), 151.5 (d, J = 237.5 Hz, Ar, Cq) ppm. 
19F-NMR (CDCl3, 280 MHz): δ = -136.6 (s) ppm. 
[α]D20 =  +166.6 (c = 0.53, DCM) 
MS (EI): m/z (rel. intensity) = 265 (M+, 27 %), 250 (9 %), 155 (100 %), 128 (8 %), 122 
(6 %), 115 (5 %), 95 (3 %), 75 (2 %). 
HR-MS (ESI): C18H16FN (M+)  calculated: 265.126   
      found:  265.126 
 
 
4.2.1.4 (S)-2-fluoro-N-(1-(naphthalene-2-yl)ethyl)aniline (44) 
 
 
 
This synthesis was performed under argon. rac-BINAP (186.7 mg, 0.30 mmol) and 
palladium acetate (44.8 mg, 0.20 mmol) were dissolved in toluene (15 mL). 1-Bromo-
2-fluorobenzene (20 mmol, 2.2 mL) and (S)-1-(naphthalene-2-yl)ethanamine 
(20 mmol, 3.425 g) were added to the yellow solution. Adding sodium tert-butanolate 
(30 mmol, 2.883 g) the solution turned purple. The mixture was refluxed for 72 h and 
conversion was controlled by TLC. After cooling down to room temperature the 
reaction was quenched with destilled water (100 mL) and extracted with 
dichloromethane (3x50 mL). The organic phase was dried over NaSO4 and filtered. 
The solvent was removed under reduced pressure and the oily brownish residue was 
purified by column chromatography (SiO2, pentane:ethylacetate 20:1, Rf = 0.54). The 
product was obtained as a yellow solid. 
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Yield: 3.5787 g (13.5 mmol, 68 %) 
1H-NMR (300 MHz, CDCl3): δ = 1.52 (d, J = 6.6 Hz, 3H, CH3), 4.29 (b, 1H, NH), 4.55 
(quin, J = 6.6 Hz, 1H, CH), 6.40 (m, 2H, Ar), 6.67 (m, 1H, Ar), 6.88 (m, 1H, Ar), 7.36 
(m, 3H, Ar), 7.67 (m, 4H, Ar) ppm. 
 
13C{1H}-NMR (75 MHz, CDCl3): δ = 25.2 (CH3), 53.7 (CH), 113.5 (Ar), 114.3 (Ar), 
114.5 (Ar), 116.7 (Ar), 124.3 (Ar), 124.6 (Ar), 125.7 (Ar), 126.3 (Ar), 127.9 (Ar), 128.7 
(Ar), 133.0 (Ar), 133.7 (Ar), 135.9 (Ar), 142.5 (Ar), 150.0 (Ar),  153.2 (Ar) ppm. 
 
19F-NMR (280 MHz, CDCl3): δ = -136.47 ppm. 
[α]D20 =  -12.2 (c = 0.53, DCM) 
MS (EI): m/z (rel. intensity) = 265 (M+, 5 %), 205 (19 %), 190 (16 %), 170 (40 %), 156 
(11 %), 155 (100 %). 
HR-MS (ESI): C18H16FN (M+)  calculated: 265.126   
      found:  265.126 
 
 
4.2.1.5   (S)-N-(2-fluorophenyl)-1,2,3,4-tetrahydronaphthalene-1-amine (45) 
 
 
 
This synthesis was performed under argon. rac-BINAP (373.4 mg, 0.60 mmol) and 
palladium acetate (89.6 mg, 0.40 mmol) were dissolved in toluene (30 mL). 1-Bromo-
2-fluorobenzene (40 mmol, 4.36 mL) and (S)-1,2,3,4-tetrahydronaphtalene-1-amine 
(40 mmol, 5.83 mL) were added to the yellow solution. Adding sodium tert-butanolate 
(60 mmol, 5.766 g) the solution turned purple. The mixture was refluxed for 120 h 
and conversion was controlled by TLC. After cooling down to room temperature the 
reaction was quenched with destilled water (100 mL) and extracted with 
dichloromethane (3x50 mL). The organic phase was dried over NaSO4 and filtered. 
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The solvent was removed under reduced pressure and the oily brownish residue was 
purified by column chromatography (SiO2, pentane:ethylacetate 20:1, Rf = 0.54). The 
product was obtained as an orange oil. 
Yield:  5.583 g (23.1 mmol, 58 %) 
1H-NMR (300 MHz, CDCl3): δ = 1.83 (m, 4H, CH2), 2.75 (m, 2H, CH2), 4.10 (b, 1H,  
NH), 4.57 (m, 1H, CH), 6.54 (m, 1H, Ar), 6.77 (m, 1H, Ar), 6.92 (m, 2H, Ar) 7.10 (m, 
3H, Ar), 7.32 (m, 1H, Ar), ppm. 
13C{1H}-NMR (75 MHz, CDCl3): δ = 19.5 (CH2), 28.9 (CH2), 29.4 (CH2), 51.0 (CH), 
112.2 (d, J = 3.2 Hz, 3.2, Ar), 114.5 (Ar), 114.8 (Ar), 116.3 (d, J = 7.2 Hz, Ar), 124.6 
(d, J = 3.2 Hz, Ar), 126.2 (Ar), 127.3 (Ar), 129.2 (d, J = 4.5 Hz, Ar), 136.0 (d, 
J = 12.1 Hz, Ar), 137.7 (d, J = 2.7 Hz, Ar), 146.2 (Ar) 150.0 (Ar) ppm. 
19F-NMR (280 MHz, CDCl3): δ = -136.15 ppm. 
[α]D20 =  -6.6 (c = 0.72, DCM) 
MS (EI): m/z (rel. intensity) = 241 (M, 17 %), 231 (71 %), 230 (100 %), 129 (63 %), 
128 (34 %), 127 (14 %), 115 (37 %), 111 (79 %), 91 (15 %), 83 (11 %). 
HR-MS (ESI): C16H16FN (M)  calculated: 241.126   
      found:  241.126 
 
 
4.2.1.6   (S)-N-(2-fluorophenyl)-2,3-dihydro-1H-indene-1-amine (46) 
 
 
 
This synthesis was performed under argon. rac-BINAP (211.0 mg, 0.34 mmol) and 
palladium acetate (50.6 mg, 0.22 mmol) were dissolved in toluene (30 mL). 1-Bromo-
2-fluorobenzene (40 mmol, 4.36 mL) and (S)-1,2,3,4-tetrahydronaphtalene-1-amine 
(40 mmol, 5.13 mL) were added to the yellow solution. Adding sodium tert-butanolate 
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(60 mmol, 5.766 g) the solution turned purple. The mixture was refluxed for 168 h 
and conversion was controlled by TLC. After cooling down to room temperature the 
reaction was quenched with destilled water (100 mL) and extracted with 
dichloromethane (3x50 mL). The organic phase was dried over NaSO4 and filtered. 
The solvent was removed under reduced pressure and the oily brownish residue was 
purified by column chromatography (SiO2, pentane:ethylacetate 20:1, Rf = 0.54). The 
product was obtained as an orange oil. 
Yield:  3.3654 g (14.8 mmol, 37 %) 
1H-NMR (300 MHz, CDCl3): δ = 1.98 (m, 1H, CH2), 2.65 (m, 1H, CH2), 2.89-3.14 (m, 
2H, CH2), 4.24 (b, 1H,  NH), 5.07 (m, 1H, CH), 6.69 (m, 1H, Ar), 6.90-7.44 (m, 11H, 
Ar) ppm. 
13C{1H}-NMR (75 MHz, CDCl3): δ = 30.3 (CH2), 33.8 (CH2), 58.5 (CH), 112.9 (Ar), 
114.5 (Ar), 114.8 (Ar), 116.9 (Ar), 124.3 (Ar), 124.6 (d, J = 3.9 Hz, Ar), 124.9 (Ar), 
125.2 (Ar), 126.7 (Ar), 128.1 (Ar), 143.6 (Ar), 144.0 (Ar) ppm. 
19F-NMR (280 MHz, CDCl3): δ = -136.14 ppm. 
[α]D20 =  +41.6 (c = 0.68, DCM) 
MS (EI): m/z (rel. intensity) = 227 (M, 27 %), 187 (14 %), 186 (100 %), 185 (35 %), 
183 (18 %), 170 (10 %), 165 (24 %), 117 (81 %), 116 (89 %), 115 (86 %), 111 (93 
%), 91 (18 %), 89 (12 %), 84 (10 %), 83 (15 %). 
HR-MS (ESI): C15H14FN (M)  calculated: 227.110   
      found:  227.110 
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4.2.1.7   (R)-2-(diphenylphosphino)-N-(1-phenylethyl)aniline (47)  
 
 
 
Synthesis and work-up were performed under argon. Potassium diphenylphosphide 
(60 mmol, 120 mL, 0.5M in THF) was transferred into a three-necked round bottom 
flask. THF was removed under reduced pressure and a solution of 41 (60 mmol, 
12.9 g) in 1,4-dioxane (60 mL) was added. The reaction mixture was refluxed for 168 
h and conversion was controlled via 31P-NMR spectroscopy. The solvent was 
removed under reduced pressure and degassed water (50 mL) was added to the 
residue. The product was extracted with dichloromethane (3 x 40 mL). The collected 
organic phase was dried with degassed and dried sodium sulfate. After filtration and 
remove of the solvent the crude product was obtained as yellow oil. It was dissolved 
in toluene (10 mL) and ethanol (30 mL) was added. At -18°C the product is obtained 
via phase separation from the lower of two phases in sufficient purity (≥95 %  31P-
NMR) for further syntheses. The product was obtained as yellow oil that slowly 
solidified at room temperature. 
Yield: 12.6 g (32.8 mmol, 55 %) 
1H-NMR (CDCl3, 300 MHz): δ = 1.26 (d, J = 6.4 Hz, 3H, CH3), 4.38 (quin, J = 6.4 Hz, 
1H, CH), 4.91 (b, 1H, NH), 6.29 (dd, J = 5.1 Hz, J = 8.4 Hz, 1H, Ar), 6.48 (t, 
J = 7.5 Hz, 1H, Ar), 6.75 (td, J = 7.5 Hz, 1.8 Hz, 1H, Ar), 6.95-7.20 (m, 8H, Ar), 7.29 
(m, 7H, Ar) ppm. 
13C{1H}-NMR (75 MHz, CDCl3): δ = 25.3 (CH3), 53.6 (CH), 111.4 (d, J = 2.0 Hz, Ar, 
CH), 117.1 (d, J = 2.0 Hz, Ar, CH), 118.6 (d, J = 2.0 Hz, Ar, Cq), 125.8 (Ar, CH),126.7 
(Ar, CH), 128.52 (Ar, CH), 128.58 (Ar, CH), 128.68 (Ar, CH), 128.82 (Ar, CH), 128.85 
(Ar, CH), 130.5 (Ar, CH), 133.6 (d, J = 4.2 Hz, Ar, CH), 133.8 (d, J = 4.2 Hz, Ar, CH), 
134.6 (d, J = 6.9 Hz, Ar, CH), 135.4 (d, J = 7.9 Hz, Ar, Cq), 135.5 (d, J = 7.9 Hz, Ar, 
Cq), 145.2 (Ar, Cq), 149.7 (d, J = 16.1 Hz, Ar, Cq) ppm. 
31P{1H}-NMR (CDCl3, 125 MHz): -19.9 (s) ppm. 
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4.2.1.8 (S)-2-(diphenylphosphino)-N-(1-phenylpropyl)aniline (48) 
 
 
 
Synthesis and work-up were performed under argon. Potassium diphenylphosphide 
(10 mmol, 20 mL, 0.5M in THF) was transferred into a three-necked round bottom 
flask. THF was removed under reduced pressure and a solution of 42 (10 mmol, 
2.2929 g) in 1,4-dioxane (40 mL) was added. The reaction mixture was refluxed for 
72 h and conversion was controlled via 31P-NMR spectroscopy. The solvent was 
removed under reduced pressure and degassed water (30 mL) was added to the 
residue. The product was extracted with dichloromethane (3 x 25 mL). The collected 
organic phase was dried with degassed and dried sodium sulfate. After filtration and 
remove of the solvent the crude product was obtained as yellow oil. It was dissolved 
in toluene (10 mL), filtered over neutral alumina and eluted with additional toluene 
(30 mL). The solvent was removed under reduced pressure and the residue was 
taken up in pentane (15 mL). At -18°C the product was obtained as a colourless 
highly viscous oil. 
Yield: 3.06 g (7.73 mmol, 77 %) 
1H-NMR (CDCl3, 300 MHz): δ = 0.62 (t, J = 7.4 Hz, 3H, CH3), 1.50 (qint, J = 7.3 Hz, 
2H, CH2), 4.09 (m, 1H, CH), 4.93 (b, 1H, NH), 6.25 (m, 1H, Ar), 6.39 (m, 1H, Ar), 6.71 
(m, 1H, Ar), 7.08 (m, 16H, Ar) ppm. 
 
13C{1H}-NMR (75 MHz, CDCl3): δ = 10.7 (CH3), 31.8 (CH2), 59.5 (CH), 111.4 (d, J = 
2.3 Hz, Ar), 117.2 (d, J = 3.3 Hz, Ar), 118.7 (Ar), 118.8 (Ar), 126.4 (Ar), 126.8 (Ar), 
128.4 (Ar), 128.5 (Ar), 128.6 (d, J = 2.8 Hz, Ar), 128.7 (d, J = 2.8 Hz, Ar), 128.9 (Ar), 
130.6 (Ar), 133.7 (d, J = 3.4 Hz, Ar), 133.9 (d, J = 3.4 Hz, Ar), 134.1 (Ar), 134.5 (Ar), 
134.6 (Ar), 135.4 (Ar), 135.5 (Ar), 135.6 (Ar), 135.7 (Ar), 143.8 (Ar), 149.7 (Ar), 149.9 
(Ar) ppm. 
31P{1H}-NMR (CDCl3, 125 MHz): δ = -19.41 (s) ppm. 
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[α]D20 =  +246.7 (c = 0.55, DCM) 
MS (EI): m/z (rel. intensity) = 395 (M+, 49 %), 367 (27 %), 366 (100 %), 305 (10 %), 
304 (44 %), 288 (10 %), 277 (28 %), 276 (18 %), 262 (50 %), 261 (13 %), 202 
(58 %), 201 (100 %), 200 (27 %), 186 (34 %), 183 (42 %), 182 (18 %), 124 (24 %),  
(70 %), 108 (42 %), 107 (20), 105 (21), 91 (28 %), 78 (21 %), 77 (40 %), 72 (47 %), 
71 (44 %). 
HR-MS (ESI): C27H26NP (M+)  calculated: 395.179   
      found:  395.180 
 
 
4.2.1.9   (S)-2-(diphenylphosphino)-N-(1-(naphthalene-1-yl)ethyl)aniline (49) 
 
H
N
PPh2
 
 
Synthesis and work-up were performed under argon. Potassium diphenylphosphide 
(30 mmol, 60 mL, 0.5M in THF) was transferred into a three-necked round bottom 
flask. THF was removed under reduced pressure and a solution of 43 (30 mmol, 
6.3622 g) in 1,4-dioxane (30 mL) was added. The reaction mixture was refluxed for 
168 h and conversion was controlled via 31P-NMR spectroscopy. The solvent was 
removed under reduced pressure and degassed water (30 mL) was added to the 
residue. The product was extracted with dichloromethane (3 x 25 mL). The collected 
organic phase was dried with degassed and dried sodium sulfate. After filtration over 
Celite® and remove of the solvent the crude product was obtained as yellow oil. It 
was dissolved in dichloromethane (10 mL) and pentane (18 mL) was added. At -18°C 
the product is obtained as colourless crystals. 
Yield: 6.3 g (14.6 mmol, 52 %) 
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1H-NMR (CDCl3, 300 MHz): δ = 1.44 (d, J = 6.6 Hz, 3 H), 5.09 (b, 1H, NH), 5.21 (m, 
1H, CH), 6.19 (m, 1H, Ar), 6.51 (m, 1H, Ar), 6.82 (m, 1H, Ar), 6.93 (m, 1H, Ar), 7.23 
7.61 (m, 14H, Ar), 7.65 (m, 1H, Ar), 7.84 (m, 1H, Ar), 8.07 (m, 1H, Ar) ppm. 
 
13C{1H}-NMR (75 MHz, CDCl3): δ = 23.9 (CH3), 49.7 (CH), 111.5 (Ar), 117.2 (Ar), 
118.6 (d, J = 7.6 Hz, Ar), 122.4 (d, J = 8.5 Hz, Ar), 125.4 (Ar), 126.0 (d, J = 8.5 Hz, 
Ar), 127.4 (Ar), 128.3 (Ar), 128.7 (d, J = 7.6 Hz, Ar), 128.9 (d, J = 5.7 Hz, Ar), 129.2 
(Ar), 130.7 (d, J = 5.7 Hz, Ar), 133.7 (Ar), 133.9 (Ar), 134.1 (Ar), 134.7 (d, J = 7.6 Hz, 
Ar), 135.4 (Ar), 135.5 (Ar), 135.6 (Ar), 140.0 (Ar), 149.5 (Ar), 149.7 (Ar) ppm. 
31P{1H}-NMR (CDCl3, 125 MHz): δ = -18.8 (s) ppm. 
[α]D20 =  +143.1 (c = 0.62, DCM) 
MS (EI): m/z (rel. intensity) = 431 (M+, 100 %), 416 (44 %), 338 (10 %), 304 (12 %), 
303 (45 %), 288 (32 %), 276 (17 %), 261 (12 %), 198 (30 %), 183 (18 %), 155 
(27 %), 153 (11 %), 77 (4 %). 
HR-MS (ESI): C30H27NP (M+ + H) calculated: 432.187   
      found:  432.187 
 
 
4.2.1.10   (S)-2-(diphenylphosphino)-N-(1-(naphthalene-2-yl)ethyl)aniline (50) 
 
 
 
Synthesis and work-up were performed under argon. Potassium diphenylphosphide 
(23.98 mmol, 47.96 mL, 0.5M in THF) was transferred into a three-necked round 
bottom flask. THF was removed under reduced pressure and a solution of 44 
(23.98 mmol, 7.5 g) in 1,4-dioxane (40 mL) was added. The reaction mixture was 
refluxed for 72 h and conversion was controlled via 31P-NMR spectroscopy. The 
solvent was removed under reduced pressure and degassed water (30 mL) was 
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added to the residue. The product was extracted with dichloromethane (3 x 25 mL). 
The collected organic phase was dried with degassed and dried sodium sulfate. After 
filtration and remove of the solvent the crude product was obtained as yellow oil. It 
was dissolved in toluene (10 mL), filtered over neutral alumina and eluted with 
additional toluene (30 mL). After removing the solvent under reduced pressure the 
residue was taken up in dichloromethane (5 mL) and pentane (10 mL) was added. At 
-18°C the product is obtained as colourless crystals. 
Yield: 2.01 g (7.56 mmol, 32 %) 
1H-NMR (CDCl3, 300 MHz): δ = 1.33 (d, J = 7.2 Hz, 3H, CH3), 4.45 (m, 1H, CH), 4.99 
(b, 1H, NH), 6.29 (m, 1H, Ar), 6.39 (m, 1H, Ar), 6.73 (m, 1H, Ar), 6.86 (m, 1H, Ar), 
7.09 (m, 2H, Ar), 7.23 (m, 11H, Ar), 7.55 (m, 4H, Ar) ppm. 
 
13C{1H}-NMR (75 MHz, CDCl3): δ = 25.1 (CH3), 53.8 (CH), 111.7 (d, J =2.3 Hz, Ar), 
117.3 (d, J = 3.7 Hz, Ar), 118.7 (Ar), 118.8 (Ar), 124.2 (Ar), 124.5 (Ar), 125.6 (Ar), 
126.0 (Ar), 127.8 (Ar), 127.9 (Ar), 128.5 (Ar), 128.7 (d, 3J = 3.0 Hz, Ar), 128.8 (d, J = 
2.3 Hz, Ar), 128.9 (Ar), 129.0 (Ar), 130.7 (Ar), 133.6 (Ar), 133.7 (Ar), 133.8 (Ar), 
133.9 (Ar), 134.0 (Ar), 134.7 (d, J = 6.4 Hz, Ar), 135.5 (Ar), 135.6 (Ar), 135.7 (Ar), 
142.8 (Ar), 149.7 (Ar), 149.9 (Ar) ppm. 
 
31P{1H}-NMR (CDCl3, 125 MHz): δ = -19.92 (s) ppm. 
[α]D20 =  +29.5 (c = 0.41, DCM) 
MS (EI): m/z (rel. intensity) = 431 (M+, 100 %), 430 (16 %), 417 (16 %), 416 (49 %), 
387 (11 %), 338 (10 %), 279 (19 %), 276 (13 %), 275 (12 %), 202 (61 %), 201 
(100 %), 198 (14 %), 186 (33 %), 183 (41 %), 170 (10 %), 167 (29 %), 156 (12 %), 
155 (70 %), 154 (18 %), 153 (14), 152 (14), 149 (70 %), 127 (16 %), 124 (25 %), 108 
(42 %), 107 (20 %), 86 (29 %), 84 (45 %), 78 (20 %), 77 (31 %), 71 (13 %), 70 (12%). 
HR-MS (ESI): C30H26NP (M+)  calculated: 431.179   
      found:  431.179 
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4.2.1.11 (S)-N-(2-(diphenylphosphino)phenyl)-1,2,3,4-tetrahydronaphthalene-1 
              amine (51) 
 
 
 
Synthesis and work-up were performed under argon. Potassium diphenylphosphide 
(22.30 mmol, 44.6 mL, 0.5M in THF) was transferred into a three-necked round 
bottom flask. THF was removed under reduced pressure and a solution of 45 
(22.30 mmol, 5.383 g) in 1,4-dioxane (20 mL) was added. The reaction mixture was 
refluxed for 168 h and conversion was controlled via 31P-NMR spectroscopy. The 
solvent was removed under reduced pressure and degassed water (200 mL) was 
added to the residue. The product was extracted with dichloromethane (3 x 30 mL). 
The collected organic phase was dried with degassed and dried sodium sulfate. After 
filtration and remove of the solvent the crude product was obtained as yellow oil. It 
was dissolved in toluene (10 mL), filtered over neutral alumina and eluted with 
additional toluene (30 mL). After removing the solvent under reduced pressure the 
residue was taken up in toluene (5 mL) and pentane (10 mL) was added. At -18°C 
the product is obtained as slightly yellowish highly viscous oil. 
Yield: 6.98 g (17.13 mmol, 77 %) 
1H-NMR (300 MHz, CDCl3): δ = 1.50-1.86 (m, 4H, CH2), 2.57 (m, 2H, CH2), 4.48 (b, 
1H,  NH), 4.72 (m, 1H, CH), 6.52 (m, 1H, Ar), 6.66-7.26 (m, 17H, Ar) ppm. 
13C{1H}-NMR (75 MHz, CDCl3): δ = 19.7 (CH2), 29.0 (CH2), 29.4 (CH2), 51.6 (CH), 
110.4 (Ar), 117.0 (d, J = 3.8 Hz, Ar), 119.1 (d, J = 8.4 Hz, Ar), 126.1 (Ar), 127.0 (Ar), 
128.5 (Ar), 128.6 (Ar), 128.70 (Ar), 128.77 (Ar), 128.80 (Ar), 128.84 (Ar), 128.9 (Ar), 
130.8 (Ar), 133.6 (Ar), 133.8 (d, J = 7.5 Hz, Ar), 133.9 (Ar), 135.1 (d, J = 5.8 Hz, Ar), 
135.4 (Ar), 135.5 (Ar), 135.6 (Ar), 137.6 (Ar), 137.8 (Ar), 150.0 (Ar), 150.2 (Ar) ppm. 
31P{1H}-NMR (125 MHz, CDCl3): δ = -19.72 ppm. 
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[α]D20 =  +34.8 (c = 0.63, DCM) 
MS (EI): m/z (rel. intensity) = 407 (M, 12 %), 278 (16 %), 277 (33 %), 276 (14 %), 
254 (14 %), 253 (13 %), 252 (12 %), 233 (19 %), 216 (12 %), 215 (27 %), 202 (43 
%), 201 (100 %), 198 (16 %), 186 (23 %), 185 (11 %), 183 (51 %), 152 (12 %), 149 
(13 %), 131 (42 %), 130 (22 %), 129 (13 %), 128 (11 %), 124 (19 %), 111 (15 %), 
108 (35 %), 107 (21 %), 92 (10 %), 91 (29 %), 86 (29 %), 84 (45 %), 78 (20 %), 77 
(38 %). 
HR-MS (ESI): C28H26NP (M)  calculated: 407.179   
      found:  407.179 
 
 
4.2.1.12 (S)-N-(2-(diphenylphosphino)phenyl)-2,3-dihydro-1H-indene-1-amine (52) 
 
 
 
Synthesis and work-up were performed under argon. Potassium diphenylphosphide 
(14.72 mmol, 29.4 mL, 0.5M in THF) was transferred into a three-necked round 
bottom flask. THF was removed under reduced pressure and a solution of 46 
(14.72 mmol, 3.3454 g) in 1,4-dioxane (15 mL) was added. The reaction mixture was 
refluxed for 120 h and conversion was controlled via 31P-NMR spectroscopy. The 
solvent was removed under reduced pressure and degassed water (150 mL) was 
added to the residue. The product was extracted with dichloromethane (3 x 30 mL). 
The collected organic phase was dried with degassed and dried sodium sulfate. After 
filtration and remove of the solvent the crude product was obtained as yellow oil. It 
was dissolved in toluene (10 mL), filtered over neutral alumina and eluted with 
additional toluene (30 mL). After removing the solvent under reduced pressure the 
residue was taken up in toluene (5 mL) and pentane (10 mL) was added. At -18°C 
the product is obtained as slightly yellowish highly viscous oil. 
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Yield: 4.1679 g (10.59 mmol, 72 %) 
1H-NMR (300 MHz, CDCl3): δ = 1.69 (m, 1H, CH2), 2.49 (m, 1H, CH2), 2.76 (m, 2H, 
CH2), 4.83 (m, 2H, NH/CH), 6.57 (m, 1H, Ar), 6.72-7.33 (m, 17H, Ar) ppm. 
13C{1H}-NMR (75 MHz, CDCl3): δ = 30.3 (CH2), 34.4 (CH2), 58.9 (CH), 110.9 (d, 
J = 2.2 Hz, Ar), 117.2 (d, J = 3.0 Hz, Ar), 119.1 (d, J = 8.5 Hz, Ar), 124.1 (Ar), 124.8 
(Ar), 125.4 (Ar), 126.7 (Ar), 127.8 (Ar), 128.3 (Ar), 128.5 (Ar), 128.6 (d, J = 1.5 Hz, 
Ar), 128.7 (d, J = 2.0 Hz, Ar), 128.8 (Ar), 128.9 (Ar), 129.2 (Ar), 130.8 (Ar), 133.7 (d, 
J = 3.4 Hz, Ar), 133.9 (d, J = 3.4 Hz, Ar), 134.9 (d, J = 5.5 Hz, Ar), 135.5 (d, 
J = 7.9 Hz, Ar), 143.4 (Ar), 144.3 (Ar), 150.5 (Ar), 150.7 (Ar) ppm. 
31P{1H}-NMR (125 MHz, CDCl3): δ = -20.04 ppm. 
[α]D20 =  +60.8 (c = 0.84, DCM) 
MS (EI): m/z (rel. intensity) = 393 (M, 2 %), 352 (17 %), 351 (35 %), 337 (18 %), 227 
(17 %), 202 (45 %), 201 (91 %), 187 (12 %), 186 (100 %), 185 (30 %), 183 (39 %), 
168 (12 %), 165 (23 %), 124 (17 %), 117 (64 %), 116 (14 %), 115 (21 %), 111 (26 
%), 108 (43 %), 107 (17 %), 92 (27 %), 91 (46 %), 86 (10 %), 84 (16 %), 78 (15 %), 
77 (23 %). 
HR-MS (ESI): C27H24NP (M)  calculated: 393.164   
      found:  393.164 
 
 
4.2.1.13 (S)-4-chloro-7a,8,9,10,11,11a,12,13,14,15-decahydrodinaphtho 
              [2,1-d:1',2'-f][1,3,2]dioxaphosphepine (55) 
 
 
 
Synthesis and work-up were performed under argon. 53 (17.46 mmol, 5 g) was 
dissolved in 20 mL PCl3 and a drop of N-methyl pyrollidone was added. The mixture 
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was refluxed for 1h. Excess of PCl3 was removed under reduced pressure using an 
additional cooling trap (N2) and a washing bottle filled with KOH(s). The yellowish 
residue was taken up in toluene and reduced to dryness (3 x 30 mL) to remove 
residues of PCl3 via azeotropic distillation. After drying the product 16 h at 80 °C 
under reduced pressure it was obtained as a colourless solid.  
 
Yield: quantitative. 
 
1H-NMR (300 MHz, CDCl3): δ = 1.72 (m, 8H, CH2), 2.22 (m, 2H, CH2), 2.59 (m, 2H, 
CH2), 2.76 (m, 4H, CH2), 6.87 (d, J = 8.5 Hz, Ar),  6.96 (d, J = 8.5 Hz, Ar), 7.05 (d, J = 
8.5 Hz, Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CDCl3): δ = 169.08 ppm. 
 
 
4.2.1.14 (11bS)-4-chloro-5-phenyl-4,5-dihydrodinaphtho[2,1-d:1',2'-f][1,3,2] 
              Oxazaphosphepine (73) 
 
 
 
Synthesis and work-up were performed under argon. (Sa)-2'-(phenylamino)-1,1'-
binaphthyl-2-ol (1.812 mmol, 0.655 g) and PCl3 (27.18 mmol, 2.42 mL) were 
dissolved in toluene (10 mL) and a drop of N-methyl pyrollidone was added. The 
mixture was stirred at 85 °C for 2h then cooled down to room temperature. Excess of 
PCl3 was removed under reduced pressure using an additional cooling trap (N2) and 
a washing bottle filled with KOH(s). The yellowish residue was taken up in toluene 
(10 mL) and reduced to dryness to remove residues of PCl3 via azeotropic 
distillation. After drying the product 16 h at 50 °C under reduced pressure it was 
obtained as a colourless solid.  
 
Yield: quantitative. 
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1H-NMR (300 MHz, CDCl3): δ = 6.86 (d, J = 7.7 Hz, 2H, Ar), 6.99 (t, J = 7.5 Hz, 1H, 
Ar),  7.12 (t, J = 7.5 Hz, 2H, Ar), 7.26 (m, 4H, Ar), 7.43 (m, 4H, Ar), 7.87 (m, 4H, Ar) 
ppm. 
 
31P{1H}-NMR (125 MHz, CDCl3): δ = 176.16 ppm. 
 
 
4.2.1.15 (S)-1,1-dichloro-N-(2-(diphenylphosphino)phenyl)-N-(1-phenylethyl) 
              Phosphinamine (S-74) 
 
 
 
To a solution of (S)-2-(diphenylphosphino)-N-(1-phenylethyl)aniline (3.0510 g, 8.00 
mmol) in CH2Cl2 (30 mL) NEt3 (5.54 mL, 40 mmol) was added at 0 °C and stirred for 
1 h. Then PCl3 (10.50 mg, 120 mmol) was added dropwise. The mixture was allowed 
to warm to room temperature and stirred over night. The solvent and excessive PCl3 
were removed under reduced pressure. The residue was taken up in toluene and 
filtered through a PTFE membrane. Removing the solvent under reduced pressure 
gave the desired product as a yellow solid.  
 
Yield: quantitative 
 
1H-NMR (600 MHz, CD2Cl2): δ =  1.91 (dd, J = 6.80 Hz, 3H, CH3), 5.18 (m, 1H, CH), 
6.99 (m, 1H, Ar), 7.18 (m, 8H, Ar), 7.61 (m, 4H, Ar), 7.76 (m, 2H, Ar), 8.01 (m, 2H, 
Ar), 8.20(m, 2H, Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 27.3 (d, J = 296.2 Hz), 90.2 (d, J = 296.2 Hz) 
ppm. 
 
13C{1H}-NMR (150 MHz, CD2Cl2): δ = 22.45 (CH3), 58.08 (CH), 117.51 (Ar), 123.44 
(Ar), 125.28 (Ar), 126.09 (Ar), 127.95 (Ar), 128.22 (Ar), 128.97 (Ar), 129.03 (Ar), 
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129.17 (Ar), 129.31 (Ar), 129.60 (Ar), 129.73 (Ar), 133.80 (Ar),134.58 (Ar), 134.68 
(Ar),135.59 (Ar), 135.71 (Ar),135.88 (Ar), 135.98 (Ar), 140.99 (Ar) ppm. 
 
 
4.2.1.16 (R)-1,1-dichloro-N-(2-(diphenylphosphino)phenyl)-N-(1-phenylethyl) 
              Phosphinamine (R-74) 
 
 
To a solution of  (R)-2-(diphenylphosphino)-N-(1-phenylethyl)aniline (3.0510 g, 8.00 
mmol) in CH2Cl2 (30 mL) NEt3 (5.54 mL, 40 mmol) was added at 0 °C and stirred for 
1 h. Then PCl3 (10.50 mg, 120 mmol) was added dropwise. The mixture was allowed 
to warm to room temperature and stirred over night. The solvent and excessive PCl3 
were removed under reduced pressure. The residue was taken up in toluene and 
filtered through a PTFE membrane. Removing the solvent under reduced pressure 
gave the desired product as a yellow solid  
 
Yield: quantitative. 
 
1H-NMR (600 MHz, CD2Cl2): δ =  1.92 (dd, J = 6.86 Hz, 3H, CH3), 5.18 (m, 1H, CH), 
6.99 (m, 1H, Ar), 7.18 (m, 8H, Ar), 7.61 (m, 4H, Ar), 7.77 (m, 2H, Ar), 8.02 (m, 2H, 
Ar), 8.20(m, 2H, Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 27.4 (d, J = 297.0 Hz), 90.2 (d, J = 297.0 Hz) 
ppm. 
 
13C{1H}-NMR (150 MHz, CD2Cl2): δ = 22.43 (CH3), 58.09 (CH), 117.52 (Ar), 123.64 
(Ar), 125.28 (Ar), 126.09 (Ar), 127.98 (Ar), 128.20 (Ar), 128.96 (Ar), 129.01 (Ar), 
129.25 (Ar),129.38 (Ar), 129.67 (Ar), 129.80 (Ar), 133.77 (Ar), 134.70 (Ar), 134.80 
(Ar), 135.54 (Ar), 135.64 (Ar), 135.84 (Ar), 135.93 (Ar), 140.88 (Ar) ppm.  
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4.2.1.17 (11bS)-N-(2-(diphenylphosphino)phenyl)-N-((S)-1-(naphthalene-1-yl)ethyl) 
              dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine (L1) 
 
 
 
Synthesis and work-up were performed under argon. To a solution of 49 (0.5 mmol, 
214.8 mg)  and TMEDA (0.6 mmol, 0.09 mL) in toluene (10 mL), n-Buthyllithium 
(0.55 mmol, 0.34 mL, 1.6M in hexane) was added dropwise at -78°C (dry 
ice/acetone bath). After stirring the reaction mixture for 1h at -78°C and for 1h at 0°C 
a solution of (11bS)-4-chlorodinaphtho[2,1-d:1',2'f][1,3,2]dioxaphosphepine (0.55 
mmol, 192.9 mg) in toluene (5 mL) was slowly added at -78°C. The reaction was 
allowed to warm up to room temperature and stirred for 16h. The reaction mixture 
was filtered over a PTFE membrane. Toluene was removed under reduced pressure 
and the product was precipitated with ethanol from toluene. After the first 
precipitation the colourless solid had a sufficient purity (88%  31P-NMR) for 
catalyses. Purity after second precipitation: 100%. 
Yield: 1st  precipitation:  236.0 mg (0.32 mmol, 66 %) 
           2nd precipitation:  19.0 mg (0.02 mmol, 5 %) 
1H-NMR (600 MHz, CD2Cl2): δ = 2.04 (br, 3H, CH3), 5.48 (br, 1H, CH), 6.38 (br, 2H, 
Ar), 6.69 (br, 1H, Ar), 6.92 (br, 1H, Ar), 6.69–7.81 (m, 28H, Ar) 8.26 (m, 1H, Ar) ppm. 
 
13C{1H}-NMR (150 MHz, CD2Cl2): δ = 23.5 (d, J = 26.9 Hz, CH3), 60.2 (CH), 122.4 
(Ar, CH), 123.2 (Ar, CH), 125.3 (Ar, CH), 125.9 (Ar, CH), 126.3 (Ar, CH), 126.5 (Ar, 
CH), 126.8 (Ar, CH), 127.2 (Ar, CH), 127.4 (Ar, CH), 128.3 (Ar, CH), 128.4 (Ar, CH), 
128.6 (Ar, CH), 128.8 (Ar, CH), 129.0 (Ar, CH), 129.2 (Ar, CH), 129.3 (Ar, CH), 129.9 
(Ar, CH), 130.7 (Ar, CH), 130.9 (Ar, Cq), 131.1 (Ar, CH), 131.9 (Ar, Cq), 133.1 (d, J = 
12.6 Hz, Ar, Cq), 133.6 (d, J = 19.6 Hz, Ar, CH), 134.3 (Ar, Cq), 134.5 (d, J = 19.6 Hz, 
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Ar, CH), 136.7 (Ar, CH), 138.6 (Ar, Cq), 138.8 (d, J = 12.6 Hz, Ar, Cq), 139.3 (Ar, Cq), 
140.5 (Ar, Cq) 150.0 (Ar, Cq), 150.3 (Ar, Cq) ppm. 
 
31P{1H}-NMR (250 MHz, CD2Cl2): δ = -17.2 (br), 138.4 (br) ppm. 
[α]D20 =  +166.3 (c = 0.51, DCM) 
MS (EI): m/z (rel. intensity) = 745 (M+, 1 %), 448 (11 %), 447 (34 %), 433 (26 %), 
432 (100 %), 431 (50 %), 430 (12 %), 416 (23 %), 287 (19 %), 286 (100 %), 268 (13 
%), 257 (13 %), 239 (16 %), 155 (12 %). 
HR-MS (ESI): C50H37NO2P2 (M+)  calculated: 745.229   
      found:  745.230 
 
 
4.2.1.18 (11bR)-N-(2-(diphenylphosphino)phenyl)-N-((S)-1-(naphthalene-1-yl)ethyl) 
              dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine-4-amine (L2) 
 
O
O
P N
Ph2P
 
 
 
Synthesis and work-up were performed under argon. To a solution of 49 (0.5 mmol, 
214.8 mg)  and TMEDA (0.6 mmol, 0.09 mL) in toluene (10 mL), n-Buthyllithium 
(0.55 mmol, 0.34 mL, 1.6M in hexane) was added dropwise at -78°C (dry 
ice/acetone bath). After stirring the reaction mixture for 1h at -78°C and for 1h at 0°C 
a solution of (11bS)-4-chlorodinaphtho[2,1-d:1',2'f][1,3,2]dioxaphosphepine (0.55 
mmol, 192.9 mg) in toluene (5 mL) was slowly added at -78°C. The reaction was 
allowed to warm up to room temperature and stirred for 16h. The reaction mixture 
was filtered over a PTFE membrane. Toluene was removed under reduced pressure 
and the product was precipitated with ethanol from toluene. After the first 
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precipitation the colourless solid had a sufficient purity (88%  31P-NMR) for 
catalyses. Purity after second precipitation: 100%. 
Yield: 1st precipitation:  157.3 mg (0.21 mmol, 44 %).  
           2nd precipitation:  16.7 mg (0.03 mmol, 7 %). 
Via 1H and 31P NMR spectroscopy two different rotamers (major:minor = 1.3:1) were 
identified. 
maj:1H-NMR (600 MHz, CD2Cl2): δ = 1.77 (br, 3H, CH3), 5.62 (br, 1H, CH), 6.92 (br, 
2H, Ar), 7.05–8.08 (m, 31H, Ar) ppm. 
min:1H-NMR (600 MHz, CD2Cl2): δ = 1.70 (br, 3H, CH3), 5.96 (br, 1H, CH), 6.24 (br, 
1H, Ar), 6.74 (br, 1H, Ar), 6.98 (br, 2H, Ar), 7.05–7.94 (m, 28H, Ar), 8.21 (br, 1H, Ar) 
ppm. 
 
13C{1H}-NMR (150 MHz, CD2Cl2): δ = 22.9 (CH3, minor), 23.9 (CH3, major) 53.3 (CH, 
minor), 56.7 (CH, major), 121.6 (Ar, Cq), 122.3 (Ar, CH), 122.5 (Ar, CH), 122.8 (Ar, 
CH), 123.1 (Ar, CH), 123.7 (Ar, CH), 124.2 (Ar, Cq), 124.8 (Ar, CH), 125.0 (Ar, CH), 
125.2 (Ar, CH), 125.3 (Ar, CH), 125.4 (Ar, CH), 125.6 (Ar, CH), 126.0 (Ar, CH), 126.3 
(Ar, CH), 126.4 (Ar, CH), 126.7 (Ar, CH), 127.2 (Ar, CH), 127.4 (Ar, CH), 127.7 (Ar, 
CH), 127.9 (Ar, CH), 128.5 (Ar, CH), 128.7 (Ar, CH), 128.9 (Ar, CH) 129.1 (Ar, CH), 
129.8 (Ar, CH), 129.9 (Ar, CH), 130.4 (Ar, CH), 130.8 (Ar, Cq), 131.0 (Ar, CH), 131.2 
(Ar, Cq), 131.5 (Ar, Cq), 131.8 (Ar, Cq), 132.1 (Ar, Cq), 133.1 (Ar, Cq), 133.4 (Ar, CH), 
133.9 (d, J = 20 Hz, Ar, CH), 134.2 (d, J = 20 Hz, Ar, CH), 134.6 (d, J = 20 Hz, Ar, 
CH), 135.2 (Ar, CH), 137.1 (Ar, CH), 138.3 (Ar, Cq), 139.1 (Ar, Cq), 139.6 (Ar, Cq), 
140.1 (Ar, Cq), 149.6 (Ar, Cq), 150.3 (Ar, Cq), 151.2 (Ar, Cq) ppm. 
 
maj: 31P{1H}-NMR (250 MHz, CD2Cl2): δ = -19.4 (d, J = 32.1 Hz), 140.3 (d, J = 32.1 
Hz) ppm. 
 
min: 31P{1H}-NMR (250 MHz, CD2Cl2): δ = -17.1 (d, J = 16.4 Hz), 141.8 (d, J = 16.4 
Hz) ppm. 
[α]D20 =  -83.3 (c = 0.47, DCM) 
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MS (EI): m/z (rel. intensity) = 745 (M+, 3 %), 448 (33 %), 447 (100 %), 433 (12 %), 
431 (81 %), 430 (27 %), 417 (11 %), 416 (33 %), 287 (18 %), 286 (100 %), 268 (21 
%), 257 (12 %), 239 (12 %), 155 (10 %). 
 
HR-MS (ESI): C50H37NO2P2 (M+)  calculated: 745.229   
      found:  745.229 
 
 
4.2.1.19 (11bS)-N-(2-(diphenylphosphino)phenyl)-N-((S)-1-phenylethyl) 
              8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2] 
              dioxaphosphepine-4-amine (L3) 
 
 
 
 
Synthesis and work-up were performed under argon. To a solution of (S)-2-
(diphenylphosphino)-N-(1-phenylethyl)aniline (1.24 mmol, 472.3 mg)  and TMEDA 
(1.49 mmol, 0.24 mL) in toluene (5 mL), n-Buthyllithium (1.36 mmol, 0.85 mL, 1.6M 
in hexane) was added dropwise at -78°C (dry ice/acetone bath). After stirring the 
reaction mixture for 1h at -78°C and for 1h at 0°C a solution of 55 (1.49 mmol, 534.6 
mg) in toluene (5 mL) was slowly added at -78°C. The reaction was allowed to warm 
up to room temperature and stirred for 16h. The reaction mixture was filtered over a 
short pad of basic alumina and the product was eluted with toluene (40 mL). Toluene 
was removed under reduced pressure and the product was precipitated with ethanol 
from toluene. The product is obtained as a colourless solid. 
Yield: 322.2 mg (0.46 mmol, 37 %). 
Via 31P NMR spectroscopy two different rotamers (major:minor = 1.26:1) were 
identified. 
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1H-NMR (400 MHz, CD2Cl2): δ = 1.22– 1.76 (m, 11H, CH3/CH2), 2.03 (m, 2H, CH2), 
2.43 (m, 2H, CH2), 2.68 (m, 4H, CH2), 4.46 (br, 1H, CH), 6.09 (br, 1H, Ar), 6.47 (br, 
1H, Ar), 6.72 (br, 1H, Ar), 6.79–7.23 (m, 16H, Ar) ppm. 
 
13C{1H}-NMR (100 MHz, CD2Cl2): δ = 23.0 (CH3), 27.8 (CH2), 28.1 (CH2), 29.4 (CH2), 
29.5 (CH2), 60.2 (CH), 118.9 (Ar), 119.6 (Ar), 126.7 (Ar), 127.5 (Ar), 128.1 (Ar), 128.4 
(Ar), 128.48 (Ar), 128.51 (Ar), 128.57 (Ar), 128.6 (Ar), 128.8 (Ar), 128.9 (Ar), 129.0 
(Ar), 129.2 (Ar), 129.4 (Ar), 129.5 (Ar), 133.4 (Ar), 133.9 (Ar), 138.1 (Ar), 138.6 (Ar), 
138.7 (Ar), 139.5 (Ar), 139.6 (Ar), 149.0 (Ar)  ppm. 
 
maj:31P{1H}-NMR (125 MHz, CD2Cl2): δ = -17.1 (b), 136.2 (s) ppm. 
 
min: 31P{1H}-NMR (125 MHz, CD2Cl2): δ = -17.1 (b), 135.9 (s) ppm. 
 [α]D20 =  +30.3 (c = 0.48, DCM) 
MS (EI): m/z (rel. intensity) = 703.1 (M, 1 %), 382 (12 %), 381 (15 %), 380 (11 %), 
337 (27 %), 183 (22 %), 92 (65 %), 91 (100 %). 
 
HR-MS (ESI): C44H39NO2P2 (M+)  calculated: 703.276   
      found:  703.275 
 
 
4.2.1.20 (11bS)-N-(2-(diphenylphosphino)phenyl)-5-phenyl-N-((R)-1-phenylethyl) 
              dinaphtho[2,1-d:1',2'-f][1,3,2]oxazaphosphepin-4(5H)-amine (L5) 
 
 
 
 
To a solution of  (S)-2'-(phenylamino)-1,1'-binaphthyl-2-ol (214.6 mg, 0.59 mmol) in 
CH2Cl2 (10 mL) NEt3 (1.23 mL, 8.85 mmol) was added at 0 °C and stirred for 30 min. 
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This solution was added dropwise to a solution of (R)-1,1-dichloro-N-(2-
(diphenylphosphino)phenyl)-N-(1-phenylethyl)phosphinamine (284.6 mg, 0.59 mmol) 
in CH2Cl2 (10 mL) at 0 °C. The mixture was allowed to warm to room temperature 
and stirred over night. The solvent was removed under reduced pressure. The 
residue was taken up in toluene and filtered through a PTFE membrane. After 
removing the solvent under reduced pressure the crude product was purified by 
column chromatography under argon atmosphere over silica (eluent: THF/pentane: 
1/5, Rf = 0.60). The product was obtained as colourless solid. 
Yield:  113.7 mg ( 0.15 mmol, 25 %). 
1H-NMR (600 MHz, CD2Cl2): δ =  1.91 (b, 3H, CH3), 4.52 (b, 1H, CH), 6.44 (b, 1H, Ar-
H), 6.59 (b, 1H, Ar-H), 6.84 (m, 2H, Ar-H), 6.96  (t, J = 7.53 Hz, 1H, Ar-H), 7.08-7.15 
(m, 12H, Ar-H), 7.19-7.30 (m, 10H, Ar-H), 7.34 (bs, 3H, Ar-H), 7.39 (m, 2H, Ar-H), 
7.56 (bd, J = 8.33 Hz, 1H, Ar-H), 7.73 (d, J = 8.01 Hz, 1H, Ar-H), 7.90 (d, J = 8.33 Hz, 
1H, Ar-H), 7.96 (d, J = 8.65 Hz, 1H, Ar-H) ppm.  
 
31P{1H}-NMR (250 MHz, CD2Cl2): δ = -22.0, 132.2 ppm. 
 
13C{1H}-NMR (150 MHz, CD2Cl2): δ = 21.9 (CH3), 63.0 (CH), 121.27 (d, J = 4.44 Hz, 
Ar), 121.36 (d, J = 4.44 Hz, Ar, CH), 121.97 (Ar, CH), 122.31 (Ar, CH), 124.93 (Ar, 
CH), 125.57 (Ar, CH), 125.96 (Ar, CH), 126.40 (Ar, Cq), 126.44 (Ar, Cq), 126.49 (Ar, 
CH), 126.54 (Ar, CH), 126.78 (Ar, CH), 127.32 (Ar, CH), 127.60 (Ar, CH), 127.65 (Ar, 
CH), 128.12 (2C, Ar, CH), 128.19 (Ar, CH), 128.22 (2C, Ar, CH), 128.65 (2C, Ar, CH), 
128,72 (2C, Ar, CH), 128.76 (Ar, CH), 128.78 (Ar, CH), 128.82 (2C, Ar, CH), 128.92 
(2C, Ar, CH), 129.08 (Ar, CH), 129.28 (Ar, CH),  130.44 (Ar, CH), 131.66 (Ar, Cq), 
131.82 (Ar, Cq), 132.62 (Ar, Cq), 133.35 (Ar, Cq), 133.84 (Ar, CH), 133.97 (Ar, CH), 
134.11 (Ar, CH), 134.25 (Ar, CH), 136.73 (Ar, CH), 139.32 (Ar, Cq), 139.43 (Ar, Cq), 
141.40 (Ar, Cq), 141.43 (Ar, Cq), 143.09 (Ar, Cq), 148.17 (Ar, Cq), 148.34 (Ar, Cq), 
150.06 (Ar, Cq) ppm.  
 
[α]D20 =  +316.2 (c = 0.61, DCM) 
 
MS (ESI): m/z (%) = 771 ([M+H]+, <1), 681 (10), 621 (27), 406 (18), 357 (11), 356 
(100), 343 (13), 276 (54).  
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HRMS (ESI) =  [M+H]+ 771.26898 calcd. for C52H41N2OP2: 771.268 
 
 
4.2.1.21 (11bS)-N-(2-(diphenylphosphino)phenyl)-5-phenyl-N-((S)-1-phenylethyl) 
              dinaphtho[2,1-d:1',2'-f][1,3,2]oxazaphosphepin-4(5H)-amine (L4) 
 
 
 
 
 
To a solution of  (S)-2'-(phenylamino)-1,1'-binaphthyl-2-ol (214.6 mg, 0.59 mmol) in 
CH2Cl2 (10 mL) NEt3 (1.23 mL, 8.85 mmol) was added at 0 °C and stirred for 30 min. 
This solution was added dropwise to a solution of (S)-1,1-dichloro-N-(2-
(diphenylphosphino)phenyl)-N-(1-phenylethyl)phosphinamine (284.6 mg, 0.59 mmol) 
in CH2Cl2 (10 mL) at 0 °C. The mixture was allowed to warm to room temperature 
and stirred over night. The solvent was removed under reduced pressure. The 
residue was taken up in toluene and filtered through a PTFE membrane. After 
removing the solvent under reduced pressure the crude product was purified by 
column chromatography under argon atmosphere over silica (eluent: THF/pentane: 
1/5, Rf = 0.60). The product was obtained as colourless solid. 
Yield:  141.0 mg ( 0.18 mmol, 31 %). 
1H-NMR (600 MHz, CD2Cl2): δ =  1.49 (b, 3H, CH3), 4.83 (quin, J = 7.59 Hz, 1H, CH), 
6.74 (b, 1H, Ar-H), 6.80 (m, 4H, Ar-H), 6.89 (m, 1H, Ar-H), 6.99 (m, 2H, Ar-H), 7.04 
(m, 1H, Ar-H), 7.11 (m, 4H, Ar-H),  7.19-7.31 (m, 11 H, Ar-H), 7.31-7.40 (m, 4H, Ar-
H), 7.42-7.58 (m, 5H, Ar-H), 7.81 (d, J = 8.14 Hz, 1H, Ar-H), 7.87 (m, 2H, Ar-H) ppm. 
 
31P{1H}-NMR (250 MHz, CD2Cl2): δ = -21.1, 135.9 ppm. 
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13C{1H}-NMR (150 MHz, CD2Cl2): δ = 20.6 (CH3), 61.1 (CH), 121.10 (Ar, CH), 121.20 
(Ar, CH), 121.91 (Ar, CH), 122.35 (Ar, CH), 124.91 (Ar, CH), 125.71 (Ar, CH), 126.10 
(Ar, CH), 126.35 (Ar, Cq), 126.46 (Ar, CH), 126.55 (Ar, CH), 126.95 (Ar, CH), 127.84 
(Ar, CH), 127.92 (Ar, CH), 128.18 (Ar, CH), 128.32 (Ar, CH), 128.44 (2C, Ar, CH), 
128.60 (Ar, CH), 128.69 (2C, Ar, CH), 128.73 (3C, Ar, CH), 128.81 (Ar, CH), 128.92 
(3C, Ar, CH), 129.56 (Ar, CH), 130.45 (Ar, CH), 131.64 (Ar, Cq), 132.07 (Ar, Cq), 
132.88 (Ar, Cq), 133.29 (Ar, Cq), 133.68 (Ar, CH), 133.97 (Ar, CH), 134.10 (Ar, CH), 
137.19 (Ar, CH), 138.89 (Ar, Cq), 138.99 (Ar, Cq), 139.63 (Ar, Cq), 139.73 (Ar, Cq), 
148.00 (Ar, Cq), 148.20 (Ar, Cq), 148.57 (Ar, Cq), 148.74 (Ar, Cq), 150.08 (Ar, Cq) 
ppm.  
 
[α]D20 =  +324.3 (c = 0.56, DCM) 
 
MS (EI): m/z (%) = 770 (M+, <1), 92 (17), 91 (25), 72 (100), 71 (96). 
 
HRMS (ESI) = 770.26097 calcd. for C52H40N2OP2: 770.261 
 
 
4.2.1.22 (11bS)-N-(2-(diphenylphosphino)phenyl)-N-((S)-1-phenylethyl) 
              dinaphtho[2,1-d:1',2'-f][1,3,2]oxazaphosphepin-4(5H)-amine (L6) 
 
 
 
To a solution of  (S)-2'-amino-1,1'-binaphthyl-2-ol (218.8 mg, 0.77 mmol) in CH2Cl2 
(10 mL) NEt3 (1.60 mL, 11.5 mmol) was added at 0 °C and stirred for 30 min. This 
solution was added dropwise to a solution of (S)-1,1-dichloro-N-(2-
(diphenylphosphino)phenyl)-N-(1-phenylethyl)phosphinamine (371.4 mg, 0.77 mmol)  
in CH2Cl2 (10 mL) at 0 °C. The mixture was allowed to warm to room temperature 
and stirred over night. The solvent was removed under reduced pressure. The 
residue was taken up in toluene and filtered through a PTFE membrane. After 
removing the solvent under reduced pressure the crude product was purified by 
4 Experimental 116 
column chromatography under argon atmosphere over basic alumina (eluent: 
THF/pentane/NEt3: 1/4/0.025, Rf = 0.63). The product was obtained as colourless 
solid. Single crystals suitable for X-ray defraction were obtained via recrystallisation 
from acetonitrile. 
Yield:  123.0 mg ( 0.18 mmol, 23 %). 
1H-NMR (600 MHz, CD2Cl2): δ =  1.62 (d, J = 7.07 Hz, 3H, CH3), 4.48 (b, 1H, NH), 
4.85 (b, 1H, CH), 6.89-7.08 (m, 3H, Ar-H), 7.17 (m, 5H, Ar-H), 7.26 (m, 5H, Ar-H), 
7.32 (m, 8H, Ar-H), 7.42 (m, 5H, Ar-H), 7.52 (d, 1H, J = 8.6 Hz, Ar-H), 7.95 (m, 4H, 
Ar-H) ppm. 
 
31P{1H}-NMR (250 MHz, CD2Cl2): δ> = -17.8 (d, J = 42.4 Hz), 142.2 ppm. 
 
13C{1H}-NMR (150 MHz, CD2Cl2): δ = 23.07 (CH3), 58.93 (CH), 122.52 (Ar, CH), 
122.97 (Ar, Cq), 124.38 (Ar, CH), 124.84 (Ar, CH), 125.23 (Ar, CH), 126.09 (d, J = 2.8 
Hz, Ar, Cq), 126.17 (Ar, CH), 126.23 (Ar, CH), 127.12 (Ar, CH), 127.26 (Ar, CH), 
127.46 (Ar, CH), 127.63 (Ar, CH), 128.12 (Ar, CH, 2C), 128.49 (Ar, CH), 128.69 (Ar, 
CH), 128.74 (Ar, CH, 2C), 128.97 (Ar, CH), 128.99 (Ar, CH), 129.02 (Ar, CH, 2C), 
129.17 (Ar, CH), 129.44 (Ar, CH, 2C), 129.97 (Ar, CH), 130.28 (Ar, CH), 130.69 (Ar, 
Cq), 131.54 (Ar, Cq),  132.72 (Ar, CH), 133.12 (Ar, Cq), 133.68 (Ar, Cq), 134.11 (m, Ar, 
CH, 4C), 136.14 (Ar, CH), 138.39 (d, J = 11.6 Hz, Ar, Cq), 138.83 (d, J = 14.1 Hz, Ar, 
Cq), 139.24 (Ar, Cq), 139.92 (d, J = 6.5 Hz, Ar, Cq), 142.09 (Ar, Cq), 148.00 (m, Ar, 
Cq), 150.88 (Ar, Cq) ppm.  
 
[α]D20 = -69.4 (c = 0.49, DCM) 
 
MS (EI): m/z (%) = 694 (M, <1), 382 (28), 381 (100), 380 (20), 367 (16), 366 (60), 
337 (11), 304 (11), 303 (15), 302 (11), 288 (33), 277 (20), 276 (31), 261 (38), 199 
(10), 198 (60), 194 (37), 183 (78), 181 (44), 180 (14), 167 (22), 152 (16), 107 (15), 
105 (79), 104 (14), 103 (17), 79 (22), 77 (31). 
 
HRMS (ESI) =  [M+H]+ 695.23724 calcd. for C46H37N2OP2: 695.237 
 
Absolute configuration on phosphorus: (S) (X-ray data: Appendix 6.2, p.143) 
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4.2.1.23 (11bS)-N-(2-(diphenylphosphino)phenyl)-N-((R)-1-phenylethyl) 
              dinaphtho[2,1-d:1',2'-f][1,3,2]oxazaphosphepin-4(5H)-amine (L7) 
 
 
 
To a solution of  (S)-2'-amino-1,1'-binaphthyl-2-ol (218.8 mg, 0.77 mmol) in CH2Cl2 
(10 mL) NEt3 (1.60 mL, 11.5 mmol) was added at 0 °C and stirred for 30 min. This 
solution was added dropwise to a solution of (R)-1,1-dichloro-N-(2-
(diphenylphosphino)phenyl)-N-(1-phenylethyl)phosphinamine (371.4 mg, 0.77 mmol)  
in CH2Cl2 (10 mL) at 0 °C. The mixture was allowed to warm to room temperature 
and stirred over night. The solvent was removed under reduced pressure. The 
residue was taken up in toluene and filtered through a PTFE membrane. After 
removing the solvent under reduced pressure the crude product was purified by 
column chromatography under argon atmosphere over basic alumina (eluent: 
THF/pentane/NEt3: 1/4/0.025, Rf = 0.59). The product was obtained as colourless 
solid. 
Yield:  111.2 mg ( 0.16 mmol, 21 %). 
1H-NMR (600 MHz, CD2Cl2): δ =  1.33 (b, 3H, CH3), 4.62 (b, 1H, CH), 6.22 (b, 1H, 
NH), 7.02-7.47 (m, 27H, Ar-H), 7.72 (b, 2H, Ar-H), 7.82 (d, 3J = 8.3 Hz, 1H, Ar-H), 
7.87 (d, 3J = 8.3 Hz, 1H, Ar-H) ppm. 
 
31P{1H}-NMR (250 MHz, CD2Cl2): δ> = -19.4, 138.3 ppm. 
 
13C{1H}-NMR (150 MHz, CD2Cl2): δ = 24.90 (CH3), 58.39 (CH), 122.51 (Ar, Cq), 
122.62 (Ar, CH, 2C), 124.25 (Ar, CH), 124.40 (Ar, CH), 124.86 (Ar, CH), 126.19 (Ar, 
CH, 2C), 126.23 (Ar, Cq, 2C), 127.00 (Ar, CH), 127.26 (Ar, CH), 127.28 (Ar, CH, 2C), 
127.43 (Ar, CH), 128.23 (Ar, CH, 2C), 128.75 (Ar, CH), 128.89 (Ar, CH, 2C), 128.93 
(Ar, CH, 3C), 129.09 (Ar, CH, 2C), 129.14 (Ar, CH, 2C), 130.25 (Ar, CH, 2C), 130.49 
(Ar, Cq), 131.58 (Ar, Cq), 132.81 (Ar, CH), 133.15 (Ar, Cq, 2C), 133.73 (Ar, CH, 2C), 
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133.86 (Ar, CH, 2C), 138.27 (d, J = 7.9 Hz, Ar, Cq, 3C), 140.13 (d,3J = 7.9 Hz, Ar, 
Cq), 143.38 (Ar, Cq), 150.57(Ar, Cq) ppm.  
 
[α]D20 =  65.1 (c = 0.56, DCM) 
 
MS (EI): m/z (%) = 694 (M, <1), 382 (28), 381 (100), 380 (20), 367 (16), 366 (60), 
337 (11), 304 (11), 303 (15), 302 (11), 288 (33), 277 (20), 276 (31), 261 (38), 199 
(10), 198 (60), 194 (37), 183 (78), 181 (44), 180 (14), 167 (22), 152 (16), 107 (15), 
105 (79), 104 (14), 103 (17), 79 (22), 77 (31). 
 
HRMS (ESI) =  [M+H]+ 695.23724 calcd. for C46H37N2OP2: 695.237 
 
 
4.2.1.24 (3aS)-N-(2-(diphenylphosphino)phenyl)-2-phenyl-N-((S)-1-phenylethyl) 
              hexahydro-1H-pyrrolo[1,2-c][1,3,2]diazaphosphol-1-amine (L8) 
 
N
Ph
P
N
N
Ph
Ph2P
 
 
To a solution of  (S)-N-(pyrrolidin-2-ylmethyl)aniline (103.1 mg, 0.58 mmol) in CH2Cl2 
(4 mL) NEt3 (1.04 mL, 7.4 mmol) was added at 0 °C and stirred for 30 min. This 
solution was added dropwise to a solution of (S)-1,1-dichloro-N-(2-
(diphenylphosphino)phenyl)-N-(1-phenylethyl)phosphinamine (281.9 mg, 0.58 mmol)  
in CH2Cl2 (6 mL) at 0 °C. The mixture was allowed to warm to room temperature and 
stirred over night. The solvent was removed under reduced pressure. The residue 
was suspended in toluene (10 mL), NEt3 (1 mL) was added and the solution was 
filtered through a short pad of basic alumina (ca. 1 cm, pretreated with toluene (5 mL) 
and of NEt3 (0.5 mL)). The pad was washed with toluene (10 mL). After removing the 
solvent under reduced pressure the product was obtained as colourless solid. 
Yield: 58.6 mg ( 0.10 mmol, 18 %). 
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1H-NMR (600 MHz, CDCl3): δ =  1.34 (m, 1H, CH2), 1.54 (d, J = 7.06 Hz, 3H, CH3), 
1.67 (m, 2H, CH2), 1.80 (m, 1H, CH2), 3.04 (m, 1H, CH2), 3.29 (m, 1H, CH2), 3.44 (m, 
1H, CH2),  3.58 (m, 1H, CH2), 3.70 (m, 1H, CH), 4.95 (quin, J = 6.27 Hz, 1H, CH), 
6.78 (t, J = 7.45 Hz, 1H, Ar-H), 6.87 (m, 2H, Ar-H), 6.91 (b, 2H, Ar-H), 6.99-7.41  (m, 
19H, Ar-H) ppm. 
 
31P{1H}-NMR (250 MHz, CDCl3): δ = -20.55 (d, JP-P = 52.8 Hz), 107.7 (d, JP-P = 52.8 
Hz) ppm. 
 
13C{1H}-NMR (150 MHz, CDCl3):  δ = 21.17 (d, J = 7.06 Hz, CH3), 26.09 (d, J = 4.36 
Hz, CH2), 33.22  (CH2), 50.69  (dd, J = 4.36 Hz / 39.25 Hz, CH2), 53.37  (d, J = 7.99 
Hz, CH2), 58.44 (CH), 62.79 (d, J = 7.99 Hz, CH), 115.53 (Ar, CH), 115.62 (Ar, CH), 
117.69 (Ar, CH), 125.15 (Ar, CH), 125.48 (Ar, CH), 125.72 (Ar, CH), 126.73 (Ar, CH), 
127.52 (Ar, CH), 127.61 (Ar, CH), 127.77 (Ar, CH), 127.92 (Ar, CH), 127.96 (Ar, CH), 
128.06 (Ar, CH), 128.10 (Ar, CH), 128.25 (Ar, CH), 128.43 (Ar, CH), 128.82 (Ar, CH), 
129.04 (Ar, CH), 129.25 (Ar, CH), 132.91 (Ar, CH), 133.04 (Ar, CH), 133.08 (Ar, CH), 
133.20 (Ar, CH), 137.17 (Ar, Cq), 137.27 (Ar, CH), 139.88 (Ar, Cq, 2C), 142.42 (Ar, 
Cq), 146.49 (Ar, Cq),150.18 (Ar, Cq) ppm.  
 
MS (EI): m/z (%) =  585 ([M], 23), 508 (25), 480 (10), 381 (23), 380 (43), 206 (16), 
205 (100), 183 (10), 136 (23). 
 
HRMS (ESI) =  [M] 585.24636 calcd. for C37H37N3P2: 585.246 
 
4.2.1.25 [Rh(COD)(36)][NTf2] (56) 
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Synthesis and work-up were performed under argon. [Rh(COD)(acac)] (0.077 mmol, 
24.3 mg) and Bis(trifluoromethyl)sulfonamide (0.077 mmol, 21.9 mg) were dissolved 
in ethanol (5 mL). The mixture was stirred until a clear solution was formed (ca. 
10min). A solution of 36 (0.07 mmol, 53.6 mg) in THF (2 mL) was added dropwise, 
the yellow solution turned orange and the mixture was stirred for 30 min. After 
removing the solvent under reduced pressure the residue was precipitated with 
pentane from dichloromethane. The product was obtained as an orange solid.  
 
Yield:  83.2 mg (0.07 mmol, 91 %). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.19 (br, 3H, CH3), 1.85–2.50 (m, 8H, COD), 4.50 
(m, 1H, COD), 4.69 (m, 1H, COD), 5.48 (m, 1H, CH), 5.54 (m, 1H, COD), 5.66 (m, 
1H, COD), 7.03–8.11 (m, 31H, Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 21.5 (dd, JP-P = 61.2 Hz, JRh-P = 136.4 Hz), 
136.4 (dd, JP-P = 61.2 Hz, JRh-P = 249.3 Hz) ppm. 
 
19F-NMR (280 MHz, CD2Cl2): δ = -79.46 ppm. 
 
MS(Cation) (SIMS): m/z = 906.3 
for: C54H47NO2P2Rh [Rh(COD)(36)]+ (calc.:906.2) 
 
MS(Anion) (SIMS): m/z = 279.8 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
 
4.2.1.26 [Rh(COD)(L1)][NTf2] (57) 
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Synthesis and work-up were performed under argon. [Rh(COD)(acac)] (0.1 mmol, 
31.2 mg) and Bis(trifluoromethyl)sulfonamide (0.1 mmol, 28.6 mg) were dissolved in 
ethanol (5 mL). The mixture was stirred until a clear solution was formed (ca. 
10min). A solution of L1 (0.1 mmol, 74.6 mg) in THF (2 mL) was added dropwise, 
the yellow solution turned orange and the mixture was stirred for 30 min. After 
removing the solvent under reduced pressure the residue was precipitated with 
pentane from dichloromethane. The product was obtained as an orange solid.  
 
Yield: 108.8 mg (0.09 mmol, 88 %). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.07 (br, 3H, CH3), 1.70–2.40 (m, 8H, COD), 3.83 
(m, 1H, COD), 4.34 (m, 1H, COD), 4.57 (m, 1H, CH), 5.49 (m, 1H, COD), 5.57 (m, 
1H, COD), 6.99–8.02 (m, 35H, Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 13.4 (dd, JP-P = 67.5 Hz, JRh-P = 135.1 Hz), 
149.6 (dd, JP-P = 67.5 Hz, JRh-P = 237.7 Hz) ppm. 
 
19F-NMR (280 MHz, CD2Cl2): δ = -79.46 ppm. 
 
MS(Cation) (SIMS): m/z = 956.6 
for: C58H49NO2P2Rh [Rh(COD)(L1)]+ (calc.:956.9) 
 
MS(Anion) (SIMS): m/z = 279.6 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
 
4.2.1.27 [Rh(COD)(L2)][NTf2] (58) 
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Synthesis and work-up were performed under argon. [Rh(COD)(acac)] (0.1 mmol, 
31.2 mg) and Bis(trifluoromethyl)sulfonamide (0.1 mmol, 28.6 mg) were dissolved in 
ethanol (5 mL). The mixture was stirred until a clear solution was formed (ca. 
10min). A solution of L2 (0.1 mmol, 74.6 mg) in THF (2 mL) was added dropwise, 
the yellow solution turned orange and the mixture was stirred for 30 min. After 
removing the solvent under reduced pressure the residue was precipitated with 
pentane from dichloromethane. The product was obtained as an orange solid.  
 
Yield: 101.4 mg (0.08 mmol, 82%). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.17 (d, J = 7.2 Hz, 3H, CH3), 1.99–2.47 (m, 8H, 
COD), 4.64 (m, 1H, COD), 4.95 (m, 1H, COD), 5.73 (m, 1H, CH), 5.98 (m, 1H, COD), 
6.17 (m, 1H, COD), 6.68–8.18 (m, 35H, Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 14.3 (dd, JP-P = 58.7 Hz, JRh-P = 141.1 Hz), 
141.1 (dd, JP-P = 58.7 Hz, JRh-P = 242.9 Hz) ppm. 
 
19F-NMR (280 MHz, CD2Cl2): δ = -79.27 ppm. 
 
MS(Cation) (SIMS): m/z = 956.6 
for: C58H49NO2P2Rh [Rh(COD)(L2)]+ (calc.:956.9) 
 
MS(Anion) (SIMS): m/z = 279.7 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
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4.2.1.28 [Rh(COD)(L3)][NTf2] (59) 
 
 
 
Synthesis and work-up were performed under argon. [Rh(COD)(acac)] (0.1 mmol, 
31.2 mg) and Bis(trifluoromethyl)sulfonamide (0.1 mmol, 28.6 mg) were dissolved in 
ethanol (5 mL). The mixture was stirred until a clear solution was formed (ca. 
10min). A solution of L3 (0.1 mmol, 74.6 mg) in THF (2 mL) was added dropwise, 
the yellow solution turned orange and the mixture was stirred for 30 min. After 
removing the solvent under reduced pressure the residue was precipitated with 
pentane from dichloromethane. The product was obtained as an orange solid.  
 
Yield: 118.7 mg (0.10 mmol, 96%). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.17 (d, J = 7.2 Hz, 3H, CH3), 1.39–2.85 (m, 8H, 
COD), 4.56 (m, 1H, COD), 4.98 (m, 1H, CH), 5.04 (m, 1H, COD), 5.67 (m, 1H, COD), 
5.96 (m, 1H, COD), 6.57–7.54 (m, 23H, Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 15.0 (dd, JP-P = 61.1 Hz, JRh-P = 142.0 Hz), 
135.4 (dd, JP-P = 61.1 Hz, JRh-P = 236.6 Hz) ppm. 
 
19F-NMR (280 MHz, CD2Cl2): δ = -79.46 ppm. 
 
MS(Cation) (SIMS): m/z = 914.3 
for: C54H55NO2P2Rh [Rh(COD)(L3)]+ (calc.:914.3) 
 
MS(Anion) (SIMS): m/z = 279.9 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
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4.2.1.29 [Rh(COD)(L6)][NTf2] (75) 
 
 
 
Synthesis and work-up were performed under argon. [Rh(COD)(acac)] (0.047 mmol, 
14.7 mg) and Bis(trifluoromethyl)sulfonamide (0.047 mmol, 13.4 mg) were stirred  in 
DCM (5 mL) for 1 h. A solution of L6 (0.049 mmol, 33.8 mg) in DCM (2 mL) was 
added dropwise, the yellow solution turned orange and the mixture was stirred for 16 
h. After removing the solvent under reduced pressure the residue was precipitated 
with pentane from dichloromethane. The product was obtained as an orange solid.  
 
Yield: 47.4 mg (0.04 mmol, 88 %). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.56 (d, J = 7.48 Hz, 3H, CH3), 2.20–2.55 (m, 8H, 
COD), 4.62 (d, J = 33.21 Hz, 1H, NH), (d, 4.83 (b, 1H, COD), 4.93 (b, 1H, COD), 5.30 
(m, 1H, CH), 5.73 (b, overl., 2H, Ar/COD), 5.87 (m, 1H, COD), 6.19–8.03 (m, 30H, 
Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 13.18 (dd, JP-P = 68.5 Hz, JRh-P = 141.3 Hz), 
138.58 (dd, JP-P = 68.5 Hz, JRh-P = 199.3 Hz) ppm. 
 
19F-NMR (280 MHz, CD2Cl2): δ = -79.27 ppm. 
 
MS(Cation) (SIMS): m/z = 905.3 
for: C54H48N2OP2Rh [Rh(COD)(L6)]+ (calc.:905.2) 
 
MS(Anion) (SIMS): m/z = 279.8 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
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4.2.1.30 [Rh(COD)(L7)][NTf2] (76) 
 
HN
O
P
N
Ph2P
CH3
Rh
NTf2
 
 
Synthesis and work-up were performed under argon. [Rh(COD)(acac)] (0.044 mmol, 
13.8 mg) and Bis(trifluoromethyl)sulfonamide (0.044 mmol, 12.6 mg) were stirred  in 
DCM (5 mL) for 1 h. A solution of L7 (0.046 mmol, 31.8 mg) in DCM (2 mL) was 
added dropwise, the yellow solution turned orange and the mixture was stirred for 16 
h. After removing the solvent under reduced pressure the residue was precipitated 
with pentane from dichloromethane. The product was obtained as an orange solid.  
 
Yield: 35.6 mg (0.03 mmol, 79 %). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.39 (d, J = 6.73 Hz, 3H, CH3), 2.21–2.71 (m, 8H, 
COD), 4.77 (d, J = 32.65 Hz, 1H, NH), 4.85 (b, 1H, COD), 4.92 (b, 1H, COD), 5.27 
(m, 1H, CH), 5.76 (b, overl., 2H, Ar/COD), 5.87 (m, 1H, COD), 6.64–8.08 (m, 30H, 
Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 12.98 (dd, JP-P = 66.4 Hz, JRh-P = 140.6 Hz), 
138.71 (dd, P-PJ = 66.4 Hz, JRh-P = 202.3 Hz) ppm. 
 
19F-NMR (280 MHz, CD2Cl2): δ = -79.27 ppm. 
 
MS(Cation) (SIMS): m/z = 905.4 
for: C54H48N2OP2Rh [Rh(COD)(L7)]+ (calc.:905.2) 
 
MS(Anion) (SIMS): m/z = 279.9 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
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4.2.1.31 [Rh(COD)(L4)][NTf2] (77) 
 
PhN
O
P
N
Ph2P
CH3
Rh
NTf2
 
 
Synthesis and work-up were performed under argon. [Rh(COD)(acac)] (0.047 mmol, 
14.7 mg) and Bis(trifluoromethyl)sulfonamide (0.047 mmol, 13.4 mg) were stirred  in 
DCM (5 mL) for 1 h. A solution of L4 (0.049 mmol, 37.8 mg) in DCM (2 mL) was 
added dropwise, the yellow solution turned orange and the mixture was stirred for 16 
h. After removing the solvent under reduced pressure the residue was precipitated 
with pentane from dichloromethane. The product was obtained as an orange solid.  
 
Yield: 25.2 mg (0.02 mmol, 52 %). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.26 (d, J = 6.45 Hz, 3H, CH3), 1.75–2.62 (m, 8H, 
COD), 3.67 (m, 1H, CH), 4.10 (b, 1H, COD), 4.69 (b, 1H, COD), 5.57 (b, 1H, COD), 
6.09 (m, 1H, Ar) 6.27 (b, 1H, COD), 6.43–8.32 (m, 34H, Ar) ppm. 
 ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 13.78 (dd, JP-P = 40.0 Hz, JRh-P = 151.1 Hz), 
138.71 (dd, JP-P = 40.0 Hz, JRh-P = 219.2 Hz) ppm. 
 
19F-NMR (280 MHz, CD2Cl2): δ = -79.25 ppm. 
 
MS(Cation) (SIMS): m/z = 981.2 
for: C54H48N2OP2Rh [Rh(COD)(L4)]+ (calc.: 981.3) 
 
MS(Anion) (SIMS): m/z = 279.9 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
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4.2.1.32 [Rh(COD)(L5)][NTf2] (78) 
 
 
 
Synthesis and work-up were performed under argon. [Rh(COD)(acac)] (0.046 mmol, 
12.3 mg) and Bis(trifluoromethyl)sulfonamide (0.046 mmol, 11.2 mg) were stirred  in 
DCM (5 mL) for 1 h. A solution of L5 (0.048 mmol, 33.3 mg) in DCM (2 mL) was 
added dropwise, the yellow solution turned orange and the mixture was stirred for 16 
h. After removing the solvent under reduced pressure the residue was precipitated 
with pentane from dichloromethane. The product was obtained as an orange solid.  
 
Yield: 37.9 mg (0.03 mmol, 55 %). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.13 (d, J = 7.02 Hz, 3H, CH3), 2.14–2.77 (m, 8H, 
COD), 3.38 (b, 1H, COD), 3.55 (m, 1H, CH), 4.14 (bs, 1H, COD), 4.50 (b, 1H, COD), 
4.64 (m, 1H, COD), 6.12–8.07 (m, 35H, Ar) ppm. 
 ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 12.75 (dd, JP-P = 36.2 Hz, JRh-P = 152.2 Hz), 
140.40 (dd, JP-P = 36.2 Hz, JRh-P = 221.4 Hz) ppm. 
 
19F-NMR (280 MHz, CD2Cl2): δ = -79.27 ppm. 
 
MS(Cation) (SIMS): m/z = 981.2 
for: C54H48N2OP2Rh [Rh(COD)(L5)]+ (calc.: 981.3) 
 
MS(Anion) (SIMS): m/z = 279.9 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
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4.2.1.33 [Ir(COD)(L6)][NTf2] (79) 
 
HN
O
P
N
Ph2P
CH3
Ir
NTf2
 
 
Synthesis and work-up were performed under argon. [Ir(COD)(acac)] (0.0236 mmol, 
9.4 mg) and Bis(trifluoromethyl)sulfonamide (0.0236 mmol, 6.6 mg) were stirred  in 
DCM (5 mL) for 1 h. A solution of L6 (0.0236 mmol, 16.4 mg) in DCM (2 mL) was 
added dropwise, the yellow solution turned red and the mixture was stirred for 16 h. 
After removing the solvent under reduced pressure the residue was precipitated with 
pentane from dichloromethane. The product was obtained as a brownish solid.  
 
Yield: 25.5 mg (0.020 mmol, 85 %). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.61 (bs, 3H, CH3), 2.12–2.40 (m, 8H, COD), 4.52 
(b, 1H, COD), 4.82 (b, 1H, COD), 5.27 (b overl., 2H, CH/COD), 5.51 (b, 1H, COD), 
5.81 (d, J = 8.44 Hz, 1H, NH), 6.21 (m, 1H, Ar), 6.36 (m, 2H, Ar), 6.66 (m, 2H, Ar), 
6.78-7.56 (m, 21H, Ar), 7.82- 7.99 (m, 5H, Ar) ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 8.92 (d, JP-P = 43.8 Hz), 115.87 (d, JP-P = 43.8 
Hz) ppm. 
 
MS(Cation) (SIMS): m/z = 995.2 
for: C54H48IrN2OP2 [Ir(COD)(L6)]+ (calc.: 995.1) 
 
MS(Anion) (SIMS): m/z = 279.9 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
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4.2.1.34 [Ir(COD)(L7)][NTf2] (80) 
 
HN
O
P
N
Ph2P
CH3
Ir
NTf2
 
 
Synthesis and work-up were performed under argon. [Ir(COD)(acac)] (0.0236 mmol, 
9.4 mg) and Bis(trifluoromethyl)sulfonamide (0.0236 mmol, 6.6 mg) were stirred  in 
DCM (5 mL) for 1 h. A solution of L7 (0.0236 mmol, 16.4 mg) in DCM (2 mL) was 
added dropwise, the yellow solution turned red and the mixture was stirred for 16 h. 
After removing the solvent under reduced pressure the residue was precipitated with 
pentane from dichloromethane. The product was obtained as a brownish solid.  
 
Yield: 24.2 mg (0.019 mmol, 79 %). 
 
1H-NMR (400 MHz, CD2Cl2): δ = 1.34 (d, J = 6.51 Hz, 3H, CH3), 2.06–2.41 (m, 8H, 
COD), 4.55 (b, 1H, COD), 4.78 (b, 1H, COD), 5.19 (b, 1H, COD), 5.25 (m, 1H, CH), 
5.46 (b, 1H, COD), 6.61 (m, 1H, Ar), 6.78–7.55 (m, 25H, Ar), 7.79-7.99 (m, 5H, Ar) 
ppm. 
 
31P{1H}-NMR (125 MHz, CD2Cl2): δ = 6.42 (d, JP-P = 43.5 Hz), 113.87 (d, JP-P = 43.5 
Hz) ppm. 
 
MS(Cation) (SIMS): m/z = 995.2 
for: C54H48IrN2OP2 [Ir(COD)(L7)]+ (calc.: 995.1) 
 
MS(Anion) (SIMS): m/z = 279.9 
for: C2F6NO4S2 [NTf2]- (calc.:279.9) 
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4.2.2 General procedures for catalytic reactions 
 
4.2.2.1 Rh-catalysed asymmetric hydrogenation of olefines 
 
The preparation of the reaction was carried out under inert gas. In a 10 mL stainless 
steel autoclave with glass inlet and magnetic stirrer 1 mmol of the substrate was 
placed and degassed under reduced pressure. 2 mL of a stock solution of the 
[Rh(COD)(PP*)][NTf2] complex (0.5µM, dried and degassed dichloromethane) were 
added. The mixture was stirred for 15 min, than pressurised with 10 bar of hydrogen. 
After 1 h of stirring at room temperature the reaction was stopped by a careful 
release of the hydrogen pressure. The solution was filtered over silica (eluent: DCM) 
and analysed via GC (conditions  chapter 4.1.7) and 1H-NMR.  
In case of substrate D the described procedure is not suitable. The retention times of 
the observed enantiomers are overlapping with the retention time of DCM and the 
products are too volatile to be separated from the solvent. The procedure was 
performed placing the solid Rh-complex (3.89 mmol) in the autoclave adding neat 
substrate (3.89 mmol, 0.5 mL) without any additional solvent. This mixture was stirred 
for 15 min and pressurised with 15 bar of hydrogen. After 1 h of stirring at room 
temperature the reaction was stopped by a careful release of the hydrogen pressure. 
Conversion was analysed via NMR and enantiomeric excess was determined via GC 
analysis of the gas phase over the reaction mixture. 
 
A) Dimethyl 2-methylsuccinate 
 
 
 
CAS-Nr.: (R) [22644-27-5], (S) [63163-08-6], (rac) [41771-07-7] 
1H-NMR (300 MHz, CDCl3): δ = 3.69 (s, 3H, CO2CH3), 3.67 (s, 3H, CO2CH3), 2.99-
2.84 (m, 1H), 2.74 (dd, J =8.1 Hz, J =16.5 Hz, 1H), 2.39 (dd, J = 6.0 Hz, J = 16.5Hz, 
1H), 1.21 (d, J = 7.1 Hz, 3H, CH3) ppm. 
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B) Methyl 2-acetamidopropanoate 
 
 
 
CAS-Nr.: (R) [19914-36-4], (S) [3619-02-1], (rac) [26629-33-4] 
1H-NMR (300 MHz, DMSO-d6): δ = 1.37 (d, J = 7.3 Hz, 3H), 1.98 (s, 3H), 3.72 (s, 
3H), 4.56 (q, J = 7.3 Hz, 1H), 6.26 (br. s, 1H, NH) ppm. 
 
C) Methyl 2-acetamido-3-phenylpropanoate 
 
 
 
CAS-Nr.: (S) [3618-96-0] 
1H-NMR (300 MHz, CDCl3): δ = 1.98 (s, 3H), 3.07 (m, 1H), 3.16 (m, 1H), 3.73 (s, 3H, 
CH3), 4.95 (m, 1H), 6.44 (d, J = 7.7 Hz, 1H, NH), 7.09-7.20 (m, 2H, Ar), 7.22-7.37 (m, 
3H, Ar) ppm. 
 
 
D) 1,1,1-trifluoropropan-2-yl acetate 
 
 
 
 
1H-NMR (400 MHz, CDCl3): δ = 1.32 (d, 3H, J = 6.6 Hz, CHCH3); 2.06 (s, 3H, 
CH3COO); 5.23 (h, 1H, J = 6.6 Hz, CH) ppm. 
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4.2.2.2 Ir-catalysed asymmetric hydrogenation of 2-sbstituted quinolines 
 
The preparation of the reaction was carried out under inert gas. A solution of the 
ligand (0.011 mmol) in toluene (1.5 mL) was added dropwise to a solution of 
[Ir(COD)Cl]2 (3.4 mg, 0.005 mmol, 0.01 mmol Ir) in toluene (1.5 mL). After 30 min of 
stirring iodine (12.6 mg, 0.05 mmol) was added and the mixture was stirred again for 
10 min. In case of a liquid substrate (1 mmol) it was added directly to the mixture 
before the mixture was placed in a 10 mL autoclave with glass inlet and magnetic 
stirrer. A solid substrate was provided and degassed in the autoclave before. The 
autoclave was pressurised with 40 bar of hydrogen and stirred at room temperature 
for the stated time. The reaction was stopped by a careful release of the hydrogen 
pressure and a sample for NMR (ca 0.3 mL) analysis was taken. The rest of the 
mixture was diluted with DCM, and extracted with NaHCO3(aq), then extracted from 
the NaHCO3(aq)-phase with DCM. The collected organic phases were dried over 
sodium sulphate and filtrated. The solvent was removed under reduced pressure and 
the residue was analysed via GC or HPLC.  
 
A) 2-methyl-1,2,3,4-tetrahydroquinoline 
 
 
 
CAS-Nr.: (R)-(+) [63430-95-5], (S)-(–) [200125-70-8], (rac) [50830-46-1] 
1H-NMR (300 MHz, CDCl3): δ = 1.13 (δ, J = 6.4 Hz, 3H, CH3), 1.51 (m, 1H), 1.85 (m, 
1H), 2.71 (m, 2H), 3.32 (m, 1H), 3.61 (b, 1H, NH), 6.39 (m, 1H, Ar), 6.52 (m, 1H, Ar), 
6.88 (m, 2H, Ar) ppm. 
 
 
B) 2-butyl-1,2,3,4-tetrahydroquinoline 
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CAS-Nr.: (R)-(+) [608525-21-9], (S)-(–) [769121-83-7], (rac) [123612-55-5] 
1H-NMR (300 MHz, CDCl3): δ = 0.96 (t, J = 6.8 Hz, 3H, CH3), 1.27-1.73 (m, 7H), 1.99 
(m, 1H), 2.80 (m, 2H), 3.27 (m, 1H), 3.79 (br, 1H, NH), 6.50 (m, 1H, Ar), 6.62 (m, 1H, 
Ar), 6.98 (m, 2H, Ar) ppm. 
 
C) 2-phenyl-1,2,3,4-tetrahydroquinoline 
 
 
 
CAS-Nr.: (R)-(-) [769121-85-9], (S)-(+), (rac) [50830-46-1] 
1H-NMR (300 MHz, CDCl3): δ = 2.02 (m, 1H, CH2), 2.15 (m, 1H, CH2), 2.76 (m, 1H, 
CH2), 2.96 (m, 1H, CH2), 4.06 (br. s, 1H, NH), 4.48 (dd, J = 3.3 Hz, 9.2 Hz, 1H, CH), 
6.57 (m, 1H, Ar), 6.68 (m, 1H, Ar), 7.03 (m, 2H, Ar), 7.15-7.47 (m, 5H, Ar) ppm. 
 
 
4.2.2.3 Ir-catalysed asymmetric hydrogenation of (E)-N-(1-phenylethylidene)aniline 
 
The preparation of the reaction was carried out under inert gas. 
-in situ catalyst: 
In a schlenk flask [Ir(COD)Cl]2 (0.0005 mmol, 0.33 mg) and the ligand (0.001 mmol) 
were stirred in DCM (2 mL) for 30 min. AgNTf2 (0.001 mmol, 0.25 mg) and I2 (0.01 
mmol, 1.3 mg) were added and the mixture was stirred for 15 min. The solution was 
placed in a 10 mL autoclave with glass inlet, magnetic stirrer and (E)-N-(1-
phenylethylidene)aniline (1 mmol, 192 mg) and pressurised with 30 bar of hydrogen. 
After stirring for 20 h at 40 °C the reaction was stopped by a careful release of the 
hydrogen pressure. The solution was filtered over silica (eluent: DCM). Conversion 
and enantiomeric excess were determined via NMR and GC analysis. 
-with preformed complex: 
In a schlenk flask [Ir(COD)(PP*)][NTf2] (0.001 mmol) and I2 (0.01 mmol, 1.3 mg) were 
stirred in DCM (2 mL) for 15 min. The solution was placed in a 10 mL autoclave with 
glass inlet, magnetic stirrer and (E)-N-(1-phenylethylidene)aniline (1 mmol, 192 mg) 
and pressurised with 30 bar of hydrogen.  After stirring for 20 h at 40 °C the reaction 
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was stopped by a careful release of the hydrogen pressure. The solution was filtered 
over silica (eluent: DCM). Conversion and enantiomeric excess were determined via 
NMR and GC analysis. 
 
A) N-(1-phenylethyl)aniline 
 
HN
Ph
Ph
 
 
CAS-Nr.: (rac) [76716-27-3] 
1H-NMR (400 MHz, CDCl3): δ = 1.44 (d, J = 6.5 Hz, 3H, CH3), 3.95 (b, 1H, NH), 4.41 
( q, J = 13.34 Hz, 1H, CH), 6.43 (d, J = 7.5 Hz, 2H, Ar,CH), 6.56 (t, J = 7.5 Hz, 1H, 
Ar,CH), 7.01 (t, J = 7.5 Hz, 2H, Ar,CH), 7.12-7.32 (m, 5H, Ar,CH) ppm. 
 
4.2.2.4 Ru-catalysed asymmetric hydrogenation of keto ester 
 
The preparation of the reaction was carried out under inert gas. [RuCl2(p-cymene)]2 
(0.005 mmol, 2.9 mg) and the ligand (0.01 mmol) were stirred in a schlenk flask in 
toluene (1 mL) at 80 °C for 1 h. The solvent was removed under reduced pressure 
und the residue was taken up in methanol (2 mL). The substrate (1 mmol) was 
placed and degassed in a 10 mL autoclave with glass inlet and magnetic stirrer. 
Then, the catalyst solution was placed in the reactor, the mixture was stirred for 15 
min and pressurised with 60 bar of hydrogen. After a reaction time of 16 h at 60 °C 
the mixture was cooled down to room temperature and the hydrogen pressure was 
carefully released. The solvent was removed under reduced pressure and the 
residue was taken up in DCM. This solution was filtered over silica and analysed via 
NMR and GC.  
 
A) Methyl 3-hydroxypentanoate 
 
 
 
CAS-Nr.: (R)-(-) [60793-22-8], (S)-(+) [42558-50-9]  
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1H-NMR (300 MHz, Aceton-d6): δ = 0.93 (t, 3H, CH3), 1.47 (m, 2H, CH2), 2.39 (m, 2H, 
CH2), 3.62 (s, 3H OCH3), 3.77 (br, 1H, OH), 3.89 (br, CH) ppm. 
 
4.2.2.5 Pd-catalysed hydrophosphorylation of styrene 
 
The reaction was carried out under inert gas. A dioxane solution (1 mL) of 
[CpPd(allyl)] (17.5 µmol, 3.7 mg), the ligand (19.25 µmol), pinacol H-phosphonate 
(0.35 mmol, 57.45 mg), and styrene (0.7 mmol, 0.08 mL) was placed in a closed 
microwave vessel with magnetic stirrer. The mixture was stirred and heated up in the 
microvawe to 100 °C for 8 h. The solvent was removed under reduced pressure and 
the residue was analysed via GC and 31P-NMR.  
 
A) 4,4,5,5-Tetramethyl-2-(2-phenylethyl)1,3,2-dioaphospholane 2-oxide (linear) 
     4,4,5,5-Tetramethyl-2-(1-phenylethyl)1,3,2-dioaphospholane 2-oxide (branched) 
     
 
 
31P-NMR (125 MHz, CDCl3): δ = 40.88 (b, linear product), 41.55 (b, branched 
product) 
 
4.2.2.6 Rh-catalysed hydroformylation of styrene 
 
The preparation of the reaction was carried out under inert gas. In a schlenk tube the 
ligand (8 µmol) was mixed with a stock solution of [Rh(acac)(CO)2] (2 µmol in 2 mL 
toluene) and styrene (2 mmol, 0.22 mL). After stirring for 30 min the mixture was 
transferred into a 10 mL autoclave with glass inlet and magnetic stirrer. It was 
pressurised with 40 bar CO/H2 and stirred for 16 h at 60 °C. At room temperature the 
pressure was carefully released and the solution was filtered over silica (eluent: 6 mL 
toluene). This mixture was analysed by NMR and GC. 
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A) 3-phenylpropanal (linear), 2-phenylpropanal (branched) 
 
 
 
linear: 
1H-NMR (400 MHz, toluene): δ = 2.80 (t, 4H, CH2), 7.10 (m, 5H, Ar, CH), 9.50 (s, 1H, 
CHO) ppm. 
branched: 
1H-NMR (400 MHz, toluene): δ = 1.39 (b, 3H, CH3), 3.28 (q, 1H, CH), 7.10 (m, 5H, Ar, 
CH), 9.55 (s, 1H, CHO) ppm. 
 
4.2.2.7 Kinetic measurements: Rh-catalysed asymmetric hydrogenation of  
            dimethyl 2-methylsuccinate 
 
51 (5.0 mmol, 791.0 mg) was degassed in a 10 mL steel autoclave with glass inlet 
and magnetic stirrer under reduced pressure. A stock solution of a 
[Rh(COD)(PP*)][NTf2] complex (2 mL, 0.5µM in DCM) was added and stirred for 30 
min while the temperature was maintained via a cryostate at 20 °C. This temperature 
was kept constant during the whole procedure. The mixture was pressurised with 15 
bar of hydrogen and the hydrogen consumption was observed via Labview. Data 
acquisition was stopped when a constant pressure was reached. The raction mixture 
was treated and analysed in the same way described before (4.2.2.1). The obtained 
data was used to calculate the average turnover frequency (TOF) and the initial 
turnover frequency (TOFinit.) using Excel. 
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6 Appendices 
 
6.1 Abbreviations 
 
[α]D20   optical rotation  
Å   Ångström 
acac   acetylacetonate 
b   broad 
BINAP  2,2’-Bis(diphenylphosphino)-1,1’-binaphthyl 
BINOL  1,1’-Bi-2-naphthol 
BuLi   Buthyl-lithium 
C   catalyst 
cod   1,4-cyclooctadiene 
DCM   dichloromethane 
DFT   density functional theory 
DMAP  4-dimethylaminopyridine 
DMSO  dimethylsulfoxide 
δ   chemical shift 
ee   enantiomeric excess 
Et   ethyl 
eq   equivalent 
FID   flame ionisation detector 
GC   gas chromatography 
h   hour(s) 
HPLC  high performance liquid chromatography 
HR-MS high resolution mass spectroscopy 
Hz   Hertz 
IR   infrared 
J   coupling constant 
L   ligand 
M   Molar 
m   multiplet 
Me   methyl 
min   minute(s) 
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MS   mass spectroscopy 
NMP   N-methyl pyrollidone 
NMR   nuclear magnetic resonance 
NOBIN  2'-amino-1,1'-binaphthyl-2-ol 
Ph   phenyl 
ppm   parts per million 
q   quartet 
rf   retention factor 
RT   room temperature 
s   singlet 
S   substrate 
t   time 
t   triplet 
T   temperature 
Tf   trifluormethanesulfonyl 
THF   tetrahydrofurane 
TLC   thin layer chromatography 
TMEDA  N,N,N,N-tetramethylethylene diamine 
TOF   turnover frequency (during reaction time) 
TOFinit  initial turnover frequency 
TON   turnover number 
z   charge 
*   symbol for a stereogenic centre 
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6.2 Crystal structure data for ligand L6 
 
 
 
 
 
Empirical formula C46H35N2OP2 
Mr (g mol-1) 693.73 
Crystal system orthorhombic 
Space group P212121 
a (Å) 9.0686(7) 
b (Å) 17.5384(13) 
c (Å) 22.3664(17) 
α (°) 90 
β (°) 90 
γ (°) 90 
V (Å3) 3557.3(5) 
Z 4 
Dcalc (g cm−3) 1.297 
T (K) 143(2) 
µ(Mo Kα) (mm−1) 0.71073 
F(000) 1456 
θ Range (°) 1.48 – 30.52 
Number of reflections collected 53496 
Number of reflections observed [I > 2σ (I)] 7928 
Number of independent reflections (Rint) 10232 
Data/restraints/parameters 10232 / 0 / 463 
Goodness-of-fit on F2 0.701 
R1, wR2 [I> 2σ (I)] 0.0472 
R1, wR2 (all data) 0.1294 
Largest difference peak and hole (e Å-3) 0.364 and -0.280 
Flack parameter -0.01(7) 
 
6 Appendices 144 
6.3 Curriculum Vitae 
 
Personal data: 
 
Name    Anika Meppelder, born Thomas 
Date of birth   14.02.1982 
Place of birth  Düsseldorf, Germany 
Nationality   German 
 
 
Education: 
 
1988-1992   Elementary school: Gemeinschaftsgrundschule Ahe 
1992-2001   Grammar school: Gutenberg-Gymnasium Bergheim 
2001-2008  Studies for diploma degree in Chemistry, RWTH Aachen 
University 
2008    Diploma in Chemistry 
2008-2011  Dissertation at the ITMC, RWTH Aachen University under the 
supervision of Prof. Dr. W. Leitner 
since 11-2011 Chemical development engineer at SABIC Limburg B. V. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 Appendices 145 
6.4 Acknowledgements 
 
First of all, I thank Prof. Dr. Walter Leitner for his support and for giving me the 
opportunity to work in his group. Furthermore, I would like to thank Prof. Dr. Carsten 
Bolm for being my second examiner and Prof. Dr. Marcel Liauw and Prof. Dr. 
Wolfgang Stahl for being part of the promotion committee. I thank my subgoup-leader 
Dr. Giancarlo Franciò for continuous discussions and support with respect to the 
experimental work. 
 
All members of the team and especially my lab colleagues Wenjing Li, Jens 
Langanke and Mike Schmitkamp, I want to thank for the nice and supportive 
atmosphere. My research student Fabian Langensiepen and my trainees Kevin 
Göbbels and Marcel Gerhards I would like to thank for their valuable contributions to 
the experimental part, as well as Andreas Uhe for performing the DFT calculations. 
Ines Bachmann-Remy (NMR), Hannelore Eschmann and Julia Wurlitzer (GC), 
Brigitte Pütz ((HR)MS) and the group of Prof. Dr. Uli Englert (X-ray), I thank for the 
performance of numerous analyses – without their effort this thesis would not exist. 
 
Last but not least, I would like to thank my family for their support over the last years 
and especially my husband Geert-Jan for reading and correcting my thesis and for 
his love. 
 
